syndrome	score	normalized_score
DRAVET SYNDROME	2.6655187000000002	100.0
CHILDHOOD ABSENCE EPILEPSY	2.52074085	94.56849242888448
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1	2.02066968	75.80774728761047
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.0	75.03230046744747
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.31953969	49.50404924940125
MYOCLONIC-ASTASTIC EPILEPSY	1.2192351540000002	45.741009207701296
DIGEORGE SYNDROME; DGS	1.2132820729999998	45.51767252655176
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.782803437094614
NORRIE DISEASE	1.0536243989999998	39.527931242800875
ISOTRETINOIN-LIKE SYNDROME	1.03301453	38.75472830109952
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	1.019834649	38.26026990544092
ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE	1.0119048	37.96277249902617
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.000541419	37.53646219026713
BROWN SYNDROME	1.0	37.516150233723735
EHLERS-DANLOS SYNDROME, TYPE I	1.0	37.516150233723735
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.516150233723735
STRABISMUS, SUSCEPTIBILITY TO	1.0	37.516150233723735
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.056619936674984
LAFORA DISEASE	0.7715289599999999	28.94479637302863
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.91058689627651
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.7621951	28.59462587900809
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.748578964	28.083800875229276
EARLY MYOCLONIC ENCEPHALOPATHY	0.7087289139999999	26.588780412607864
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.7015659139999999	26.320052228483704
W SYNDROME	0.618698804	23.211197280289195
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59274141	22.237375787309237
ROLANDIC EPILEPSY	0.5906213	22.15783742203722
PALLISTER-HALL SYNDROME	0.586854744	22.016530741277485
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.5583152840000001	20.94584007232814
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.84230735278653
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.550936494	20.669016278145037
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.55092596	20.668621083018476
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.5424316290000001	20.3499464850875
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.53954418	20.241620514611284
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.5338703539999999	20.02876040599527
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.77202410922872
GABRIELE-DE VRIES SYNDROME	0.52335864	19.634401364357338
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.52282005	19.614195541002953
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.516847064	19.390112100883027
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.5121951	19.215588320577154
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.50969036	19.121620118440735
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.50969036	19.121620118440735
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.50740741	19.035972623264655
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.02227322584531
PAROXYSMAL HEMICRANIA	0.50621118	18.991094678870567
SSR4-CDG	0.504375733	18.922235773472533
RESTRICTIVE DERMOPATHY	0.50297619	18.869730308025975
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.501790884	18.825262190057042
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.501086973	18.798854159229872
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.500541419	18.778387073405263
CREST SYNDROME	0.5	18.758075116861868
FRAXE INTELLECTUAL DISABILITY	0.5	18.758075116861868
BRANCHIOOTORENAL SYNDROME 1	0.5	18.758075116861868
INHALATIONAL ANTHRAX	0.5	18.758075116861868
613241 PSEUDOPILI ANNULATI	0.5	18.758075116861868
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.758075116861868
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.758075116861868
LEBER CONGENITAL AMAUROSIS, TYPE II	0.5	18.758075116861868
LEBER CONGENITAL AMAUROSIS, TYPE I	0.5	18.758075116861868
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.4816883	18.07109062862699
21Q22.11Q22.12 MICRODELETION SYNDROME	0.46584713899999997	17.476791252674385
C SYNDROME	0.453780829	17.024109753947698
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.4536205199999999	17.01809557741988
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.443672114	16.644869683337802
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.43830405	16.44348058784956
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.434614804	16.305074280664396
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.43355804899999995	16.265428901324157
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42149728000000003	15.81295527958592
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.417133064	15.649226696477497
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.41374257899999994	15.522028751852309
SPINOCEREBELLAR ATAXIA TYPE 10	0.40889129999999996	15.3400274400626
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.39775455	14.92221945394718
PLACENTAL INSUFFICIENCY	0.3887161	14.58313160586718
ELSAHY-WATERS SYNDROME; ESWS	0.37703802399999997	14.145015152210336
CANAVAN DISEASE	0.37037	13.894856562064259
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.369922354	13.878062607476735
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.676884352752804
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.412686243769361
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.412686243769361
CENTRALOPATHIC EPILEPSY	0.3547009	13.30701225243702
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.35371573	13.270052466711263
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.352174819	13.212243418138463
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.352121464	13.210241743942744
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.35148571	13.186390701367054
COG4-CDG	0.349340884	13.105925086925858
PSEUDOAMINOPTERIN SYNDROME	0.348584454	13.077546745404561
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.34755226399999994	13.038822950294811
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.346659854	13.005343162664737
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.3459912	12.980257838746356
OROFACIODIGITAL SYNDROME TYPE 3	0.3455281	12.96288410957312
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3448273	12.936592791489327
ACITRETIN/ETRETINATE EMBRYOPATHY	0.34249279	12.849010963607194
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.34113168	12.79794735636257
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.769569014841275
CONGENITAL ENTEROVIRUS INFECTION	0.33532646000000005	12.580157850702756
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.335165554	12.574121277033246
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	0.33462	12.553654191208635
SPINOCEREBELLAR ATAXIA TYPE 42	0.33457833	12.552090893228396
PALLISTER-HALL SYNDROME	0.334419973	12.546149948225835
EPIDERMAL NEVUS SYNDROME	0.333878554	12.525837991682442
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.333874419	12.525682862401228
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.505370905857834
NON-INVOLUTING CONGENITAL HEMANGIOMA	0.333333	12.505370905857834
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.505370905857834
PELVIC DYSPLASIA-ARTHROGRYPOSIS OF LOWER LIMBS SYNDROME	0.333333	12.505370905857834
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.333333	12.505370905857834
RAPIDLY INVOLUTING CONGENITAL HEMANGIOMA	0.333333	12.505370905857834
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO CD3DELTA/CD3EPSILON/CD3ZETA	0.333333	12.505370905857834
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.333333	12.505370905857834
NEUROMYELITIS OPTICA	0.333333	12.505370905857834
CHROMOSOME 16P13.3 DELETION SYNDROME	0.315486733	11.835847671974689
PEHO SYNDROME	0.30483668399999997	11.436298833694169
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.30358739999999995	11.38943050746558
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	11.302918790252717
AL KAISSI SYNDROME; ALKAS	0.294901293	11.063561212307382
CHROMOSOME 17Q12 DELETION SYNDROME	0.29488410000000004	11.062916197136415
INFANTILE MYOFIBROMATOSIS	0.29346490000000003	11.009673276724714
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.28834590000000004	10.817628103678283
HYPERTRICHOSIS CUBITI	0.28833898399999996	10.817368641983263
MILLER-DIEKER SYNDROME	0.285768719	10.720942194102783
WEST SYNDROME	0.2822581	10.589237284285419
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.281718684	10.569000472590943
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.27791268399999997	10.42621400480139
TUFTED ANGIOMA	0.27633168	10.366900821217273
TUBEROUS SCLEROSIS COMPLEX	0.2734533	10.258915084707528
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.27066968	10.15448437859393
MARFAN SYNDROME; MFS	0.27066968	10.15448437859393
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.267678154	10.042253839749838
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.26676428399999996	10.007968955535745
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.266062384	9.981636369686694
ROBERTS SYNDROME	0.265199854	9.949277564625602
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.26385092	9.898670754026224
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.2611111	9.795883255292862
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.258465073	9.696614508838373
SLC35A2-CDG	0.258351184	9.692341832004404
ALLAN-HERNDON-DUDLEY SYNDROME	0.25816384	9.685313406355016
CHROMOSOME 1P36 DELETION SYNDROME	0.25542907299999995	9.582715476728785
ROBERTS SYNDROME; RBS	0.25373262	9.519071091116336
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.25258484899999994	9.476011141846422
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.252332303	9.466536588169499
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.25184340299999997	9.44819494232023
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.251086973	9.419816600798935
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.25106438000000003	9.418968998416705
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.250545554	9.399504644255543
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.25	9.379037558430934
SEVERE HEMOPHILIA A	0.25	9.379037558430934
TERMINAL OSSEOUS DYSPLASIA; TOD	0.25	9.379037558430934
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.379037558430934
AMERICAN TRYPANOSOMIASIS	0.25	9.379037558430934
DYSTONIA 6, TORSION	0.25	9.379037558430934
HYPERPARATHYROIDISM 2	0.25	9.379037558430934
HEMOPHILIA B	0.25	9.379037558430934
HYPEREKPLEXIA 1; HKPX1	0.25	9.379037558430934
CONGENITAL FACTOR II DEFICIENCY	0.25	9.379037558430934
ASCHER SYNDROME	0.25	9.379037558430934
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.25	9.379037558430934
SPINOCEREBELLAR ATAXIA TYPE 37	0.25	9.379037558430934
TETANUS	0.25	9.379037558430934
TRICHOTHIODYSTROPHY	0.246813564	9.259494746744789
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.245542003	9.211790673237445
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.243045154	9.118118511042523
JUVENILE MYOCLONIC EPILEPSY	0.2427134	9.105672378137882
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.23450832900000004	8.797849701823516
LENNOX-GASTAUT SYNDROME	0.23257130999999998	8.725180206013935
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915	8.475991933577506
POLYARTERITIS NODOSA	0.2208333	8.284815259408983
JUVENILE HYALINE FIBROMATOSIS	0.22	8.253553051419223
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.217977493	8.177676374958464
CRI-DU-CHAT SYNDROME	0.21634583000000002	8.116462660719655
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.21422171	8.0367738556852
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.21391433	8.025242141426357
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.212824219	7.984345373378922
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.21217786300000002	7.960096584578453
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.211050643	7.917807629711995
SAY-BARBER-MILLER SYNDROME	0.20870939400000002	7.82997298049344
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.20840336	7.818491762972812
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.20740741000000001	7.781127553147535
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.20621118000000002	7.7362496087534485
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2051883	7.697875089002376
BROOKE-SPIEGLER SYNDROME	0.203704	7.64218986721046
TRANSALDOLASE DEFICIENCY	0.203521744	7.635352323733463
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.20128700000000002	7.551513332095551
6P22 MICRODELETION SYNDROME	0.20124533	7.5499500341153105
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.20054555400000001	7.523697132569357
ROMANO-WARD SYNDROME	0.200541419	7.52354200328814
EPISODIC ATAXIA, TYPE 4	0.2	7.503230046744748
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.2	7.503230046744748
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	7.503230046744748
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.503230046744748
BENIGN SCHWANNOMA	0.2	7.503230046744748
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.2	7.503230046744748
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.2	7.503230046744748
BETA-THALASSEMIA	0.2	7.503230046744748
MALARIA	0.2	7.503230046744748
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.2	7.503230046744748
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	7.503230046744748
UNILATERAL POLYMICROGYRIA	0.19654492	7.373608746395213
AICARDI SYNDROME; AIC	0.19611683000000002	7.357548457641659
PHACE SYNDROME	0.195640933	7.339694634293879
ESOPHAGEAL ATRESIA	0.18909610000000002	7.094157696211248
SMITH-LEMLI-OPITZ SYNDROME	0.18422622300000002	6.911458659059493
PITYRIASIS RUBRA PILARIS	0.18333370000000002	6.877974632104437
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.182697903	6.854121976334286
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.18264054899999999	6.851970275053781
PHELAN-MCDERMID SYNDROME	0.182255733	6.8375334601854405
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.181657503	6.815090173631121
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.181285814	6.801145833266897
MYOCLONIC EPILEPSY OF INFANCY	0.181285814	6.801145833266897
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.18123607300000003	6.799279742438123
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.18112029899999998	6.794936347660963
RETT SYNDROME, CONGENITAL VARIANT	0.180907019	6.786934903139115
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.18012683400000004	6.757665365469018
SCALP-EAR-NIPPLE SYNDROME	0.17777810000000002	6.669549907865963
WRINKLY SKIN SYNDROME	0.17562958399999998	6.588945858830401
MUCOLIPIDOSIS TYPE II	0.17536141000000002	6.578885002757624
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.17416518000000003	6.534007058363538
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.17407418300000002	6.53059320124072
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.172472984	6.47052237900263
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.172193074	6.460021233390709
WAARDENBURG SYNDROME	0.17204334000000002	6.454403790151613
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.17142993899999998	6.431391346082095
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.17072376	6.404898228626195
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.16996733	6.376519887104899
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.169797403	6.370144880244134
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.16954730999999998	6.36076235368373
HYPOPHOSPHATASIA, INFANTILE	0.168495419	6.32129945289823
LAMB-SHAFFER SYNDROME	0.168457884	6.319891284199206
GRANULOMATOSIS WITH POLYANGIITIS	0.167208419	6.273016167547427
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.167208419	6.273016167547427
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.167208419	6.273016167547427
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	6.252704211004034
SOLAR URTICARIA	0.166667	6.252704211004034
SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2	0.166667	6.252704211004034
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	6.252704211004034
CEREBROOCULONASAL SYNDROME	0.166667	6.252704211004034
OROMANDIBULAR DYSTONIA	0.166667	6.252704211004034
PEMPHIGUS VULGARIS	0.166667	6.252704211004034
FAMILIAL REACTIVE PERFORATING COLLAGENOSIS	0.166667	6.252704211004034
DERMATOLEUKODYSTROPHY	0.166667	6.252704211004034
PHLEBECTASIA OF LIPS	0.166667	6.252704211004034
PFAPA SYNDROME	0.166667	6.252704211004034
247150 LIP PRINTS	0.166667	6.252704211004034
%155050 MAXILLONASAL DYSPLASIA, BINDER TYPE;;BINDER SYNDROME	0.166667	6.252704211004034
XANTHOMA DISSEMINATUM	0.166667	6.252704211004034
MAXILLONASAL DYSPLASIA	0.166667	6.252704211004034
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.166667	6.252704211004034
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.16636041399999998	6.241202284568477
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1658174	6.220830489765462
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.164156114	6.15850543460828
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.161277634	6.050515946483511
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.984039804335269
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.984039804335269
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.15856221399999998	5.948643841815852
DE BARSY SYNDROME	0.158388154	5.942113780706172
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.15732748999999996	5.902321750734667
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.15633160000000001	5.864959791878406
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.15543832999999999	5.831447740359127
COFFIN-SIRIS SYNDROME 1; CSS1	0.154715353	5.8043244266116005
RESTRICTIVE DERMOPATHY, LETHAL	0.15423654999999997	5.786361581331242
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.15290564	5.736430961823678
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.14880960000000001	5.582763309820336
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14829852000000002	5.563589555758885
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.146756653	5.505744641746463
EHLERS-DANLOS SYNDROME, TYPE VI	0.14664487999999998	5.501551349086388
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.14639494400000003	5.4921747125615745
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.146189729	5.484475835791359
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.14470040299999998	5.4286020578283685
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.14370946900000003	5.391426029012665
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.14361343	5.387823015460367
GANGLIONEUROMA	0.14285699999999998	5.3594446739390715
HEREDITARY THROMBOPHILIA DUE TO CONGENITAL ANTITHROMBIN DEFICIENCY	0.14285699999999998	5.3594446739390715
CONGENITAL FACTOR XIII DEFICIENCY	0.14285699999999998	5.3594446739390715
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	5.3594446739390715
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.14285699999999998	5.3594446739390715
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.3594446739390715
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.1424031	5.3424160933479845
AICARDI SYNDROME	0.14091214	5.286481013995512
PETERS-PLUS SYNDROME; PTRPLS	0.139796233	5.244616479336647
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.13905376299999997	5.216761863272614
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.138613184	5.200233035318791
YUNIS-VARON SYNDROME	0.13793471000000002	5.174779302805117
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.13756670399999998	5.160973134422203
COG8-CDG	0.13404542899999997	5.028868452507948
SCHINZEL-GIEDION SYNDROME	0.1337536	5.017920151901391
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.970090811968417
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.13187475	4.94743293303476
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.131064923	4.917051341639434
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.13076913999999998	4.905954702174851
LISSENCEPHALY, X-LINKED, 2	0.130296759	4.888232785611296
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.129079114	4.842551432859953
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.12802738400000002	4.80309457217464
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.12683255400000001	4.75826915039088
PHENYLKETONURIA	0.126297849	4.738209077280155
DILATED CARDIOMYOPATHY WITH ATAXIA	0.125541419	4.709830735758859
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.125541419	4.709830735758859
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.12536701000000003	4.703287581512748
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.125	4.689518779215467
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.125	4.689518779215467
CENTRAL PRECOCIOUS PUBERTY	0.125	4.689518779215467
THORACOLARYNGOPELVIC DYSPLASIA	0.125	4.689518779215467
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.125	4.689518779215467
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.12315085399999999	4.6201459400753775
YUNIS-VARON SYNDROME	0.12233505400000001	4.5895402647147066
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.122036019	4.578321622729565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.120915814	4.536295843656996
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.119047944	4.46622055211993
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.118471824	4.444606747647278
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.118333664	4.4394235163309865
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.4326550776027185
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.11778424	4.418811243004972
ZIMMERMANN-LABAND SYNDROME	0.11714692899999998	4.394901787783367
INTESTINAL LYMPHANGIECTASIA	0.11666670000000001	4.376885444472778
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.1166667	4.376885444472777
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.11625473299999999	4.36143002860944
COG1-CDG	0.11511466000000001	4.318658878664029
STEINERT MYOTONIC DYSTROPHY	0.11492704000000001	4.311620098557178
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.11476995000000001	4.305726686516962
RAMOS-ARROYO SYNDROME	0.11438209000000002	4.29117567248731
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.11419973299999998	4.284334339879138
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.11344330299999998	4.255955998357842
WARBURG MICRO SYNDROME 1	0.11315442999999999	4.245118595491375
BILATERAL POLYMICROGYRIA	0.113135344	4.244402562248015
FEMORAL-FACIAL SYNDROME	0.11267177	4.227011050419567
OKAMOTO SYNDROME	0.112412984	4.2173023959651825
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.112412984	4.2173023959651825
MICROCEPHALY, AUTOSOMAL DOMINANT	0.11186742999999999	4.196835310140573
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.11186742999999999	4.196835310140573
311450 PALLISTER W SYNDROME;;W SYNDROME	0.11165241899999999	4.1887689251626705
8Q22.1 MICRODELETION SYNDROME	0.111446984	4.1810617948394055
FACIAL HYPERTRICHOSIS	0.11111099999999999	4.168456968619277
PORPHYRIA CUTANEA TARDA	0.11111099999999999	4.168456968619277
FOVEAL HYPOPLASIA 2; FVH2	0.11111099999999999	4.168456968619277
COMPLEX REGIONAL PAIN SYNDROME	0.11111099999999999	4.168456968619277
DYSTONIA 16; DYT16	0.11111099999999999	4.168456968619277
TURCOT SYNDROME WITH POLYPOSIS	0.11111099999999999	4.168456968619277
HENNEKAM-BEEMER SYNDROME	0.10999225900000001	4.126486113190652
ADNP SYNDROME	0.109367129	4.103033642195044
TRISOMY 8P	0.10830225900000001	4.063083819295659
TRICHOHEPATOENTERIC SYNDROME 1	0.1076219	4.037559368838793
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.10711848400000001	4.018673138552733
GITELMAN SYNDROME	0.10684260000000001	4.008323032961652
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000002	4.005181580605681
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.1036789	3.8896331884672204
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.101287	3.7998983087231766
KAPOSIFORM LYMPHANGIOMATOSIS	0.1011629	3.795242554479171
BEHÇET DISEASE	0.100541419	3.7719269799157664
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.100541419	3.7719269799157664
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.10005725000000001	3.753762822973255
ACQUIRED ICHTHYOSIS	0.1	3.751615023372374
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.1	3.751615023372374
DRACUNCULIASIS	0.1	3.751615023372374
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.1	3.751615023372374
DISTAL MONOSOMY 17Q	0.09997898999999999	3.7508268090559627
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.09989777999999999	3.7477801224954823
NEUROFIBROMATOSIS TYPE 1	0.09957531900000001	3.735682627174966
PACHYDERMOPERIOSTOSIS	0.09903390000000001	3.7153706706315734
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310399999999	3.712339515757289
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185000000001	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185000000001	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185000000001	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185000000001	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185000000001	3.681154065810906
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.09628854300000002	3.6123754449743686
JUVENILE ABSENCE EPILEPSY	0.09540435	3.579203927550761
MICROFORM HOLOPROSENCEPHALY	0.094590439	3.548669120197881
WOLF-HIRSCHHORN SYNDROME	0.094271993	3.5367222522205526
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.092998703	3.4889533132894543
17Q23.1Q23.2 MICRODELETION SYNDROME	0.09268974999999999	3.4773625861262945
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.09260879000000002	3.474325278603373
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.092360884	3.4650247998635306
DUANE RETRACTION SYNDROME 1	0.09180788000000001	3.444278218719681
SCHAAF-YANG SYNDROME; SHFYNG	0.090934153	3.4114993453244202
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.09063145300000001	3.4001432066486723
DIABETIC EMBRYOPATHY	0.09042503	3.392399010368976
RHEUMATOID ARTHRITIS	0.0901315	3.381386894790871
DUANE-RADIAL RAY SYNDROME; DRRS	0.08755482000000002	3.2847197808066406
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.08746936000000001	3.2815136506076663
PROTEUS SYNDROME	0.08735504899999999	3.277225141958298
DDOST-CDG	0.08722609900000002	3.2723874343856605
8Q12 MICRODUPLICATION SYNDROME	0.08685504400000002	3.258466879260686
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.086750349	3.2545391259119656
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.08663363000000002	3.2501602783728365
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08645022000000001	3.243279441258469
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.08567275400000002	3.214111910000857
BECKWITH-WIEDEMANN SYNDROME	0.08532646	3.2011202922718196
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.08516585400000001	3.1950949734473824
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.08478267999999999	3.180719760097724
TOWNES-BROCKS SYNDROME 1; TBS1	0.08463528400000002	3.1751900296178754
CONGENITAL ANALBUMINEMIA	0.08413976000000001	3.156599876789459
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.08412700000000001	3.156121170712477
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.08408973000000002	3.1547229437932667
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.083159349	3.119818630422664
DISTAL TRISOMY 6P	0.08274840400000001	3.104401556064867
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.08245	3.093206586770522
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.082438049	3.092758231259079
MYASTHENIA GRAVIS; MG	0.0820434	3.07795252008549
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.08174838400000001	3.066884655508138
ACRORENAL-MANDIBULAR SYNDROME	0.0815508	3.059472064480358
EMANUEL SYNDROME	0.080886883	3.034564454565635
WILLIAMS SYNDROME	0.08071515	3.0281216935375466
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.080705203	3.027748520391172
WILLIAMS-BEUREN SYNDROME; WBS	0.08069420000000001	3.02733573019015
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.07950794900000001	2.9828321594592455
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.07906479999999999	2.96620691499932
ETHYLMALONIC ENCEPHALOPATHY	0.078751519	2.95445381793795
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.07870984900000001	2.9528905199577107
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.07835228400000001	2.939476057699389
DISTAL MONOSOMY 12Q	0.078127614	2.931047304226378
LEPRECHAUNISM	0.07767953000000001	2.9142369175650504
274210 THYMIC APLASIA WITH FETAL DEATH	0.0776316	2.9124387684843476
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.077574294	2.910288867979054
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.906325661868364
ISOLATED BILIARY ATRESIA	0.07746451900000001	2.906170532587147
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07711512999999999	2.893062802373136
SRD5A3-CDG	0.077070183	2.8913765639685813
DOORS SYNDROME	0.07695389400000001	2.887013848374052
DIABETES MELLITUS, TRANSIENT NEONATAL, 1; TNDM1	0.07692310000000001	2.8858585760437547
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.07692310000000001	2.8858585760437547
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	2.8858585760437547
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.8858585760437547
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	2.8858585760437547
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.07692310000000001	2.8858585760437547
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.07664749900000001	2.87551908752319
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.07641948	2.8669646924630463
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.8628236598002483
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.07627231	2.861443440633149
PIERPONT SYNDROME	0.07587871300000001	2.846677196449607
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.07569283	2.8397035818957113
WHITE-SUTTON SYNDROME; WHSUS	0.075502224	2.832552778564262
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.075371959	2.827665737254066
KABUKI SYNDROME	0.07531187900000001	2.825411766948024
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.07507006	2.816339649014655
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.07475133300000002	2.8043822389991115
MESOMELIC DWARFISM-CLEFT PALATE-CAMPTODACTYLY SYNDROME	0.07407411	2.7789754391893777
VACTERL/VATER ASSOCIATION	0.07369316000000001	2.7646836617578407
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.07366436	2.7636031966311094
NEU-LAXOVA SYNDROME	0.07291763999999999	2.735589136928583
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0726316	2.724858017315729
CAMPOMELIC DYSPLASIA	0.07216120999999999	2.7072107954072875
NEUROFACIODIGITORENAL SYNDROME	0.07216120999999999	2.7072107954072875
CAMPOMELIA, CUMMING TYPE	0.07216120999999999	2.7072107954072875
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	2.700193174409169
8Q24.3 MICRODELETION SYNDROME	0.07141473300000001	2.6792058521292685
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.07128904999999999	2.674490709819443
NON-DISTAL MONOSOMY 20Q	0.071164689	2.669825163860227
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.07105861399999999	2.6658456382241846
SCHWARTZ-JAMPEL SYNDROME	0.07057316000000001	2.6476332730286227
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.0705412	2.6464342568671526
YOU-HOOVER-FONG SYNDROME; YHFS	0.069274384	2.5989081974926678
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.069270249	2.5987530682114515
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.069214014	2.596643347503058
KEUTEL SYNDROME; KTLS	0.06901971900000001	2.5893541470933967
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.068999003	2.588576962525155
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5771231693103482
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.06863431	2.5748950851479675
ELLIS VAN CREVELD SYNDROME	0.06847153	2.568788206212922
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.068331244	2.5635252155612336
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.06795369999999999	2.5493612181373924
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.06795369999999999	2.5493612181373924
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.06791203	2.5477979201571537
CROSSED POLYSYNDACTYLY	0.06791203	2.5477979201571537
URBAN-ROGERS-MEYER SYNDROME	0.06791203	2.5477979201571537
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.06791203	2.5477979201571537
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.06791203	2.5477979201571537
MESOMELIC DWARFISM, REINHARDT-PFEIFFER TYPE	0.06791203	2.5477979201571537
RHIZOMELIC SYNDROME, URBACH TYPE	0.06780633	2.5438324630774485
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.067572879	2.535074280289236
LATHOSTEROLOSIS	0.06752875900000001	2.5334190677409243
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.06752204	2.5331669967275037
MENTAL RETARDATION, X-LINKED 98; MRX98	0.06742527300000001	2.529536671417837
OROFACIODIGITAL SYNDROME TYPE 5	0.06742313	2.529456274307886
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.06742313	2.529456274307886
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.06732760399999999	2.5258725065406584
ROSSELLI-GULIENETTI SYNDROME	0.067212254	2.521545018611199
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.067212254	2.521545018611199
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.06697726400000001	2.512729098467777
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.50107793278659
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.50107793278659
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.50107793278659
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.0666667	2.50107793278659
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.0666667	2.50107793278659
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.50107793278659
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.50107793278659
MEIGE DISEASE	0.0666667	2.50107793278659
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0666667	2.50107793278659
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.50107793278659
NIEVERGELT SYNDROME	0.0666667	2.50107793278659
FOCAL FACIAL DERMAL DYSPLASIA TYPE I	0.0666667	2.50107793278659
MECKEL SYNDROME, TYPE 1; MKS1	0.06604623000000001	2.477800287051072
NOONAN SYNDROME	0.06572950000000001	2.4659177967875445
15Q OVERGROWTH SYNDROME	0.065659989	2.463310011668648
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.06537123	2.4524768856433083
9Q33.3Q34.11 MICRODELETION SYNDROME	0.065333689	2.451068491847384
SILVER-RUSSELL SYNDROME	0.06529217	2.4495108588058296
AMISH INFANTILE EPILEPSY SYNDROME	0.06514384000000001	2.443946088241662
CORNELIA DE LANGE SYNDROME 3	0.06501796300000001	2.4392236677986916
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.4316017741687577
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.06448417000000001	2.4191978094169815
JOHANSON-BLIZZARD SYNDROME	0.06439111	2.415706556476231
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.064376203	2.415147303224697
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.06436751	2.414821175330715
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0643116	2.412723647371147
MAYER-ROKITANSKY-KÜSTER-HAUSER SYNDROME	0.0641259	2.405756898272745
H SYNDROME	0.06406828	2.403595217696278
KNIEST-LIKE DYSPLASIA, LETHAL	0.06401115	2.4014519200334252
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06384318	2.3951503322786665
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.06310167400000001	2.367331881783459
1P36 DELETION SYNDROME	0.062920493	2.3605346681679626
SECKEL SYNDROME 10; SCKL10	0.06252321000000001	2.3456301394546584
SMITH-MAGENIS SYNDROME; SMS	0.062123983	2.3306526793452997
DIPHALLIA	0.061799690000000004	2.3184864544375547
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.06176678000000001	2.3172517979333627
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.06176678000000001	2.3172517979333627
HEMOCHROMATOSIS, TYPE 1	0.06176678000000001	2.3172517979333627
ISOLATED KLIPPEL-FEIL SYNDROME	0.06156017	2.309500586133573
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.061205303	2.296187342448582
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0611888	2.295568213421275
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.06103496	2.289796728869319
SEVERE CONGENITAL NEMALINE MYOPATHY	0.06103496	2.289796728869319
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0607197	2.2779693873466353
3MC SYNDROME 2	0.060663883999999994	2.2758753859051897
RUBINSTEIN-TAYBI SYNDROME	0.060326143000000006	2.2632046438091016
MICROPHTHALMIA WITH LIMB ANOMALIES	0.060188710000000006	2.2580486867340306
MICROPHTHALMIA, SYNDROMIC 3	0.060125484	2.255676690619353
HAMAMY SYNDROME; HMMS	0.05931858999999999	2.225405134092662
BLEPHAROCHALASIS AND DOUBLE LIP	0.0592948	2.2245126248786025
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.05918063	2.220229406006418
SHPRINTZEN OMPHALOCELE SYNDROME	0.05902681	2.2144586717774666
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.058884754	2.2091292775398648
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.05888254	2.209046216783247
234800 HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES	0.058873	2.2086883127100174
3P25.3 MICRODELETION SYNDROME	0.058852989999999994	2.2079376145438405
ACRO-RENAL-MANDIBULAR SYNDROME	0.0588235	2.206831263273448
PHAVER SYNDROME	0.0588235	2.206831263273448
SPONDYLOCOSTAL DYSOSTOSIS 6, AUTOSOMAL RECESSIVE; SCDO6	0.0588235	2.206831263273448
ULNAR HEMIMELIA	0.0588235	2.206831263273448
SPONDYLOCOSTAL DYSOSTOSIS 5	0.0588235	2.206831263273448
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.05840336	2.1910692279142516
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.05838522	2.1903886849490117
FONTAINE PROGEROID SYNDROME; FPS	0.05813389000000001	2.1809597509107705
RENAL AGENESIS, BILATERAL	0.05812611	2.180667875261952
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.058038603999999994	2.1773849870195994
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.057826813	2.1694394040454488
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.167604751750569
ULBRIGHT-HODES SYNDROME	0.057407410000000006	2.1537050180889747
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.057407410000000006	2.1537050180889747
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0573294	2.150778383209242
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.05725402	2.1479504158046234
HAND-FOOT-GENITAL SYNDROME	0.05722363000000001	2.146810299999021
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.0571896	2.145533625406567
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.05717591	2.145020029309867
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.05684260000000001	2.132515521275465
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.05684260000000001	2.132515521275465
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.05684260000000001	2.132515521275465
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.05684260000000001	2.132515521275465
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.05684260000000001	2.132515521275465
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.05645220999999999	2.117869591385721
PYGMY	0.05641948	2.1166416877885714
SPONDYLO-OCULAR SYNDROME	0.05633598000000001	2.1135090892440562
NIJMEGEN BREAKAGE SYNDROME	0.056312030000000006	2.1126105774459583
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.056101154	2.1046993217492713
OBESITY DUE TO SIM1 DEFICIENCY	0.056101154	2.1046993217492713
MEIER-GORLIN SYNDROME 1; MGORS1	0.05592036	2.0979166268839156
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0558611	2.095693419821065
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.055632623	2.0871218423641142
LETHAL KNIEST-LIKE DYSPLASIA	0.055607790000000004	2.086190203805361
TRICHO-DENTO-OSSEOUS SYNDROME	0.055555600000000004	2.0842322359246626
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.0842322359246626
HEMOCHROMATOSIS, TYPE 4; HFE4	0.055555600000000004	2.0842322359246626
BLEPHARO-CHEILO-ODONTIC SYNDROME	0.055555600000000004	2.0842322359246626
ANIRIDIA	0.055555600000000004	2.0842322359246626
ESTROGEN RESISTANCE; ESTRR	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.0842322359246626
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.0842322359246626
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.0842322359246626
HYPERTRIGLYCERIDEMIA, FAMILIAL	0.055555600000000004	2.0842322359246626
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.055555600000000004	2.0842322359246626
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.0842322359246626
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.055555600000000004	2.0842322359246626
ARGININOSUCCINIC ACIDURIA	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.0842322359246626
X-LINKED SIDEROBLASTIC ANEMIA	0.055555600000000004	2.0842322359246626
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.0842322359246626
HYPOGONADISM, MALE, WITH MENTAL RETARDATION AND SKELETAL ANOMALIES	0.055555600000000004	2.0842322359246626
DERMATOMYOSITIS	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.0842322359246626
HYPERLIPOPROTEINEMIA, TYPE IV	0.055555600000000004	2.0842322359246626
BAMFORTH-LAZARUS SYNDROME	0.055555600000000004	2.0842322359246626
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.055555600000000004	2.0842322359246626
ESTROGEN RESISTANCE SYNDROME	0.055555600000000004	2.0842322359246626
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.055555600000000004	2.0842322359246626
CAUDAL REGRESSION SEQUENCE	0.055494510000000004	2.0819403743068845
PGM3-CDG	0.05539991899999999	2.0783916841401258
PRIMARY CILIARY DYSKINESIA	0.055383100000000005	2.077760700009345
CHRISTIANSON SYNDROME	0.05529573	2.0744829139634247
KBG SYNDROME	0.055243703000000005	2.072531061215215
ROTHMUND-THOMSON SYNDROME	0.055178914	2.070100427357722
POTOCKI-LUPSKI SYNDROME	0.055160293000000006	2.06940183912422
GORLIN SYNDROME	0.054949029999999996	2.0614760646773926
KASABACH-MERRITT SYNDROME	0.0548941	2.0594153025450543
ISOLATED CEREBELLAR AGENESIS	0.054832548999999994	2.057106145982018
PERLMAN SYNDROME	0.054823984	2.0567848201552663
HYPOPLASMINOGENEMIA	0.0545894	2.0479841315688385
FASCIAL DYSTROPHY, CONGENITAL	0.0545894	2.0479841315688385
CRANIOLENTICULOSUTURAL DYSPLASIA	0.05455904	2.046845141247743
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.054460019	2.043130254535449
COG2-CDG	0.05426045399999999	2.0356433440140558
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.054062673	2.0282233623046797
CROUZON DISEASE	0.05387693	2.0212550000118177
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.05342888900000001	2.0044462265449496
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.053177154	1.9950020984658632
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.053177154	1.9950020984658632
HYPOPLASTIC LEFT HEART SYNDROME	0.052976190000000006	1.9874627028502931
PENILE AGENESIS	0.052976190000000006	1.9874627028502931
CLEIDOCRANIAL DYSPLASIA	0.0526316	1.9745350126412542
CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION	0.0526316	1.9745350126412542
46,XY DISORDER OF SEX DEVELOPMENT DUE TO 5-ALPHA-REDUCTASE 2 DEFICIENCY	0.0526316	1.9745350126412542
MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 1	0.0526316	1.9745350126412542
BIEMOND SYNDROME II	0.0526316	1.9745350126412542
PERINEURAL CYST	0.0526316	1.9745350126412542
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.0526316	1.9745350126412542
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0526316	1.9745350126412542
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.0526316	1.9745350126412542
THIOUREA TASTINGPHENYLTHIOCARBAMIDE TASTING, INCLUDED	0.0526316	1.9745350126412542
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.0526316	1.9745350126412542
POLYEMBRYOMA	0.0526316	1.9745350126412542
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0526316	1.9745350126412542
ECTODERMAL DYSPLASIA WITH ADRENAL CYST	0.0526316	1.9745350126412542
MYXOPAPILLARY EPENDYMOMA	0.0526316	1.9745350126412542
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0526316	1.9745350126412542
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.052427214	1.9668672367595845
SLC39A8-CDG	0.052206949	1.9586037419283533
AMYLOIDOSIS	0.052139099999999994	1.956058308651145
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.052037644	1.9522520701130326
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.0517429	1.941194409928544
XQ12-Q13.3 DUPLICATION SYNDROME	0.051682389999999995	1.938924307677901
ABLEPHARON MACROSTOMIA SYNDROME	0.051431264000000004	1.9295030269343074
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.051327884	1.9256246073231447
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.051241319	1.9223770217781628
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9201185495340927
TRIOPIA	0.0511111	1.9174917062108772
FOIX-CHAVANY-MARIE SYNDROME	0.051086973	1.9165865540541882
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.051066104	1.9158036295149605
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.051046094	1.9150529313487838
16Q24.3 MICRODELETION SYNDROME	0.051012179000000005	1.9137805711136076
FETAL HYDANTOIN SYNDROME	0.050869884	1.9084422105160992
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.05059527	1.8981397504358157
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.05045762300000001	1.8929757649045944
16P13.11 MICRODELETION SYNDROME	0.050362633999999996	1.889412143310043
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.050273330000000005	1.8860618010295709
CRANIOLENTICULOSUTURAL DYSPLASIA	0.05019154000000001	1.8829933551019546
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.05015248900000001	1.8815283119191772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.050015589	1.8763923509521803
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.05	1.875807511686187
SYMBRACHYDACTYLY OF HANDS AND FEET	0.05	1.875807511686187
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13	0.05	1.875807511686187
DIABETES MELLITUS, TRANSIENT NEONATAL, 3	0.05	1.875807511686187
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.05	1.875807511686187
FRASER SYNDROME	0.04972924000000001	1.8656496388489041
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.04960590300000001	1.8610225094275272
DISTAL TRISOMY 18Q	0.049518364	1.857738383152217
PYRIDOXINE-DEPENDENT EPILEPSY	0.049331164	1.8507153598284638
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076854	1.8411746276625256
SMITH-MAGENIS SYNDROME	0.049009343	1.8386418748440967
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.04896773	1.8370807152844209
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.04893246	1.8357575206656773
LICHTENSTEIN SYNDROME	0.048854640000000005	1.8328380138544893
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.048849473000000004	1.8326441679062315
7Q11.23 MICRODUPLICATION SYNDROME	0.04883717900000001	1.8321829443552582
TARP SYNDROME	0.048828463	1.831855953589821
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.048750749	1.8289404234905573
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.048456250000000006	1.817891954762876
TRISOMY 13	0.04796201900000001	1.7993503103167126
WHITE FORELOCK WITH MALFORMATIONS	0.047699820000000004	1.7895136132415803
PSEUDOTRISOMY 13 SYNDROME	0.04721092	1.7711719673923128
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.046964	1.7619084795766016
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.04687735899999999	1.7586580428042013
DYSKERATOSIS CONGENITA	0.046756733999999994	1.7541326571822586
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.04670776	1.7522953412407123
ZELLWEGER SYNDROME	0.046702509	1.7520983439358349
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.046528904	1.7455853526745095
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.04648261000000001	1.7438485800155896
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.045956699999999996	1.7241184614461713
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.045891573000000005	1.7216751471299
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0458128	1.718719887427539
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.045807523999999995	1.7185219522189055
POEMS SYNDROME	0.045807379999999995	1.7185165498932717
MICROHYDRANENCEPHALY; MHAC	0.045729990000000005	1.7156131750266843
NEVUS COMEDONICUS SYNDROME	0.045688049	1.7140397101697316
PRIMARY BASILAR INVAGINATION	0.0456668	1.7132425294934153
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.045605179999999995	1.7109307843160129
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.04555310900000001	1.708977280857193
OCULODENTODIGITAL DYSPLASIA	0.045539149	1.7084535553999303
MESOMELIA-SYNOSTOSES SYNDROME	0.04549451	1.706778871969647
ALG13-CDG	0.045416	1.703833479014797
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.045321703000000005	1.700295818596208
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.045317009000000005	1.700119717787011
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.0452381	1.697159355888218
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.045200840000000006	1.6957615041305094
22Q11.2 MICRODUPLICATION SYNDROME	0.04501149299999999	1.6886579336322043
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.685432182486658
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.044894593	1.6842722956698821
BRADDOCK SYNDROME	0.04476530000000001	1.6794217200577135
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.04472363000000001	1.6778584220774742
ALLAN-HERNDON-DUDLEY SYNDROME	0.044444410000000004	1.6673831626092137
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.044419559	1.6664508487597551
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.044297953999999994	1.661888697310583
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.04423473000000001	1.6595167762282066
RING CHROMOSOME 1 SYNDROME	0.04423473000000001	1.6595167762282066
XP22.13P22.2 DUPLICATION SYNDROME	0.044209878999999994	1.6585844623787478
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.044120203000000004	1.6552201640903887
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.044069950000000004	1.6533348649926936
HYDROXYKYNURENINURIA	0.044023854	1.6516055205315197
FAMILIAL THROMBOCYTOSIS	0.044019719000000006	1.6514503912503036
LASSA FEVER	0.044019719000000006	1.6514503912503036
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.044019719000000006	1.6514503912503036
VIRAL HEMORRHAGIC FEVER	0.044019719000000006	1.6514503912503036
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04387814000000001	1.6461388922163631
20Q13.33 MICRODELETION SYNDROME	0.043878049	1.6461354782466915
CHARGE SYNDROME	0.043776914	1.6423412823928039
PENTASOMY X	0.043776914	1.6423412823928039
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.043763244	1.641828436619109
SOTOS SYNDROME	0.043561903	1.6342748974149008
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0435606	1.634226013871146
PREPAPILLARY VASCULAR LOOPS	0.0435606	1.634226013871146
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.043518509999999996	1.6326469591078085
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.043495753000000005	1.6317932040769403
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.04348908	1.6315428588064302
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.043478300000000004	1.631138434706911
YELLOW FEVER	0.043478300000000004	1.631138434706911
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.043478300000000004	1.631138434706911
RINGED HAIR DISEASE	0.043478300000000004	1.631138434706911
OCULOTRICHOANAL SYNDROME	0.043478300000000004	1.631138434706911
GESTATIONAL TROPHOBLASTIC NEOPLASM	0.043478300000000004	1.631138434706911
FAMILIAL AFIBRINOGENEMIA	0.043478300000000004	1.631138434706911
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.043478300000000004	1.631138434706911
PLACENTAL SITE TROPHOBLASTIC TUMOR	0.043478300000000004	1.631138434706911
HYDATIDIFORM MOLE	0.043478300000000004	1.631138434706911
NEONATAL LUPUS ERYTHEMATOSUS	0.043478300000000004	1.631138434706911
ASHERMAN SYNDROME	0.043478300000000004	1.631138434706911
GESTATIONAL CHORIOCARCINOMA	0.043478300000000004	1.631138434706911
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.043478300000000004	1.631138434706911
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.043478300000000004	1.631138434706911
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.043478300000000004	1.631138434706911
JUVENILE XANTHOGRANULOMA	0.043478300000000004	1.631138434706911
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	1.631138434706911
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.043478300000000004	1.631138434706911
WERNER SYNDROME	0.043478300000000004	1.631138434706911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.043248754	1.6225267524853604
FETAL ALCOHOL SYNDROME	0.043142363999999996	1.6185354092619941
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.042964549	1.611864475008185
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.042964549	1.611864475008185
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.04296454899999999	1.6118644750081845
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.042778384	1.604880280899924
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.604061153275721
MOWAT-WILSON SYNDROME	0.04254317900000001	1.596056294784201
DISTAL 17P13.1 MICRODELETION SYNDROME	0.042423129999999996	1.591552518464792
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.042250359	1.5850708156727618
FRONTOOCULAR SYNDROME	0.041804074000000004	1.5683279205657046
184705 STEINFELD SYNDROME	0.04178951	1.5677815353537006
ANDROGEN INSENSITIVITY SYNDROME	0.0416667	1.5631741769434968
49,XXXYY SYNDROME	0.041666699999999994	1.5631741769434964
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	1.5631741769434964
49,XYYYY SYNDROME	0.041666699999999994	1.5631741769434964
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.041666699999999994	1.5631741769434964
HISTIDINEMIA	0.041666699999999994	1.5631741769434964
MERRF	0.041517359999999996	1.5575715150675924
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.041412723	1.5536459376555865
EPIDERMOLYSIS BULLOSA SIMPLEX DUE TO PLAKOPHILIN DEFICIENCY	0.041287000000000004	1.548929294699752
ACRODERMATITIS ENTEROPATHICA	0.041287000000000004	1.548929294699752
SARCOSINEMIA	0.041091234	1.5415849080330966
GRISCELLI SYNDROME	0.041086973	1.5414250517169508
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.041086973	1.5414250517169508
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.04095251	1.5363805176080736
611426 TENTED EYEBROWS	0.0408333	1.5319082173387115
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.04082213	1.5314891619406006
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.040817743999999996	1.5313246161056755
1Q44 MICRODELETION SYNDROME	0.040778644	1.5298577346315372
9P13 MICRODELETION SYNDROME	0.04073268	1.528133342302194
OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE; OPLL	0.040693980000000005	1.5266814672881492
TRANSALDOLASE DEFICIENCY	0.04068145000000001	1.5262113899257208
SHORT SYNDROME	0.0405229	1.5202632043061637
TETRASOMY 9P	0.040487973000000003	1.5189528777269505
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.040250143999999995	1.5100304492330139
ACRODYSOSTOSIS	0.040065699999999996	1.5031108204193049
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.040065699999999996	1.5031108204193049
BÖÖK SYNDROME	0.04	1.5006460093489495
CENTRAL CONGENITAL HYPOTHYROIDISM	0.04	1.5006460093489495
MONILETHRIX	0.04	1.5006460093489495
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.04	1.5006460093489495
ACROMICRIC DYSPLASIA	0.04	1.5006460093489495
VOGT-KOYANAGI-HARADA DISEASE	0.04	1.5006460093489495
ACQUIRED HYPERTRICHOSIS LANUGINOSA	0.04	1.5006460093489495
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.04	1.5006460093489495
ULERYTHEMA OPHRYOGENESIS	0.04	1.5006460093489495
ROMBO SYNDROME	0.04	1.5006460093489495
PILI TORTI	0.04	1.5006460093489495
LEUKOMELANODERMA-INFANTILISM-INTELLECTUAL DISABILITY-HYPODONTIA-HYPOTRICHOSIS SYNDROME	0.04	1.5006460093489495
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.04	1.5006460093489495
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.039972900000000006	1.4996293216776158
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.039968699999999996	1.4994717538466338
FILIPPI SYNDROME; FLPIS	0.03972025900000001	1.4901512039664178
HOLOPROSENCEPHALY	0.039631123000000004	1.4868071643991843
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4733380035938222
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.039264363	1.4730477411394636
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.03924148400000001	1.4721894091382666
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.039238	1.472058702870852
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.038937112999999995	1.4607705809754774
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.038925434	1.460332429856898
STURGE-WEBER SYNDROME	0.038823749000000005	1.456517600120382
GALLOWAY-MOWAT SYNDROME	0.038818162999999996	1.4563080349051758
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.445170877998342
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	1.4429274122143656
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	1.4429274122143656
ACROCEPHALOPOLYDACTYLY	0.0384615	1.4429274122143656
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	1.4429274122143656
LIP, HAMARTOMATOUS	0.0384615	1.4429274122143656
ABLEPHARON-MACROSTOMIA SYNDROME	0.0384615	1.4429274122143656
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	1.4429274122143656
CYCLIC NEUTROPENIA	0.0384615	1.4429274122143656
MAL DE MELEDA	0.0384615	1.4429274122143656
LIP, MEDIAN NODULE OF UPPER	0.0384615	1.4429274122143656
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	1.4429274122143656
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	1.4429274122143656
BAZEX SYNDROME; BZX	0.0384615	1.4429274122143656
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	1.4429274122143656
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	1.4429274122143656
PHEOCHROMOCYTOMA	0.038405800000000004	1.4408377626463473
LISSENCEPHALY 2; LIS2	0.038338984	1.4383310835523306
CLAPO SYNDROME	0.038324	1.4377689415572283
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.038299149000000005	1.4368366277077704
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.038253430000000005	1.4351214268352348
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.038204969000000005	1.4333033566787583
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.038123973	1.4302646985744274
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	1.428416165303961
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.421234073503217
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.03779343	1.4178639977277216
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.03779343	1.4178639977277216
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.037779182999999994	1.4173295051353416
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.037640329	1.4121202376107884
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.03763444	1.4118993050020618
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.037582554	1.4099527420310347
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.037578419	1.4097976127498186
HYPOPARATHYROIDISM, X-LINKED	0.037578419	1.4097976127498186
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.037578419	1.4097976127498186
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.037578419	1.4097976127498186
TREACHER-COLLINS SYNDROME	0.037560684	1.4091322638254233
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.037557703000000005	1.4090204281815768
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.037557703000000005	1.4090204281815768
3MC SYNDROME 1	0.037509219999999996	1.4072015326697949
SCIMITAR SYNDROME	0.03745899	1.405317096443555
COFS SYNDROME	0.037276659000000004	1.3984767392552901
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.03714713399999999	1.3936174598962667
COFFIN-SIRIS SYNDROME 3; CSS3	0.037099812999999995	1.3918421581510567
COFFIN-SIRIS SYNDROME 4; CSS4	0.037099812999999995	1.3918421581510567
FIBROSCLEROSIS, MULTIFOCAL	0.037037	1.389485656206426
KIKUCHI-FUJIMOTO DISEASE	0.037037	1.389485656206426
PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA	0.037037	1.389485656206426
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.389485656206426
CERVICAL VERTEBRAE, AGENESIS OF	0.037037	1.389485656206426
CARCINOMA OF ESOPHAGUS	0.037037	1.389485656206426
PAROTIDOMEGALY, HEREDITARY BILATERAL	0.037037	1.389485656206426
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.037037	1.389485656206426
MYOCLONUS AND ATAXIA	0.037037	1.389485656206426
PULMONARY ARTERIAL HYPERTENSION	0.037037	1.389485656206426
CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION; CMAVM	0.037037	1.389485656206426
BRANCHIAL CLEFT ANOMALIESBRANCHIAL CYSTS, INCLUDED	0.037037	1.389485656206426
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.389485656206426
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.037037	1.389485656206426
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.037037	1.389485656206426
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.389485656206426
VON HIPPEL-LINDAU DISEASE	0.037037	1.389485656206426
MALAKOPLAKIA	0.037037	1.389485656206426
MCLEOD SYNDROME; MCLDS	0.037037	1.389485656206426
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.037037	1.389485656206426
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.037012149	1.3885533423569678
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.037012149	1.3885533423569678
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.037012149	1.3885533423569678
CORNELIA DE LANGE SYNDROME	0.036922049	1.3851731372209093
CARDIOFACIOCUTANEOUS SYNDROME	0.03680490399999999	1.3807783078017795
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.036709953000000003	1.3772161118209376
NEURONAL CEROID LIPOFUSCINOSIS	0.036587399	1.3726183575451936
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.036587399	1.3726183575451936
15Q13.3 MICRODELETION SYNDROME	0.036361043	1.364126351842889
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.036353194	1.3638318875797042
COFFIN-SIRIS SYNDROME 2; CSS2	0.036343383	1.3634638166297612
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.036273684	1.360848978474621
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.036273684	1.360848978474621
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.036255719000000006	1.3601750008356723
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.036123224	1.355204298510455
ALPERS-HUTTENLOCHER SYNDROME	0.036122034000000004	1.355159654291677
MARFANOID HYPERMOBILITY SYNDROME	0.0361111	1.3547494527050212
THUMBS, CONGENITAL CLASPED	0.0361093	1.3546819236346004
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.03604598	1.352306401001801
TETRASOMY X	0.035856794000000004	1.3452088706036842
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.035784784	1.3425073326253534
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.035728130000000004	1.3403818926500122
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.338060393273549
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.338060393273549
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.035569773	1.3344409476474501
HYDRANENCEPHALY	0.035569773	1.3344409476474501
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.035551614	1.333759691875356
PYCNODYSOSTOSIS	0.0355013	1.3318721042924964
CHROMOSOME 18Q DELETION SYNDROME	0.035430399	1.3292121717247753
DOWN SYNDROME	0.03531124	1.324741784779075
NON-DISTAL TRISOMY 13Q	0.035279279999999996	1.323542768617605
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.035064823	1.3154971675869316
JAWAD SYNDROME	0.035028354	1.3141289911040577
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.035024219	1.3139738618228414
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.035024219	1.3139738618228414
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.035024219	1.3139738618228414
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457724
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.034820050000000005	1.3063142269457724
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.034801279	1.3056100112897349
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.034660294	1.3003207968490333
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.0344828	1.293661905279449
BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1	0.0344828	1.293661905279449
ULNA METAPHYSEAL DYSPLASIA SYNDROME	0.0344828	1.293661905279449
CERVICAL VERTEBRAL BRIDGE	0.0344828	1.293661905279449
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.0344828	1.293661905279449
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.0344828	1.293661905279449
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.0344828	1.293661905279449
MICROCEPHALY-POLYMICROGYRIA-CORPUS CALLOSUM AGENESIS SYNDROME	0.0344828	1.293661905279449
FRYNS MICROPHTHALMIA SYNDROME	0.0344828	1.293661905279449
SPINAL INTRADURAL ARACHNOID CYSTS	0.0344828	1.293661905279449
ACROCRANIOFACIAL DYSOSTOSIS	0.0344828	1.293661905279449
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.0344828	1.293661905279449
CALCIFICATION OF JOINTS AND ARTERIES; CALJA	0.0344828	1.293661905279449
ANKYLOSING VERTEBRAL HYPEROSTOSIS WITH TYLOSIS	0.0344828	1.293661905279449
BRACHYDACTYLY, TYPE A6	0.0344828	1.293661905279449
COFFIN-LOWRY SYNDROME; CLS	0.034455749	1.2926470558994765
ACROCALLOSAL SYNDROME; ACLS	0.034380999	1.2898427236695056
MEIER-GORLIN SYNDROME 5; MGORS5	0.03430153	1.2868613527265818
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.034101503	1.2793571097437806
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.03409065399999999	1.2789500970298948
SANDHOFF DISEASE	0.034086518999999996	1.2787949677486783
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.278147101350292
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034069249999999995	1.278147101350292
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.034048984	1.2773867990496557
LEIGH SYNDROME	0.034044849	1.2772316697684394
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.034044849	1.2772316697684394
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.034044848999999995	1.2772316697684392
SECKEL SYNDROME 9; SCKL9	0.034040074	1.2770525301510731
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0338384	1.2694864980688372
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.033560084	1.2590451532003881
ATYPICAL RETT SYNDROME	0.033555949	1.2588900239191718
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.033555948999999995	1.2588900239191716
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.033545099999999994	1.2584830112052858
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.03350343	1.256919713225047
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.03350343	1.256919713225047
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.033390993	1.2527015098412178
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.033350794	1.2511933981179724
GRISCELLI SYNDROME TYPE 1	0.033345072999999996	1.2509787682224849
17Q12 MICRODUPLICATION SYNDROME	0.033284149	1.2486931342856455
GAPO SYNDROME	0.033233399999999996	1.2467892271774341
MYELOPEROXIDASE DEFICIENCY	0.033199679999999995	1.245524182591553
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.033199679999999995	1.245524182591553
BLOOD GROUP, DUFFY SYSTEM; FY	0.033199679999999995	1.245524182591553
SECKEL SYNDROME 2; SCKL2	0.03301453	1.2385780673757794
SECKEL SYNDROME	0.03301453	1.2385780673757794
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.032937614000000004	1.2356924751644023
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.03286257	1.2328771131862628
OXOGLUTARIC ACIDURIA	0.032803653999999995	1.2306668116790924
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.032803653999999995	1.2306668116790924
TUBEROUS SCLEROSIS-1	0.032799519	1.2305116823978761
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2305116823978761
DEND SYNDROME	0.032799519	1.2305116823978761
FLYNN-AIRD SYNDROME	0.032799519	1.2305116823978761
LOEYS-DIETZ SYNDROME 5	0.03264813	1.2248321499301429
WIEDEMANN-STEINER SYNDROME	0.032611079	1.2234421390478332
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.032563	1.221638400060746
DUBOWITZ SYNDROME	0.032442489000000005	1.21711729127993
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.032325443	1.2127261759596735
HUNTINGTON DISEASE	0.0322581	1.2101997258544837
HSD10 DISEASE, ATYPICAL TYPE	0.0322581	1.2101997258544837
DIENCEPHALIC SYNDROME	0.0322581	1.2101997258544837
MILD CANAVAN DISEASE	0.0322581	1.2101997258544837
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	1.2101997258544837
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0322581	1.2101997258544837
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.0322581	1.2101997258544837
LESCH-NYHAN SYNDROME	0.0322581	1.2101997258544837
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	1.2101997258544837
DENT DISEASE	0.0322581	1.2101997258544837
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.2101997258544837
DYSTONIA, JUVENILE-ONSET	0.0322581	1.2101997258544837
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0322581	1.2101997258544837
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	1.2101997258544837
KAGAMI-OGATA SYNDROME	0.032217632999999996	1.2086815598029754
CONGENITAL DISORDER OF GLYCOSYLATION	0.032190703	1.2076712498771813
HELSMOORTEL-VAN DER AA SYNDROME	0.032134122999999994	1.205548586096957
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.032129244	1.205365544799967
EPILEPSY, PYRIDOXINE-DEPENDENT	0.032129244	1.205365544799967
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.03210905	1.204607943662147
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.03201384	1.2010360309983945
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.031999320000000005	1.2004912964970007
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.031940384	1.1982802446668261
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.031782859999999996	1.1923705506174087
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.031752599000000006	1.1912352743951864
MEIER-GORLIN SYNDROME 7	0.031623574	1.18639475311128
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.031610043000000004	1.1858871220824674
RAMON SYNDROME	0.031556419	1.1838753560423343
RING CHROMOSOME 12 SYNDROME	0.031515664	1.1823463853395588
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.031462003	1.1803332312018668
EPIDERMOLYSIS BULLOSA SIMPLEX	0.0313726	1.1769791748225213
KEPPEN-LUBINSKY SYNDROME	0.031268858999999996	1.1730872118811244
NAVAJO NEUROHEPATOPATHY	0.031244354	1.1721678786196472
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.17151344689497
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.031214043	1.1710307265899127
FATCO SYNDROME	0.031130659999999998	1.167902517434974
DISTAL MONOSOMY 7Q36	0.031114579000000003	1.1672992202230659
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.031060203	1.1652592420379568
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.031040214	1.1645093317109347
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.030987783999999997	1.1625423599541806
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.030917759000000003	1.1599152915340643
ZIMMERMANN-LABAND SYNDROME 1	0.030917759000000003	1.1599152915340643
4Q21 MICRODELETION SYNDROME	0.030827469	1.1565279583294612
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.030657129999999998	1.1501374948147989
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.030657129999999998	1.1501374948147989
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.030621653000000002	1.1488065343529574
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.030467402999999997	1.1430196681794051
KABUKI SYNDROME 1	0.030455123000000004	1.1425589698545353
WARBURG MICRO SYNDROME 3; WARBM3	0.030446719000000004	1.142243684127971
20P13 MICRODELETION SYNDROME	0.030427548999999998	1.1415244995279903
ALG1-CDG	0.030414803	1.1410463186771116
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.030325114	1.137681532678799
MUCOPOLYSACCHARIDOSIS, TYPE II	0.030303319000000002	1.136863868184455
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.030264433	1.1354050151664665
TRANSIENT NEONATAL DIABETES MELLITUS	0.030038863999999995	1.1269425346743955
PERMANENT NEONATAL DIABETES MELLITUS	0.030038863999999995	1.1269425346743955
CIRCUMVALLATE PLACENTA SYNDROME	0.029979	1.124696667856804
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.029957354	1.1238845932688446
TOWNES-BROCKS SYNDROME	0.02989872	1.1216848713160406
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.02982123	1.1187777448344294
PETERS PLUS SYNDROME	0.029760514000000002	1.1164999142568386
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.029658373000000002	1.112667977155816
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.029627039	1.1114924461043922
RECOMBINANT CHROMOSOME 8 SYNDROME	0.029585593000000004	1.1099375517418055
MYHRE SYNDROME	0.029430863	1.1041326778161413
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0294118	1.1034175074442356
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0294118	1.1034175074442356
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0294118	1.1034175074442356
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0294118	1.1034175074442356
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0294118	1.1034175074442356
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0294118	1.1034175074442356
ECHO VIRUS 11 SENSITIVITY	0.0294118	1.1034175074442356
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0294118	1.1034175074442356
RAGWEED SENSITIVITY	0.0294118	1.1034175074442356
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0294118	1.1034175074442356
IMMUNE SUPPRESSION	0.0294118	1.1034175074442356
MONOMELIC AMYOTROPHY	0.0294118	1.1034175074442356
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0294118	1.1034175074442356
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0294118	1.1034175074442356
OROFACIODIGITAL SYNDROME TYPE 4	0.029360094	1.101477697380251
BRAIN-LUNG-THYROID SYNDROME	0.029199683999999997	1.095459731721259
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.029188803	1.095051518490566
PROPIONIC ACIDEMIA	0.029116954	1.0923560206124232
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.029079784	1.0909615453082357
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.029079784	1.0909615453082357
MENKES DISEASE	0.029075649000000002	1.0908064160270192
EDINBURGH MALFORMATION SYNDROME	0.029064800000000002	1.090399403313134
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.029064800000000002	1.090399403313134
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.02905676	1.0900977734652546
DUANE RETRACTION SYNDROME	0.029006113	1.088197693004367
TRISOMY 20P	0.02882295	1.0813261223791075
RENPENNING SYNDROME 1; RENS1	0.028819699000000004	1.0812041573746978
ALKAPTONURIA	0.028787880000000002	1.0800104309904108
HOOFT DISEASE	0.028787880000000002	1.0800104309904108
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.02865274	1.0749404984478255
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901082
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901082
48,XXYY SYNDROME	0.028581172999999998	1.0722555801240485
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.0285714	1.0718889347878144
ALG12-CDG	0.0285714	1.0718889347878144
ALPHA-THALASSEMIA	0.0285714	1.0718889347878144
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.0285714	1.0718889347878144
CHEILITIS GLANDULARIS	0.0285714	1.0718889347878144
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.0285714	1.0718889347878144
COG7-CDG	0.0285714	1.0718889347878144
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.0285714	1.0718889347878144
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.0285714	1.0718889347878144
CONGENITAL LOBAR EMPHYSEMA	0.0285714	1.0718889347878144
15Q24 RECURRENT MICRODELETION SYNDROME	0.02853423	1.070494459483627
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.02853423	1.070494459483627
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.02853423	1.070494459483627
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.028372483000000004	1.0644263347317728
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.028352500000000003	1.0636766495016523
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.028323354000000002	1.0625832037869403
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.02831885	1.0624142310462874
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.028084744000000002	1.0536314751796714
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.027987973000000003	1.0500009998054038
JACOBSEN SYNDROME	0.027977092999999998	1.0495928240908607
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.027962943	1.0490619705650537
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.027959189000000002	1.0489211349370762
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.02791536	1.0472768395884822
MONOSOMY X	0.02785599	1.045049505749106
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.02785599	1.045049505749106
TURNER SYNDROME	0.02785599	1.045049505749106
MOSAIC MONOSOMY X	0.02785599	1.045049505749106
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.02778486	1.0423809819829815
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.0421161179623313
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0421161179623313
OROFACIAL CLEFT 3	0.027777800000000002	1.0421161179623313
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	1.0421161179623313
CLEFT CHIN	0.027777800000000002	1.0421161179623313
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.0421161179623313
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	1.0421161179623313
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	1.0421161179623313
MENINGIOMA	0.027777800000000002	1.0421161179623313
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.027777800000000002	1.0421161179623313
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	1.0421161179623313
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	1.0421161179623313
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.0421161179623313
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	1.0421161179623313
DIMPLES, FACIAL	0.027777800000000002	1.0421161179623313
NASAL BONES, ABSENCE OF	0.027777800000000002	1.0421161179623313
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.0421161179623313
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.0421161179623313
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	1.0421161179623313
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.0421161179623313
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	1.0421161179623313
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.0421161179623313
GANGLIOCYTOMA	0.027777800000000002	1.0421161179623313
DWARFISM, LEVI TYPE	0.027777800000000002	1.0421161179623313
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0421161179623313
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.0277778	1.042116117962331
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.02769053	1.0388420835314343
CARTILAGE-HAIR HYPOPLASIA	0.02769053	1.0388420835314343
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.0344160781914604
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	1.034260948910244
PRADER-WILLI SYNDROME; PWS	0.027567783000000002	1.0342370886386953
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.027519154	1.0324127157689795
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.02744162	1.029503938576758
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.02740741	1.0282205110772622
11Q22.2Q22.3 MICRODELETION SYNDROME	0.027371733000000002	1.0268820473853737
CONGENITAL ALVEOLAR CAPILLARY DYSPLASIA	0.02736639	1.026681598594675
BALLER-GEROLD SYNDROME	0.027364100000000002	1.0265956866106398
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.027299654000000003	1.0241779207926773
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0139489923668514
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668514
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0139489923668514
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0139489923668514
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.026992324	1.012648082341347
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.026983783999999997	1.0123276944183508
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.026906103	1.009413402352045
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.02690456	1.0093555149322344
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.02690456	1.0093555149322344
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.026828419000000003	1.0064989977372885
MEND SYNDROME	0.026778773000000002	1.004636470942785
JOUBERT SYNDROME WITH OCULAR DEFECT	0.026722503	1.0025254371691332
LATERAL MENINGOCELE SYNDROME	0.026715554	1.002264737441159
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.02669808	1.001609180231975
ANGELMAN SYNDROME	0.026575603000000003	0.9970143146997994
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.026560483000000003	0.9964470705082655
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.026494883999999996	0.9939860485690831
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.02648081	0.9934580462706939
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.026397870000000004	0.990346456770309
FLOATING-HARBOR SYNDROME	0.02630463	0.9868484509225164
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.02628886	0.9862568212333306
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.026233603	0.9841837913198658
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.026222754	0.9837767786059801
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.026218619000000002	0.9836216493247637
FG SYNDROME TYPE 1	0.026211853000000004	0.9833678150522823
EPIDERMOLYSIS BULLOSA ACQUISITA	0.02621118	0.983342566683175
WERNER SYNDROME; WRN	0.02621118	0.983342566683175
OSTEOGLOSPHONIC DYSPLASIA	0.0262002	0.9829306393536087
DISTAL TRISOMY 17Q	0.025977102999999998	0.9745608987849155
MOWAT-WILSON SYNDROME; MOWS	0.025898749	0.9716213583495023
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.025816033	0.9685181724667696
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.025813534	0.9684244196073355
PEHO-LIKE SYNDROME; PEHOL	0.025738453999999997	0.9656077070477876
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.025688049	0.9637167054952569
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.025620499	0.9611824895469687
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.025596762999999998	0.960292006205021
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.025550389	0.9585522322540823
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.025545554	0.9583708416677025
ZUNICH NEUROECTODERMAL SYNDROME	0.025541419000000003	0.9582157123864861
MAPLE SYRUP URINE DISEASE; MSUD	0.025541419000000003	0.9582157123864861
KLIPPEL-TRÉNAUNAY SYNDROME	0.02547172	0.9556008742313455
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.025430914	0.9540699902049082
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.025375054	0.9519743380528525
KOOLEN-DE VRIES SYNDROME; KDVS	0.025346433	0.9509005883170132
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.025272969	0.9481445018562428
BARBER-SAY SYNDROME; BBRSAY	0.02526451	0.9478271527414157
JUBERG-HAYWARD SYNDROME	0.02514663	0.9434047489518643
SPONDYLOOCULAR SYNDROME; SOS	0.02506266	0.9402545178167385
CLEFT-LIMB-HEART MALFORMATION SYNDROME	0.025	0.9379037558430935
GROWTH CONTROL, Y-CHROMOSOME INFLUENCED	0.025	0.9379037558430935
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.025	0.9379037558430935
COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT	0.025	0.9379037558430935
CZECH DYSPLASIA, METATARSAL TYPE	0.025	0.9379037558430935
LATERALITY DEFECTS, AUTOSOMAL DOMINANT	0.025	0.9379037558430935
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.025	0.9379037558430935
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.025	0.9379037558430935
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.025	0.9379037558430935
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.025	0.9379037558430935
202155 ADRENAL HYPOPLASIA, CYTOMEGALIC TYPE	0.025	0.9379037558430935
OSTEOGENESIS IMPERFECTA, TYPE I	0.025	0.9379037558430935
248110 MACROSOMIA WITH MICROPHTHALMIA, LETHAL	0.025	0.9379037558430935
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.025	0.9379037558430935
CONGENITAL TOXOPLASMOSIS	0.024952663000000003	0.9361278538394798
HURLER SYNDROME	0.024935754	0.9354934932551776
DERMOTRICHIC SYNDROME	0.024931619000000002	0.9353383639739612
GALACTOSIALIDOSIS	0.024931619000000002	0.9353383639739612
DISTAL MONOSOMY 13Q	0.024908930000000003	0.9344871600413083
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.024880463	0.9334191877926047
DISTAL MONOSOMY 10Q	0.024802743000000002	0.9305034325964399
WIEDEMANN-STEINER SYNDROME; WDSTS	0.024795973000000002	0.9302494482593576
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.024788854000000003	0.9299823707858437
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.024783544	0.9297831600281026
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.024749244	0.9284963560750857
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024730214	0.9277824237361381
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.02471529	0.92722253271005
OMODYSPLASIA 1; OMOD1	0.02471529	0.92722253271005
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.02471529	0.92722253271005
JUVENILE POLYPOSIS OF INFANCY	0.02471529	0.92722253271005
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.024675049	0.9257128453084946
OSTEOGENESIS IMPERFECTA, TYPE V	0.02462118	0.9236918878115542
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.02462118	0.9236918878115542
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.02462118	0.9236918878115542
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.024475933	0.9182427795385565
PELIZAEUS-MERZBACHER DISEASE	0.024407109000000003	0.9156607680148708
STÜVE-WIEDEMANN SYNDROME	0.024404799999999997	0.915574143223981
GM1 GANGLIOSIDOSIS	0.024392149000000002	0.9150995264073742
HOLT-ORAM SYNDROME	0.0243902	0.9150264074305686
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.0243902	0.9150264074305686
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.0243902	0.9150264074305686
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.0243902	0.9150264074305686
MESOMELIA-SYNOSTOSES SYNDROME	0.0243902	0.9150264074305686
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.0243902	0.9150264074305686
ACROPECTOROVERTEBRAL DYSPLASIA, F-FORM OF	0.0243902	0.9150264074305686
SACRAL AGENESIS WITH VERTEBRAL ANOMALIES; SAVA	0.0243902	0.9150264074305686
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.0243902	0.9150264074305686
HURLER-SCHEIE SYNDROME	0.0243902	0.9150264074305686
BEEMER LETHAL MALFORMATION SYNDROME	0.02436241	0.9139838336155736
ZTTK SYNDROME; ZTTKS	0.024318943	0.9123531191133643
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.024313749000000003	0.9121582602290503
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.024294644000000004	0.9114415141788351
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.024263183000000004	0.9102612185763319
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.024180623999999998	0.9071639227291857
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.024179759	0.9071314712592337
LARYNGOTRACHEOESOPHAGEAL CLEFT TYPE 4	0.0241525	0.9061088185200126
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.0241525	0.9061088185200126
GAUCHER DISEASE, PERINATAL LETHAL	0.024104439000000002	0.9043057548236297
TRANSKETOLASE DEFICIENCY	0.024101014	0.9041772620090791
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0240999	0.9041354690177188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.024088054	0.9036910527020501
ADRENOCORTICAL CARCINOMA	0.02406828	0.9029492083473284
144800 HYPEROSTOSIS FRONTALIS INTERNA;;MORGAGNI-STEWART-MOREL SYNDROME	0.02406828	0.9029492083473284
RING CHROMOSOME 7 SYNDROME	0.02404583	0.9021069707745812
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0240143	0.9009240865577118
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.024005734	0.9006027232148099
POSTERIOR FUSION OF LUMBOSACRAL VERTEBRAE-BLEPHAROPTOSIS SYNDROME	0.0239943	0.9001737635530374
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.023991389999999998	0.9000645915558573
HAREL-YOON SYNDROME; HAYOS	0.023945534	0.8983442509707398
17Q24.2 MICRODELETION SYNDROME	0.023923989	0.897535965513954
N-ACETYLASPARTATE DEFICIENCY; NACED	0.023850863	0.8947925595119628
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.023833033	0.8941236465532956
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.023713089	0.8896238094296618
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.023667173000000003	0.8879012178755302
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.023654814	0.8874375557747916
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.023654814	0.8874375557747916
EVEN-PLUS SYNDROME	0.023603983999999998	0.8855306098584114
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.02355546	0.8837101761844702
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0235425	0.8832239668774411
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0235425	0.8832239668774411
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.023541762999999997	0.8831963174747187
EDINBURGH MALFORMATION SYNDROME	0.023540739	0.8831579009368795
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.023525849	0.8825992854598994
16P13.2 MICRODELETION SYNDROME	0.023509783	0.8819965509902442
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.02336563	0.8765884853856022
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.023325044	0.8750658549122164
CLASSICAL EHLERS-DANLOS SYNDROME	0.02328435	0.8735391726946052
SILVER-RUSSELL SYNDROME; SRS	0.023272854	0.8731078870315184
COWDEN SYNDROME 5; CWS5	0.023268719	0.872952757750302
COWDEN SYNDROME 6; CWS6	0.023268719	0.872952757750302
HYPOADRENOCORTICISM, FAMILIAL	0.023268719	0.872952757750302
PYRUVATE DEHYDROGENASE DEFICIENCY	0.023120003	0.8673735059521435
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.023120003	0.8673735059521435
AICARDI-GOUTIERES SYNDROME 7	0.023120003	0.8673735059521435
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.023120003	0.8673735059521435
CEDNIK SYNDROME	0.023120003	0.8673735059521435
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.023109154	0.8669664932382578
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.023065033	0.8653112431737957
PRADER-WILLI-LIKE SYNDROME	0.023043653000000004	0.8645091478817989
BRANCHIO-OCULO-FACIAL SYNDROME	0.02298443	0.8622873289165068
BUSCHKE-OLLENDORFF SYNDROME	0.02298443	0.8622873289165068
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.02297619	0.861978195838581
MONOSOMY 9P	0.022888153	0.8586753865204547
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.02280507	0.8555584322105863
MARSHALL-SMITH SYNDROME; MRSHSS	0.02279743	0.8552718088228005
OROFACIODIGITAL SYNDROME TYPE 6	0.022753353	0.8536182094689487
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.022746910000000002	0.8533764929129929
ARTERIES, ANOMALIES OF	0.0227273	0.8526408012069095
RHOMBENCEPHALOSYNAPSIS	0.0227273	0.8526408012069095
CONGENITAL ATRANSFERRINEMIA	0.0227273	0.8526408012069095
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0227273	0.8526408012069095
LARSEN SYNDROME	0.0227273	0.8526408012069095
COCAINE EMBRYOFETOPATHY	0.0227273	0.8526408012069095
ATROPHODERMA VERMICULATA; AVA	0.0227273	0.8526408012069095
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0227273	0.8526408012069095
BETHLEM MYOPATHY 1	0.0227273	0.8526408012069095
SIRENOMELIA	0.0227273	0.8526408012069095
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	0.8526408012069095
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.0227273	0.8526408012069095
THUMB DEFORMITY	0.0227273	0.8526408012069095
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	0.8526408012069095
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	0.8526408012069095
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	0.8526408012069095
MUSCULAR HYPERTONIA, LETHAL	0.0227273	0.8526408012069095
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0227273	0.8526408012069095
WATSON SYNDROME	0.0227273	0.8526408012069095
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	0.8526408012069095
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.022718733999999997	0.8523194378640073
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.022676703	0.8507425965535338
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.022661709000000002	0.8501800793969293
SPINAL ARACHNOIDITIS	0.02265578	0.8499576461421935
NEPHROSIALIDOSIS	0.02265578	0.8499576461421935
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.02265578	0.8499576461421935
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.02265578	0.8499576461421935
PITT-HOPKINS-LIKE SYNDROME	0.022631049	0.8490298342307634
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.022605399999999998	0.8480675824934185
DYSTONIA 28, CHILDHOOD-ONSET	0.022578584	0.847061549408751
RAVINE SYNDROME	0.0225636	0.8464994074136488
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.022546883000000004	0.8458722499301919
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8446087435064701
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.8446087435064701
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.02250458	0.8442852042268545
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.022403858999999998	0.8405065400591636
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.022380124	0.8396160942333663
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.022380124	0.8396160942333663
WYBURN-MASON SYNDROME	0.022363573	0.838995164430848
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.022363573	0.838995164430848
JOUBERT SYNDROME 30; JBTS30	0.022363573	0.838995164430848
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.022363573	0.838995164430848
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.022363573	0.838995164430848
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.022293703999999998	0.8363739485301678
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.022280519000000002	0.8358792980893361
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.022280519000000002	0.8358792980893361
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.022280519000000002	0.8358792980893361
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.022280519000000002	0.8358792980893361
SHUKLA-VERNON SYNDROME; SHUVER	0.022131633	0.8302936685456379
HYPERCALCEMIA, INFANTILE, 1	0.0221203	0.8298684980150393
CHROMOSOME 10Q26 DELETION SYNDROME	0.022081703000000005	0.8284204871644684
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.022055544	0.8274391021905041
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.022001329000000003	0.825405164105583
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.021990333000000004	0.824992636517613
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8241416576818612
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.021906923000000002	0.8218634144266179
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.021843744	0.8194931815710014
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.021829583	0.8189619153675417
JOUBERT SYNDROME 23; JBTS23	0.021822154	0.8186832078874554
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.021819703	0.8185912558032326
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.021818019	0.818528078606239
HUNTINGTON DISEASE; HD	0.021818019	0.818528078606239
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.021818019	0.818528078606239
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.021818019	0.818528078606239
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.021818019	0.818528078606239
KNOBLOCH SYNDROME	0.021786749	0.8173549485884304
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.021756653000000004	0.8162258625309964
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.021756653000000004	0.8162258625309964
PROTEUS SYNDROME	0.0217391	0.8155673415459437
LUMBAR SYNDROME	0.0217391	0.8155673415459437
PTEN HAMARTOMA TUMOR SYNDROME	0.0217391	0.8155673415459437
ANGIOMA, HEREDITARY NEUROCUTANEOUSSPINAL ARTERIAL VENOUS MALFORMATIONS WITH CUTANEOUS HEMANGIOMAS, INCLUDED	0.0217391	0.8155673415459437
PRIMARY MYELOFIBROSIS	0.0217391	0.8155673415459437
PROTEUS-LIKE SYNDROME	0.0217391	0.8155673415459437
HEMANGIOMA-THROMBOCYTOPENIA SYNDROME	0.0217391	0.8155673415459437
LYMPHATIC MALFORMATION 1	0.0217391	0.8155673415459437
MULTIPLE ENCHONDROMATOSIS, MAFFUCCI TYPE	0.0217391	0.8155673415459437
TEMPI SYNDROME	0.0217391	0.8155673415459437
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.0217391	0.8155673415459437
COWDEN SYNDROME 7; CWS7	0.0217391	0.8155673415459437
ENCHONDROMATOSIS, MULTIPLE	0.0217391	0.8155673415459437
VERRUCOUS HEMANGIOMA	0.0217391	0.8155673415459437
ACROCEPHALOSYNDACTYLY	0.0217391	0.8155673415459437
KAPOSI SARCOMA	0.0217391	0.8155673415459437
WITTEVEEN-KOLK SYNDROME	0.021737783	0.8155179327760859
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.021716919	0.8147351958176094
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.02171232	0.8145626590426845
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.021679434000000004	0.8133289029260984
CRANIOFRONTONASAL SYNDROME; CFNS	0.021669224	0.812945863032212
SCARF SYNDROME	0.0216682	0.8129074464943726
SCARF SYNDROME	0.0216682	0.8129074464943726
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.021651563999999998	0.8122833278190843
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.021647428999999996	0.8121281985378679
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.021641214000000002	0.8118950356641655
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.021609753000000006	0.8107147400616626
12Q14 MICRODELETION SYNDROME	0.021583914	0.809745360255773
LEIGH SYNDROME; LS	0.021476403	0.8057119614279953
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.021476403	0.8057119614279953
COFFIN-LOWRY SYNDROME	0.021444888999999998	0.8045296774695294
HYPERPROLINEMIA, TYPE I	0.021430833	0.8040023504618443
BARAITSER-WINTER SYNDROME 2; BRWS2	0.021384459000000005	0.8022625765109058
RABSON-MENDENHALL SYNDROME	0.021378844	0.8020519233273434
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.021374719	0.8018971692076292
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.021287	0.7986062900252772
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7985839303997377
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.0212766	0.7982161220628465
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.0212766	0.7982161220628465
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0212766	0.7982161220628465
KURU, SUSCEPTIBILITY TO	0.0212766	0.7982161220628465
NEUROFERRITINOPATHY	0.0212766	0.7982161220628465
SUSAC SYNDROME	0.0212766	0.7982161220628465
SPINOCEREBELLAR ATAXIA 12	0.0212766	0.7982161220628465
LEBER OPTIC ATROPHY AND DYSTONIA	0.0212766	0.7982161220628465
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.0212766	0.7982161220628465
X-LINKED RETINOSCHISIS	0.0212766	0.7982161220628465
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.0212766	0.7982161220628465
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.02124533	0.7970429920450378
DISTAL MONOSOMY 3P	0.021205259000000004	0.7955396823890225
JUNG SYNDROME	0.021179299999999998	0.7945658006451051
CRANIOFACIAL DYSSYNOSTOSIS	0.02115274	0.7935693716948975
SALT-AND-PEPPER SYNDROME	0.021125533999999998	0.7925487073116386
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.021125533999999998	0.7925487073116386
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.021106009999999998	0.7918162419944754
X SMALL RINGS	0.021062034	0.7901664317717972
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02102928	0.7889376277870419
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02102928	0.7889376277870419
GRANULOMAS, CONGENITAL CEREBRAL	0.02102928	0.7889376277870419
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02102928	0.7889376277870419
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02102928	0.7889376277870419
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.020998583999999997	0.7877860320394675
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.020945833	0.7858070175984885
CYSTINOSIS, NEPHROPATHIC; CTNS	0.020917079999999998	0.784728315730818
LOWRY-MACLEAN SYNDROME	0.020900359	0.7841010081827601
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	0.7815852126642366
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	0.7815852126642366
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.7815852126642366
GAUCHER DISEASE, TYPE I	0.0208333	0.7815852126642366
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	0.7815852126642366
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	0.7815852126642366
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.7815852126642366
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.7815852126642366
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0208333	0.7815852126642366
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.7815852126642366
IMINOGLYCINURIA	0.0208333	0.7815852126642366
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.7815852126642366
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	0.7815852126642366
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.7815852126642366
AGNATHIA-OTOCEPHALY COMPLEX	0.0208333	0.7815852126642366
PUPIL, EGG-SHAPED	0.0208333	0.7815852126642366
STICKLER SYNDROME, TYPE III	0.0208333	0.7815852126642366
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.7815852126642366
DERMOIDS OF CORNEA	0.0208333	0.7815852126642366
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.7815852126642366
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	0.7815852126642366
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0208333	0.7815852126642366
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.7815852126642366
CRANDALL SYNDROME	0.0208333	0.7815852126642366
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.7815852126642366
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	0.7815852126642366
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0208333	0.7815852126642366
UNIQUE GREEN PHENOMENON	0.0208333	0.7815852126642366
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.7781168445751289
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751289
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751289
COPPER DEFICIENCY, FAMILIAL BENIGN	0.020696319	0.776446212889071
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.020669680000000003	0.7754468201629949
MOEBIUS SYNDROME; MBS	0.020669680000000003	0.7754468201629949
WOLCOTT-RALLISON SYNDROME	0.020610059	0.77321006976991
FRYNS SYNDROME	0.020607029	0.7730963958347018
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.02056531	0.7715312595631011
CONGENITAL HYPOTHYROIDISM	0.020545554	0.7707900904990836
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.020545554	0.7707900904990836
WEBB-DATTANI SYNDROME; WEDAS	0.020542583000000003	0.7706786300167394
GYRATE ATROPHY OF CHOROID AND RETINA	0.020541419	0.7706349612178672
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.020502064	0.769158513125419
ICHTHYOSIS, X-LINKED	0.02045458	0.7673770962477209
CHOROIDAL OSTEOMA, BILATERAL	0.02045458	0.7673770962477209
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.02045458	0.7673770962477209
ONCOCYTOMA	0.02045458	0.7673770962477209
DISTAL MONOSOMY 15Q	0.020334263000000005	0.7628632656000501
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.020322824000000003	0.7624341183575265
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.020231073000000002	0.758991974057432
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.020207014	0.7580893729989588
PRIMARY HYPEROXALURIA TYPE 1	0.0201549	0.7561342563456785
CORNELIA DE LANGE SYNDROME 1	0.020148418999999997	0.7558911141760136
SMITH-FINEMAN-MYERS SYNDROME	0.020143928999999998	0.7557226666614643
PALLISTER-KILLIAN SYNDROME	0.020111469000000003	0.7545048924248777
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.020073544000000002	0.7530820924272639
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.020016614	0.7509462979944578
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.02	0.7503230046744748
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6	0.02	0.7503230046744748
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.02	0.7503230046744748
TRICHODISCOMAS, FAMILIAL MULTIPLE	0.02	0.7503230046744748
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.02	0.7503230046744748
CATATRICHY	0.02	0.7503230046744748
TRICHODENTOOSSEOUS SYNDROME	0.02	0.7503230046744748
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.02	0.7503230046744748
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.02	0.7503230046744748
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.02	0.7503230046744748
VAN BOGAERT-HOZAY SYNDROME	0.02	0.7503230046744748
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.02	0.7503230046744748
MIDPHALANGEAL HAIR	0.02	0.7503230046744748
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.02	0.7503230046744748
INHERITED EPIDERMOLYSIS BULLOSA	0.02	0.7503230046744748
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.02	0.7503230046744748
MANITOBA OCULOTRICHOANAL SYNDROME	0.02	0.7503230046744748
STRIATE PALMOPLANTAR KERATODERMA	0.02	0.7503230046744748
FAMILIAL MELANOMA	0.02	0.7503230046744748
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.02	0.7503230046744748
%152800 LYMPHANGIECTASIA, INTESTINAL	0.02	0.7503230046744748
HAIRY NOSE TIP	0.02	0.7503230046744748
HAIR WHORL	0.02	0.7503230046744748
DARIER DISEASE	0.02	0.7503230046744748
DISSECTING CELLULITIS OF THE SCALP	0.02	0.7503230046744748
RINGED HAIR	0.02	0.7503230046744748
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.019997029	0.7502115441921303
BAND HETEROTOPIA; BH	0.019954873	0.7486300133628775
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.019946624	0.7483205426395995
BARDET-BIEDL SYNDROME 1; BBS1	0.019906863999999996	0.7468289005063065
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.019897659999999998	0.7464836018595554
BOHRING-OPITZ SYNDROME	0.019851923000000004	0.7447677256963158
GERMAN SYNDROME	0.019825424	0.7437735852312722
WIEACKER-WOLFF SYNDROME	0.019785633	0.7422807800973221
ATAXIA-TELANGIECTASIA	0.019740449	0.7405856503651614
49,XXXXY SYNDROME	0.019731613	0.7402541576616963
48,XXXY SYNDROME	0.019731613	0.7402541576616963
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.019731613	0.7402541576616963
BAKER-GORDON SYNDROME; BAGOS	0.019687904	0.7386143642511305
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.019580753	0.7345944712374367
ADENYLOSUCCINASE DEFICIENCY	0.019543603	0.733200746256254
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.019466383	0.7303037491352058
WARBURG MICRO SYNDROME 2; WARBM2	0.01945561	0.729899587648738
HHHH SYNDROME	0.019409319	0.7281629275382686
FANCONI ANEMIA	0.01940107	0.7278534568149906
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.01936908	0.7266533151690138
22Q11.2 DELETION SYNDROME	0.019256722999999996	0.7224381130772032
HOYERAAL-HREIDARSSON SYNDROME	0.019255684	0.7223991337971103
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.019237914000000002	0.7217324718074571
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.019227729	0.7213503698173266
OHDO SYNDROME	0.019190469	0.7199525180596182
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.019174189	0.7193417551338132
BARAITSER-WINTER SYNDROME 1; BRWS1	0.019147183	0.7183285939806012
TIMOTHY SYNDROME; TS	0.019093203	0.7163034721909848
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.019082104	0.7158870804395406
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.01907494	0.7156183147392662
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.018944073000000002	0.7107086887066296
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.018941173	0.7105998918709517
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.01890914	0.7093981370305149
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.01890503	0.7092439456530543
POLAND SYNDROME	0.01887237	0.7080186681864208
PUBIC BONE DYSPLASIA	0.0188679	0.707850970994876
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.707850970994876
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.707850970994876
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.707850970994876
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.707850970994876
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.707850970994876
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.707850970994876
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.707850970994876
TOE, MISSHAPEN	0.0188679	0.707850970994876
VAN DEN BOSCH SYNDROME	0.0188679	0.707850970994876
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.707850970994876
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.707850970994876
VESICOURETERAL REFLUX 1	0.0188679	0.707850970994876
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.707850970994876
THROMBOCYTOPENIA 3	0.0188679	0.707850970994876
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.707850970994876
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.707850970994876
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.707850970994876
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.707850970994876
TRACHEOBRONCHOMEGALY	0.0188679	0.707850970994876
RAYNAUD DISEASE	0.0188679	0.707850970994876
CARPAL DISPLACEMENT	0.0188679	0.707850970994876
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.707850970994876
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.707850970994876
MONOPHALANGY OF GREAT TOE	0.0188679	0.707850970994876
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.707850970994876
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.707850970994876
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.707850970994876
KNUCKLE PADS	0.0188679	0.707850970994876
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.707850970994876
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.707850970994876
MEGAEPIPHYSEAL DWARFISM	0.0188679	0.707850970994876
LETTERER-SIWE DISEASE	0.0188679	0.707850970994876
19P13.12 MICRODELETION SYNDROME	0.018848673	0.7071296479743323
2Q31.1 MICRODELETION SYNDROME	0.018848673	0.7071296479743323
SAETHRE-CHOTZEN SYNDROME	0.018775559	0.7043866921661438
CAMPOMELIC DYSPLASIA	0.018686309999999998	0.7010384132739341
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.018686309999999998	0.7010384132739341
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.01861353	0.6983079878599238
ADDUCTED THUMBS SYNDROME	0.01861353	0.6983079878599238
BLOOM SYNDROME	0.01861353	0.6983079878599238
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149318
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.01853655	0.6954199946149318
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.018518193	0.6947313106450912
CONGENITAL ADRENAL HYPERPLASIA	0.018493779999999998	0.6938154288694353
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.01840836	0.6906107993164706
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.018402654	0.6903967321632372
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.018402654	0.6903967321632372
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.018402654	0.6903967321632372
HEREDITARY COPROPORPHYRIA	0.018398519000000002	0.6902416028820207
TENORIO SYNDROME; TNORS	0.018398519000000002	0.6902416028820207
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.01830672	0.686797657806715
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.018179383000000004	0.6820204637844034
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.018155739999999997	0.6811334694444272
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.018146659000000002	0.680792785284155
INTELLECTUAL DISABILITY, WOLFF TYPE	0.018122728999999997	0.6798950238090619
PERIPARTUM CARDIOMYOPATHY	0.018115979999999997	0.6796418273111344
AFRICAN IRON OVERLOAD	0.018115979999999997	0.6796418273111344
2Q37 MICRODELETION SYNDROME	0.018100373	0.6790563127544368
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.018085902999999997	0.6785134540605547
9Q SUBTELOMERIC DELETION SYNDROME	0.01803757	0.6767001859713083
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.017970094000000002	0.6741687462181376
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.017968684	0.674115848446308
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.017968684	0.674115848446308
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.0179537	0.6735537064512058
X-LINKED AGAMMAGLOBULINEMIA	0.0179537	0.6735537064512058
AASE-SMITH SYNDROME	0.01791203	0.6719904084709665
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.017893569999999998	0.6712978603376519
PORPHYRIA CUTANEA TARDA, TYPE I	0.0178571	0.6699296463386282
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.0178571	0.6699296463386282
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.0178571	0.6699296463386282
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.0178571	0.6699296463386282
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.0178571	0.6699296463386282
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.0178571	0.6699296463386282
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.0178571	0.6699296463386282
PAPILLON-LEFÈVRE SYNDROME	0.0178571	0.6699296463386282
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.0178571	0.6699296463386282
DENTAL ANOMALIES AND SHORT STATURE; DASS	0.0178571	0.6699296463386282
ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 2; EKVP2	0.0178571	0.6699296463386282
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.017836303	0.6691494229622175
COHEN SYNDROME	0.017794633	0.6675861249819781
ADENYLOSUCCINATE LYASE DEFICIENCY	0.017752719	0.6660136730610818
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.01774999	0.665911291487094
COFFIN-SIRIS SYNDROME 7; CSS7	0.017749414	0.6658896821845595
ACROCRANIOFACIAL DYSOSTOSIS	0.01774524	0.6657330897734838
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.017680833000000003	0.6633167870853804
GAUCHER DISEASE	0.01754684	0.6582898855671131
AYMÉ-GRIPP SYNDROME	0.017544484	0.6582014975171623
FOUNTAIN SYNDROME	0.017412059	0.6532334213224615
14Q24.1Q24.3 MICRODELETION SYNDROME	0.01739999	0.6527806389052907
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.017399309999999998	0.6527551279231316
FRANK-TER HAAR SYNDROME; FTHS	0.017399309999999998	0.6527551279231316
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.017399309999999998	0.6527551279231316
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.017399309999999998	0.6527551279231316
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.017399309999999998	0.6527551279231316
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.017399309999999998	0.6527551279231316
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.017362040000000002	0.651356901003921
8P11.2 DELETION SYNDROME	0.017319593	0.6497644529749501
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.017317903	0.649701050681055
COCKAYNE SYNDROME	0.017249079	0.6471190391573691
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397245
PALMOMENTAL REFLEX	0.0172414	0.6468309526397245
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6468309526397245
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6468309526397245
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397245
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397245
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397245
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6468309526397245
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6468309526397245
DIASTEMATOMYELIA	0.0172414	0.6468309526397245
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6468309526397245
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397245
MOTION SICKNESS	0.0172414	0.6468309526397245
TRANSSEXUALITY	0.0172414	0.6468309526397245
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397245
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6468309526397245
CERVICAL RIB	0.0172414	0.6468309526397245
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397245
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397245
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397245
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397245
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397245
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6468309526397245
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397245
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397245
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397245
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397245
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6468309526397245
SICKLE CELL ANEMIA	0.0172414	0.6468309526397245
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397245
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6468309526397245
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6468309526397245
MOSAIC TRISOMY 15	0.0172414	0.6468309526397245
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397245
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397245
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397245
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6468309526397245
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397245
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397245
ERYTHERMALGIA, PRIMARY	0.0172414	0.6468309526397245
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397245
TRISOMY 17P	0.017223014	0.6461411807015272
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.017212254	0.6457375069250123
HEREDITARY METHEMOGLOBINEMIA	0.017179839000000002	0.6445214209151863
SALLA DISEASE	0.017069953	0.6403989212306032
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.017045503000000004	0.6394816513573888
1Q21.1 MICRODELETION SYNDROME	0.017033933	0.6390475894991845
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.016996014	0.6376250145984719
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.016988854	0.6373563989627985
ACROFACIAL DYSOSTOSIS, RODRÍGUEZ TYPE	0.01698881	0.6373547482521881
CHST3-RELATED SKELETAL DYSPLASIA	0.01698881	0.6373547482521881
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.01698881	0.6373547482521881
LATERAL MENINGOCELE SYNDROME	0.016858230000000002	0.6324558893546686
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.016798388999999997	0.6302108854085321
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.016793279	0.6300191778808379
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.016772424	0.6292367785677137
DUPLICATION/INVERSION 15Q11	0.016769079	0.6291112870451818
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.016757954	0.6286939198738316
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.01672152	0.6273270564562162
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.016716283999999998	0.6271306218935924
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.01670766	0.6268070826139767
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.016679644	0.6257560301490287
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.0166667	0.6252704211004034
NASOPHARYNGEAL CARCINOMA	0.0166667	0.6252704211004034
BUTYRYLCHOLINESTERASE DEFICIENCY	0.0166667	0.6252704211004034
N SYNDROME	0.0166667	0.6252704211004034
HEPATOCELLULAR CARCINOMA	0.0166667	0.6252704211004034
ANTISYNTHETASE SYNDROME	0.0166667	0.6252704211004034
ACQUIRED PURPURA FULMINANS	0.0166667	0.6252704211004034
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.0166667	0.6252704211004034
PRIMARY PERITONEAL CARCINOMA	0.0166667	0.6252704211004034
%165660 OSLAM SYNDROME;;OSTEOSARCOMA, LIMB ANOMALIES, AND MACROCYTOSIS;;OSTEOSARCOMA, LIMB ANOMALIES, AND ERYTHROID MACROCYTOSIS WITH MEGALOBLASTICMARROW	0.0166667	0.6252704211004034
ADAMANTINOMA OF LONG BONES	0.0166667	0.6252704211004034
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.0166667	0.6252704211004034
PERITONEAL CYSTIC MESOTHELIOMA	0.0166667	0.6252704211004034
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.0166667	0.6252704211004034
MALIGNANT PERITONEAL MESOTHELIOMA	0.0166667	0.6252704211004034
BROOKE-SPIEGLER SYNDROME; BSS	0.0166667	0.6252704211004034
HURIEZ SYNDROME; HRZ	0.0166667	0.6252704211004034
TRIGEMINAL NEURALGIA	0.0166667	0.6252704211004034
THYMOMA, FAMILIAL	0.0166667	0.6252704211004034
CANCER, FAMILIAL, WITH IN VITRO RADIORESISTANCE	0.0166667	0.6252704211004034
PAGET DISEASE, EXTRAMAMMARY	0.0166667	0.6252704211004034
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.0166667	0.6252704211004034
KAPOSI SARCOMA, SUSCEPTIBILITY TO	0.0166667	0.6252704211004034
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.0166667	0.6252704211004034
117600 CEREBRAL SARCOMA	0.0166667	0.6252704211004034
SECONDARY INTESTINAL LYMPHANGIECTASIA	0.0166667	0.6252704211004034
CHYLOUS ASCITES	0.0166667	0.6252704211004034
GALACTOSEMIA	0.016549303	0.620866137611415
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.016538453999999998	0.6204591248975292
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.016534319	0.6203039956163128
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.016534319	0.6203039956163128
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.016499949000000003	0.6190145655327798
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.016496784	0.6188958269172901
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.01648744	0.618545276009506
HALLERMANN-STREIFF SYNDROME; HSS	0.01645142	0.6171939442780874
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.016435503	0.6165967997148172
OGDEN SYNDROME; OGDNS	0.016428064	0.6163177170732285
VASCULAR EHLERS-DANLOS SYNDROME	0.016356324000000002	0.6136263084554613
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.01633598	0.6128630798951062
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965498
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6115698981965498
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.6115698981965498
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6115698981965498
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.01628788	0.6110585530688643
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.016287583999999997	0.611047448288395
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.016267203	0.6102828316304815
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.016246633	0.6095111244201739
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.016214684	0.6083125209363566
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.01613409	0.6052889443244198
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.01613409	0.6052889443244198
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.016072573	0.6029810633104918
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.016072573	0.6029810633104918
KLEEFSTRA SYNDROME	0.016069303	0.6028583854992275
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.016062384	0.6025988112557603
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.016030903	0.6014177653302525
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.016021744	0.601074154910262
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.016007884	0.6005541810680225
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.016007884	0.6005541810680225
HARDIKAR SYNDROME	0.015992899999999997	0.5999920390729202
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.015967962999999998	0.5990564988345419
COSTELLO SYNDROME	0.01595123	0.5984287410926812
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.015930693000000003	0.5976582719153312
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.01590154	0.5965645635875673
14Q12 MICRODELETION SYNDROME	0.015894539	0.596301913019781
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.01589181	0.5961995314457932
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.01588199	0.595831122850498
FREE SIALIC ACID STORAGE DISEASE	0.015792873	0.5924877960901193
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.015792873	0.5924877960901193
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.015788603000000002	0.5923276021286215
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.015772473999999998	0.5917225041415014
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.015750683999999997	0.5909050272279086
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.015746933	0.5907643041483821
KOOLEN-DE VRIES SYNDROME	0.015746933	0.5907643041483821
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.015746549	0.5907498979466922
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.015742029999999997	0.590580362463786
MONOSOMY 18P	0.015725064	0.5899438634589207
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.015716844	0.5896354807039995
TOLUENE EMBRYOPATHY	0.015701853999999998	0.5890731136119959
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.01569499	0.5888156027567917
DERMATITIS, ATOPIC	0.015692679999999997	0.5887289404497517
BARATELA-SCOTT SYNDROME	0.015606894	0.5855105799858016
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.015565809000000002	0.5839692289534492
CEREBROFACIOTHORACIC DYSPLASIA	0.01555024	0.5833851400104603
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.015531153999999998	0.5826691067670993
2Q23.1 MICRODELETION SYNDROME	0.015523748999999998	0.5823912996746186
KLEEFSTRA SYNDROME	0.015523748999999998	0.5823912996746186
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.015485348999999997	0.5809506795056435
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.5804106345230291
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5804106345230291
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.015356238999999999	0.5761069693489675
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.015328613999999999	0.5750705856987609
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.015328613999999999	0.5750705856987609
BRANCHIOSKELETOGENITAL SYNDROME	0.015326929	0.575007370985617
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01531241	0.5744626740003738
OSTEOMESOPYKNOSIS	0.01528218	0.5733285607788082
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.015251454	0.5721758395467268
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.015251454	0.5721758395467268
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.015251454	0.5721758395467268
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.015251454	0.5721758395467268
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.015247318999999999	0.5720207102655103
ADAMS-OLIVER SYNDROME 5; AOS5	0.015247318999999999	0.5720207102655103
HYPOPHOSPHATASIA	0.015247318999999999	0.5720207102655103
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.015247184	0.5720156455852289
BOHRING-OPITZ SYNDROME	0.015246583	0.5719930983789383
OCULOCEREBRORENAL SYNDROME OF LOWE	0.015223638999999999	0.5711323278279757
AMISH LETHAL MICROCEPHALY	0.015206089999999998	0.5704739569075241
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.015136933000000002	0.5678794525058106
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.015043179	0.564362163356798
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.015001303	0.5627911370496106
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.015001303	0.5627911370496106
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.015001303	0.5627911370496106
19P13.3 MICRODUPLICATION SYNDROME	0.015000583999999997	0.5627641629375925
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.015000583999999997	0.5627641629375925
DISTAL MONOSOMY 1Q	0.014997943	0.5626650827848253
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.014941288999999998	0.5605396428094839
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5599435486984202
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5599435486984202
NIEMANN-PICK DISEASE TYPE B	0.014925399999999998	0.5599435486984202
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5599435486984202
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5599435486984202
MEHMO SYNDROME	0.014916439	0.5596073664761758
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.014905313000000002	0.5591899617886755
DISTAL MONOSOMY 10P	0.014903679999999999	0.5591286979153437
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.014898980000000001	0.5589523720092453
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.014898980000000001	0.5589523720092453
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.014898980000000001	0.5589523720092453
KERATOSIS, FAMILIAL ACTINIC	0.014898980000000001	0.5589523720092453
GLOMUVENOUS MALFORMATIONS	0.014898980000000001	0.5589523720092453
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.014880989999999998	0.5582774564665405
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.014832303	0.5564509076601113
MONOSOMY 22Q13.3	0.014832303	0.5564509076601113
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.014785572999999998	0.5546977779596893
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.014785572999999998	0.5546977779596893
PEHO SYNDROME; PEHO	0.014785572999999998	0.5546977779596893
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.014785572999999998	0.5546977779596893
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.014785572999999998	0.5546977779596893
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.014785572999999998	0.5546977779596893
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.014785572999999998	0.5546977779596893
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.014785572999999998	0.5546977779596893
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.014785572999999998	0.5546977779596893
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.014785572999999998	0.5546977779596893
DESMOSTEROLOSIS	0.014783059999999999	0.554603499874152
SHPRINTZEN-GOLDBERG SYNDROME	0.014783059999999999	0.554603499874152
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.0147059	0.5517087537221178
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.0147059	0.5517087537221178
RIGHT PULMONARY ARTERY, ANOMALOUS ORIGIN OF, FAMILIAL	0.0147059	0.5517087537221178
LAMBERT SYNDROME	0.0147059	0.5517087537221178
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.0147059	0.5517087537221178
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.0147059	0.5517087537221178
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.0147059	0.5517087537221178
HIRSCHSPRUNG DISEASE	0.0147059	0.5517087537221178
HYPERTELORISM AND TETRALOGY OF FALLOT	0.0147059	0.5517087537221178
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.0147059	0.5517087537221178
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.0147059	0.5517087537221178
COMMON VARIABLE IMMUNODEFICIENCY	0.0147059	0.5517087537221178
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.0147059	0.5517087537221178
GLYCOGEN STORAGE DISEASE VI	0.0147059	0.5517087537221178
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.0147059	0.5517087537221178
HEREDITARY PULMONARY ALVEOLAR PROTEINOSIS	0.0147059	0.5517087537221178
FIBROCHONDROGENESIS 1; FBCG1	0.0147059	0.5517087537221178
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.0147059	0.5517087537221178
TRICUSPID ATRESIA	0.0147059	0.5517087537221178
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0147059	0.5517087537221178
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.0147059	0.5517087537221178
FLOATING-HARBOR SYNDROME	0.014692804	0.551217442218657
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.0146757	0.5505757659850594
DIAMOND-BLACKFAN ANEMIA 1	0.01466831	0.5502985216348322
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.014659960000000001	0.5499852617803807
SCHISIS ASSOCIATION	0.0146543	0.5497729203700578
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.014627152999999999	0.5487544694396629
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.014574634	0.5467841587455379
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.014569073	0.5465755314340881
DUBOWITZ SYNDROME	0.01450176	0.5440502068134055
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.014501603	0.5440443167778188
OTOPALATODIGITAL SYNDROME TYPE 2	0.014490754000000002	0.5436373040639333
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.014470489999999999	0.542877076795597
HEART DEFECTS-LIMB SHORTENING SYNDROME	0.014470489999999999	0.542877076795597
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.014459884000000001	0.5424791805062181
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.014459884000000001	0.5424791805062181
DUPLICATION OF THE PITUITARY GLAND	0.014459884000000001	0.5424791805062181
ALAZAMI SYNDROME; ALAZS	0.014459884	0.5424791805062181
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.014459884	0.5424791805062181
FORSYTHE-WAKELING SYNDROME; FWS	0.014459884	0.5424791805062181
COSTELLO SYNDROME; CSTLO	0.014457434000000002	0.5423872659381456
MENTAL RETARDATION, X-LINKED 102	0.014455749	0.5423240512250017
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.014455749	0.5423240512250017
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.014455749	0.5423240512250017
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.01444966	0.5420956153862285
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.014423080000000001	0.5410984361130162
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.014423080000000001	0.5410984361130162
HEART-HAND SYNDROME TYPE 2	0.014423080000000001	0.5410984361130162
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.014422173000000002	0.5410644089647542
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.014422173000000002	0.5410644089647542
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.014422173000000002	0.5410644089647542
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.014422173000000002	0.5410644089647542
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.014422173000000002	0.5410644089647542
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.014399869999999999	0.5402276862660913
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.014380503000000003	0.539501110984515
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.014380503000000003	0.539501110984515
20Q11.2 MICRODUPLICATION SYNDROME	0.014343403000000001	0.5381092618108438
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.01430491	0.536665152639897
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.01430491	0.536665152639897
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.014278772999999998	0.535684593021238
MIRAGE SYNDROME; MIRAGE	0.014244873	0.5344127955283149
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.014244873	0.5344127955283149
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.5343858214162969
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.014244153999999998	0.5343858214162969
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.5343858214162969
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.014241512999999999	0.5342867412635296
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.014240018999999998	0.5342306921350803
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.014240018999999998	0.5342306921350803
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.014240018999999998	0.5342306921350803
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.014240018999999998	0.5342306921350803
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.014240018999999998	0.5342306921350803
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.014212203	0.5331871429001792
BOWEN-CONRADI SYNDROME	0.014199769000000001	0.5327206670881731
%608572 BURN-MCKEOWN SYNDROME	0.01417148	0.5316593727142113
PMM2-CDG	0.014148883000000001	0.5308116202673798
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.014083284	0.5283505983281978
FUMARASE DEFICIENCY; FMRD	0.014083284	0.5283505983281978
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.014083284	0.5283505983281978
MARDEN-WALKER SYNDROME	0.014083283999999998	0.5283505983281976
ACROOSTEOLYSIS DOMINANT TYPE	0.01407075	0.5278803709011683
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.014038503	0.5266705876045814
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.014038503	0.5266705876045814
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.014038503	0.5266705876045814
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.014034643	0.5265257752646791
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.014027654	0.5262635748906958
PRIMARY PULMONARY HYPOPLASIA	0.013948229999999999	0.5232838921745324
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.013945200000000001	0.5231702182393243
WEAVER-WILLIAMS SYNDROME	0.01391433	0.5220120946816093
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.01391433	0.5220120946816093
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.01391433	0.5220120946816093
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.01391433	0.5220120946816093
MEIER-GORLIN SYNDROME 8; MGORS8	0.01391433	0.5220120946816093
SECKEL SYNDROME 4	0.01391433	0.5220120946816093
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.01391097	0.5218860404168238
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.013906559999999998	0.5217205941942931
HYDROLETHALUS	0.01389787	0.5213945788487621
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.013876619000000001	0.5205973231401453
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.013850920000000001	0.5196331955952889
MENTAL RETARDATION, X-LINKED 1	0.013834949000000003	0.519034025159906
JOUBERT SYNDROME	0.013826602999999998	0.5187209153700553
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.013814534	0.5182681329528845
TRISOMY 9P	0.013801984000000002	0.5177973052674513
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.01374533	0.5156718652921098
NETHERTON SYNDROME; NETH	0.013737353999999998	0.5153726364778457
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.013733218999999998	0.5152175071966292
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.013711853000000001	0.5144159371307356
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.013703454	0.5141008389849224
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.5139187355916879
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.5139187355916879
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.5139187355916879
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.5139187355916879
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.5139187355916879
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.013698599999999998	0.5139187355916879
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.5139187355916879
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.5139187355916879
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.5139187355916879
CONGENITAL HYDROCEPHALUS	0.013691548999999999	0.5136542092163899
NOONAN SYNDROME 7; NS7	0.013691509	0.5136527085703806
MONOSOMY 5P	0.01365835	0.5124087105447807
TRISOMY 18P	0.01365835	0.5124087105447807
MONOSOMY 22	0.013540179999999999	0.5079754270716614
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.013497084000000001	0.506358631061189
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.01344043	0.5042331910858475
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.01344043	0.5042331910858475
GENITOPALATOCARDIAC SYNDROME	0.013414630000000002	0.5032652744098175
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.013414630000000002	0.5032652744098175
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.013414630000000002	0.5032652744098175
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.013337703	0.5003792695207877
8P INVERTED DUPLICATION/DELETION SYNDROME	0.013325169	0.4999090420937583
ADAMS-OLIVER SYNDROME 1; AOS1	0.013294173000000001	0.4987461915011138
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.013294173000000001	0.4987461915011138
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.013282073	0.4982922460832857
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.013282073	0.4982922460832857
ELEJALDE DISEASE	0.013282073	0.4982922460832857
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.013256430000000001	0.4973302194428424
BLOOM SYNDROME	0.013256430000000001	0.4973302194428424
TRISOMY 4P	0.013243399999999999	0.49684138400529687
OCULO-PALATO-CEREBRAL SYNDROME	0.013206784	0.4954676926483389
TONNE-KALSCHEUER SYNDROME; TOKAS	0.013206784	0.4954676926483389
CEREBROFACIOARTICULAR SYNDROME	0.013206784	0.4954676926483389
LOWRY-MACLEAN SYNDROME	0.013206784	0.4954676926483389
CHOPS SYNDROME; CHOPS	0.013203754000000002	0.4953540187131308
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.013203754000000002	0.4953540187131308
CHROMOSOME 15Q25 DELETION SYNDROME	0.013203754000000002	0.4953540187131308
NOONAN SYNDROME 2; NS2	0.013203754000000002	0.4953540187131308
NOONAN SYNDROME 9; NS9	0.013203754000000002	0.4953540187131308
OCULOFACIOCARDIODENTAL SYNDROME	0.013203754000000002	0.4953540187131308
OROFACIODIGITAL SYNDROME I; OFD1	0.013202648999999999	0.4953125633671224
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.013202648999999999	0.4953125633671224
CASPASE 8 DEFICIENCY	0.013191799999999998	0.4949055506532367
CYSTIC FIBROSIS	0.013191799999999998	0.4949055506532367
LYSINURIC PROTEIN INTOLERANCE	0.013191799999999998	0.4949055506532367
IMMUNODEFICIENCY 58; IMD58	0.013191799999999998	0.4949055506532367
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.013191799999999998	0.4949055506532367
GRANGE SYNDROME; GRNG	0.0131579	0.49363375316031355
FG SYNDROME 2; FGS2	0.0131579	0.49363375316031355
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.0131579	0.49363375316031355
SHORT STATURE DUE TO GHSR DEFICIENCY	0.0131579	0.49363375316031355
ANTERIOR CUTANEOUS NERVE ENTRAPMENT SYNDROME	0.0131579	0.49363375316031355
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 63	0.0131579	0.49363375316031355
MACS SYNDROME	0.0131579	0.49363375316031355
OROFACIODIGITAL SYNDROME XVII	0.0131579	0.49363375316031355
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.0131579	0.49363375316031355
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.0131579	0.49363375316031355
OVARIAN DYSGENESIS 4; ODG4	0.0131579	0.49363375316031355
RUIJS-AALFS SYNDROME; RJALS	0.0131579	0.49363375316031355
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.0131579	0.49363375316031355
SMITH-MCCORT DYSPLASIA 2; SMC2	0.0131579	0.49363375316031355
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.01315454	0.49350769889552826
CRANIOECTODERMAL DYSPLASIA 4	0.01315454	0.49350769889552826
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.013150129999999998	0.49334225267299747
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.013135173000000002	0.49278112361395177
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.013135173000000002	0.49278112361395177
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.013135173000000002	0.49278112361395177
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.013135173000000002	0.49278112361395177
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.013135173000000002	0.49278112361395177
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.013135173000000002	0.49278112361395177
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.013135173000000002	0.49278112361395177
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.013135173000000002	0.49278112361395177
LISSENCEPHALY 1; LIS1	0.013135173000000002	0.49278112361395177
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.013135173000000002	0.49278112361395177
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.01312523	0.4924081005321778
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.013105144	0.49165455113858325
AU-KLINE SYNDROME; AUKS	0.013045554000000001	0.4894189637461557
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.013045554000000001	0.4894189637461557
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.013045554000000001	0.4894189637461557
MECKEL SYNDROME, TYPE 10; MKS10	0.013041419	0.4892638344649392
ROIFMAN SYNDROME; RFMN	0.013005674000000002	0.4879228196748348
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.012991772999999998	0.48740130767043566
ALSTRÖM SYNDROME	0.012991772999999998	0.48740130767043566
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.012991772999999998	0.48740130767043566
NETHERTON SYNDROME	0.012991772999999998	0.48740130767043566
RECOMBINANT 8 SYNDROME	0.012991733	0.48739980702442637
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.01298533	0.4871595911144799
NEONATAL ADRENOLEUKODYSTROPHY	0.012982038999999999	0.48703612546406067
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.012951530000000001	0.48589154523658
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.012951530000000001	0.48589154523658
FACIOCARDIOMELIC SYNDROME	0.012951530000000001	0.48589154523658
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.012926779	0.484962983002145
16P12.1P12.3 TRIPLICATION SYNDROME	0.012915929999999999	0.4845559702882594
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012796284	0.4800673129773953
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.012796284	0.4800673129773953
RING CHROMOSOME 14 SYNDROME	0.012796284	0.4800673129773953
BETA-UREIDOPROPIONASE DEFICIENCY	0.012796284	0.4800673129773953
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.01278375	0.47959708555036584
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.012781299999999999	0.4795051709822931
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.012757573	0.4786150252856976
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.012740654	0.47798028953989324
LERI PLEONOSTEOSIS	0.012739629999999998	0.4779418730020539
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.012736519	0.47782516025867683
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.012728263	0.47751542692234716
MILLER-DIEKER SYNDROME (MDS)	0.012661229999999999	0.47500060682372997
TRIPLOIDY	0.012658200000000001	0.47488693288852185
ATRIAL SEPTAL DEFECT-ATRIOVENTRICULAR CONDUCTION DEFECTS SYNDROME	0.012658200000000001	0.47488693288852185
CONGENITAL LARYNGEAL WEB	0.012658200000000001	0.47488693288852185
AUTOSOMAL RECESSIVE AMELIA	0.012658200000000001	0.47488693288852185
NEURONAL INTESTINAL PSEUDOOBSTRUCTION	0.012658200000000001	0.47488693288852185
CONGENITAL PULMONARY VENOUS RETURN ANOMALY	0.012658200000000001	0.47488693288852185
MELNICK-NEEDLES SYNDROME	0.012658200000000001	0.47488693288852185
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.012658200000000001	0.47488693288852185
CONGENITAL PULMONARY VEINS ATRESIA OR STENOSIS	0.012658200000000001	0.47488693288852185
CONGENITAL PERICARDIUM ANOMALY	0.012658200000000001	0.47488693288852185
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.012658200000000001	0.47488693288852185
TRACHEAL AGENESIS	0.012658200000000001	0.47488693288852185
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.012658200000000001	0.47488693288852185
DIPROSOPUS	0.012658200000000001	0.47488693288852185
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.012658200000000001	0.47488693288852185
NOONAN SYNDROME 10; NS10	0.012658200000000001	0.47488693288852185
%601612 LUNG AGENESIS, CONGENITAL HEART DEFECTS, AND THUMB ANOMALIES SYNDROME;LACHT;;MARDINI-NYHAN ASSOCIATION	0.012658200000000001	0.47488693288852185
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.012657599000000002	0.4748643856822314
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.012593754000000002	0.4724691670705593
HYPERMANGANESEMIA WITH DYSTONIA 2	0.012593754000000002	0.4724691670705593
RETT SYNDROME; RTT	0.012589619000000002	0.47231403778934283
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.012589619000000002	0.47231403778934283
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.012589619000000002	0.47231403778934283
XP22.3 MICRODELETION SYNDROME	0.0125	0.46895187792154674
VAN MALDERGEM SYNDROME 1; VMLDS1	0.0125	0.46895187792154674
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.0125	0.46895187792154674
ISOTRETINOIN SYNDROME	0.0125	0.46895187792154674
NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD	0.0125	0.46895187792154674
VAN MALDERGEM SYNDROME 2; VMLDS2	0.0125	0.46895187792154674
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.012493139	0.46869447961479316
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.012493139	0.46869447961479316
JOHANSON-BLIZZARD SYNDROME; JBS	0.01247613	0.4680563674154677
KAGAMI-OGATA SYNDROME	0.012466523	0.4676959497601723
ERYTHROKERATODERMIA VARIABILIS	0.01246212	0.4675307661506933
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.012450353999999999	0.4670893511270432
IMMUNODEFICIENCY 23; IMD23	0.012450353999999999	0.4670893511270432
48,XYYY SYNDROME	0.012450353999999999	0.4670893511270432
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.012450353999999999	0.4670893511270432
ALSTROM SYNDROME; ALMS	0.012450353999999999	0.4670893511270432
7P22.1 MICRODUPLICATION SYNDROME	0.012450353999999999	0.4670893511270432
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.012450314	0.4670878504810339
RITSCHER-SCHINZEL SYNDROME 1	0.012450314	0.4670878504810339
9Q21.13 MICRODELETION SYNDROME	0.012446218999999998	0.4669342218458267
47,XYY SYNDROME	0.012446218999999998	0.4669342218458267
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.012446218999999998	0.4669342218458267
BERNARD-SOULIER SYNDROME	0.012446218999999998	0.4669342218458267
KAPUR-TORIELLO SYNDROME	0.012446179	0.46693272119981744
CAMOS SYNDROME	0.012408949	0.4655359949266159
COFFIN-SIRIS SYNDROME 6; CSS6	0.012371304	0.46412369945106735
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.01235643	0.46356568423249095
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.012347993	0.46324916047296905
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.012316329	0.4620612490919685
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.012282263	0.4607832239181064
FEINGOLD SYNDROME	0.01225073	0.45960022715278637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.01225073	0.45960022715278637
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.01221733	0.45834718773498
11P15.4 MICRODUPLICATION SYNDROME	0.012210443	0.45808881400832036
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.0121951	0.4575132037152843
CATARACT 48; CTRCT48	0.0121951	0.4575132037152843
609612 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, WITH SYNERGISTIC DIVERGENCE;;CONGENITAL FIBROSIS SYNDROME WITH SYNERGISTIC DIVERGENCE;;EXTERNAL OPHTHALMOPLEGIA WITH SYNERGISTIC DIVERGENCEEXTERNAL OPHTHALMOPLEGIA, SYNERGISTIC DIVERGENCE, JAW WINKING, ANDOCULOCUTANEOUS HYPOPIGMENTATION, INCLUDED	0.0121951	0.4575132037152843
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.0121951	0.4575132037152843
JUBERG-MARSIDI SYNDROME	0.0121951	0.4575132037152843
X-LINKED INTELLECTUAL DISABILITY, MILES-CARPENTER TYPE	0.0121951	0.4575132037152843
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.0121951	0.4575132037152843
RHYNS SYNDROME; RHYNS	0.0121951	0.4575132037152843
LOEYS-DIETZ SYNDROME 3; LDS3	0.0121951	0.4575132037152843
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.0121951	0.4575132037152843
LELIS SYNDROME	0.0121951	0.4575132037152843
ACHROMATOPSIA	0.0121951	0.4575132037152843
COMBINED HAMARTOMA OF THE RETINA AND RETINAL PIGMENT EPITHELIUM	0.0121951	0.4575132037152843
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.012174484	0.4567397707620659
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.012136193	0.4553032398534664
WAARDENBURG SYNDROME TYPE 1	0.01211618	0.45455242913883886
MCDONOUGH SYNDROME	0.01211618	0.45455242913883886
GAUCHER DISEASE, TYPE II	0.012093883	0.4537159315370775
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.012048200000000002	0.45200208124595037
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.012048200000000002	0.45200208124595037
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.012048200000000002	0.45200208124595037
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.4516889714560996
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012039854	0.4516889714560996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.012039854	0.4516889714560996
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.012039854	0.4516889714560996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.4516889714560996
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.012039854	0.4516889714560996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012039854	0.4516889714560996
COLE-CARPENTER SYNDROME	0.012039854	0.4516889714560996
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.012035718999999999	0.4515338421748832
MUCOPOLYSACCHARIDOSIS TYPE 3	0.012035718999999999	0.4515338421748832
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.012035718999999999	0.4515338421748832
SIALIDOSIS TYPE 1	0.012035718999999999	0.4515338421748832
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.011979963	0.4494420917024517
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.011979963	0.4494420917024517
XQ28 (MECP2) DUPLICATION	0.011979963	0.4494420917024517
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.011938292999999999	0.4478787937222124
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.011938292999999999	0.4478787937222124
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.011938292999999999	0.4478787937222124
TYSHCHENKO SYNDROME	0.011925104	0.4473839932167799
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.011904799999999998	0.44662226530243426
NF1-MICRODELETION SYNDROME	0.011904799999999998	0.44662226530243426
AA AMYLOIDOSIS	0.011904799999999998	0.44662226530243426
ICHTHYOSIS VULGARIS	0.011904799999999998	0.44662226530243426
MASTOCYTOSIS	0.011904799999999998	0.44662226530243426
NEUTROPHIL CHEMOTACTIC RESPONSE	0.011904799999999998	0.44662226530243426
IGE RESPONSIVENESS, ATOPIC	0.011904799999999998	0.44662226530243426
BRONCHIAL NEUROENDOCRINE TUMOR	0.011904799999999998	0.44662226530243426
FIBULAR HEMIMELIA	0.011904799999999998	0.44662226530243426
SYSTEMIC MASTOCYTOSIS	0.011904799999999998	0.44662226530243426
EOSINOPHILIC GASTROENTERITIS	0.011904799999999998	0.44662226530243426
184800 STERNUM, PREMATURE OBLITERATION OF SUTURES OF	0.011904799999999998	0.44662226530243426
CUTANEOUS MASTOCYTOSIS	0.011904799999999998	0.44662226530243426
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.011904799999999998	0.44662226530243426
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.011904799999999998	0.44662226530243426
MYOTONIA PERMANENS	0.011904799999999998	0.44662226530243426
YAO SYNDROME	0.011904799999999998	0.44662226530243426
%614100 CUTIS LAXA, NEONATAL, WITH MARFANOID PHENOTYPE;;CUTIS LAXA-MARFANOID SYNDROME	0.011904799999999998	0.44662226530243426
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.011904799999999998	0.44662226530243426
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.011904799999999998	0.44662226530243426
AORTIC ARCH DEFECTS	0.011904799999999998	0.44662226530243426
IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	0.011904799999999998	0.44662226530243426
CARCINOID SYNDROME	0.011904799999999998	0.44662226530243426
CHILBLAIN LUPUS	0.011904799999999998	0.44662226530243426
ASTHMA, SUSCEPTIBILITY TO	0.011904799999999998	0.44662226530243426
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	0.011904799999999998	0.44662226530243426
CAT-EYE SYNDROME (TYPE I)	0.011904799999999998	0.44662226530243426
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.011904799999999998	0.44662226530243426
22Q11 DELETION SYNDROME (VELOCARDIOFACIAL / DIGEORGE SYNDROME)	0.011904799999999998	0.44662226530243426
COMBINED IMMUNODEFICIENCY DUE TO DOCK8 DEFICIENCY	0.011904799999999998	0.44662226530243426
CILIARY DYSKINESIA, PRIMARY, 30; CILD30	0.011904799999999998	0.44662226530243426
TIBIA, HYPOPLASIA OR APLASIA OF, WITH POLYDACTYLY	0.011904799999999998	0.44662226530243426
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.011904799999999998	0.44662226530243426
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.011904799999999998	0.44662226530243426
ASTHMA, SHORT STATURE, AND ELEVATED IGA	0.011904799999999998	0.44662226530243426
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.011904799999999998	0.44662226530243426
KERATOSIS PILARIS ATROPHICANS	0.011904799999999998	0.44662226530243426
POTASSIUM-AGGRAVATED MYOTONIA	0.011904799999999998	0.44662226530243426
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.011904799999999998	0.44662226530243426
MICROTRIPLICATION 11Q24.1	0.0118799	0.4456881131616146
SAY SYNDROME	0.011867530000000001	0.4452240383832235
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.011765403	0.441392626508304
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.011664889	0.4376217281837114
CURRY-JONES SYNDROME	0.011656654	0.4373127826865368
HYPERTELORISM, TEEBI TYPE	0.011628929999999999	0.43627268493745697
ACROMEGALY	0.01158752	0.4347191411562785
PRIMROSE SYNDROME; PRIMS	0.01158752	0.4347191411562785
SOMATOMAMMOTROPINOMA	0.01158752	0.4347191411562785
DIASTROPHIC DWARFISM	0.011494299999999999	0.4312218856314908
MULTIPLE EPIPHYSEAL DYSPLASIA	0.011494299999999999	0.4312218856314908
ACHONDROPLASIA	0.011494299999999999	0.4312218856314908
RADIO-RENAL SYNDROME	0.011494299999999999	0.4312218856314908
MUCOPOLYSACCHARIDOSIS TYPE 1	0.011494299999999999	0.4312218856314908
LETHAL CONGENITAL CONTRACTURE SYNDROME TYPE 1	0.011494299999999999	0.4312218856314908
SHORT RIB-POLYDACTYLY SYNDROME	0.011494299999999999	0.4312218856314908
SOLITARY BONE CYST	0.011494299999999999	0.4312218856314908
MUCOLIPIDOSIS TYPE III	0.011494299999999999	0.4312218856314908
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.011494299999999999	0.4312218856314908
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.011494299999999999	0.4312218856314908
ULNA METAPHYSEAL DYSPLASIA SYNDROME	0.011494299999999999	0.4312218856314908
KUSKOKWIM SYNDROME	0.011494299999999999	0.4312218856314908
ISOLATED CLOVERLEAF SKULL SYNDROME	0.011494299999999999	0.4312218856314908
SPONDYLOENCHONDRODYSPLASIA	0.011494299999999999	0.4312218856314908
FRONTOMETAPHYSEAL DYSPLASIA	0.011494299999999999	0.4312218856314908
METATROPIC DYSPLASIA	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.011494299999999999	0.4312218856314908
HYPOCHONDROPLASIA	0.011494299999999999	0.4312218856314908
FAMILIAL SCHEUERMANN DISEASE	0.011494299999999999	0.4312218856314908
ROBIN SEQUENCE-OLIGODACTYLY SYNDROME	0.011494299999999999	0.4312218856314908
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.011494299999999999	0.4312218856314908
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.011494299999999999	0.4312218856314908
WEISMANN-NETTER SYNDROME	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.011494299999999999	0.4312218856314908
KYPHOMELIC DYSPLASIA	0.011494299999999999	0.4312218856314908
CENANI-LENZ SYNDROME	0.011494299999999999	0.4312218856314908
PELVIS-SHOULDER DYSPLASIA	0.011494299999999999	0.4312218856314908
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.011494299999999999	0.4312218856314908
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.011494299999999999	0.4312218856314908
FIBROCHONDROGENESIS	0.011494299999999999	0.4312218856314908
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4312218856314908
MYCETOMA	0.011494299999999999	0.4312218856314908
ENDOSTEAL HYPEROSTOSIS, WORTH TYPE	0.011494299999999999	0.4312218856314908
ADAMS-OLIVER SYNDROME	0.011477109000000001	0.43057694549282277
BRANCHIOOCULOFACIAL SYNDROME	0.011471749	0.4303758589275701
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.011470573	0.43033173993489515
RETT SYNDROME	0.011434409	0.42897500587784276
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.011396874	0.42756683717882
19P13.13 MICRODELETION SYNDROME	0.011379763	0.4269248983321707
INDOMETHACIN EMBRYOFETOPATHY	0.01137955	0.426916907392171
EBSTEIN MALFORMATION	0.01137955	0.426916907392171
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.011237589	0.42159107718884126
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.011237589	0.42159107718884126
WAARDENBURG SYNDROME, TYPE 1; WS1	0.01112347	0.417309771640319
PSEUDOATROPHODERMA COLLI	0.0111111	0.41684569686192785
NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES	0.0111111	0.41684569686192785
PILONIDAL SINUS	0.0111111	0.41684569686192785
PRENATAL BOWING	0.0111111	0.41684569686192785
PIGMENTED PURPURIC ERUPTION	0.0111111	0.41684569686192785
PERIODONTITIS, AGGRESSIVE, 1	0.0111111	0.41684569686192785
POLYVALVULAR HEART DISEASE SYNDROME	0.0111111	0.41684569686192785
SIMOSA CRANIOFACIAL SYNDROME	0.0111111	0.41684569686192785
HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS	0.0111111	0.41684569686192785
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.0111111	0.41684569686192785
PAPILLOMATOSIS, FLORID, OF NIPPLE	0.0111111	0.41684569686192785
TRICHILEMMAL CYST 1	0.0111111	0.41684569686192785
PARANA HARD-SKIN SYNDROME	0.0111111	0.41684569686192785
SYRINGOMAS, MULTIPLE	0.0111111	0.41684569686192785
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.0111111	0.41684569686192785
PATELLA APLASIA-HYPOPLASIA	0.0111111	0.41684569686192785
TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL	0.0111111	0.41684569686192785
URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	0.0111111	0.41684569686192785
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1	0.0111111	0.41684569686192785
EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	0.0111111	0.41684569686192785
COMEDONES, FAMILIAL DYSKERATOTIC	0.0111111	0.41684569686192785
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.0111111	0.41684569686192785
SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE	0.0111111	0.41684569686192785
INSECT STINGS, HYPERSENSITIVITY TO	0.0111111	0.41684569686192785
TYROSINE TRANSAMINASE DEFICIENCY	0.0111111	0.41684569686192785
DERMAL RIDGES, PATTERNLESS	0.0111111	0.41684569686192785
CAROTENEMIA, FAMILIAL	0.0111111	0.41684569686192785
DERMATOSIS PAPULOSA NIGRA	0.0111111	0.41684569686192785
METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA	0.0111111	0.41684569686192785
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.0111111	0.41684569686192785
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.0111111	0.41684569686192785
131600 EPIDERMOID CYSTS	0.0111111	0.41684569686192785
FUTCHER LINE	0.0111111	0.41684569686192785
MUCOPOLYSACCHARIDOSIS TYPE IX	0.0111111	0.41684569686192785
SPINOCEREBELLAR ATAXIA 34; SCA34	0.0111111	0.41684569686192785
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.0111111	0.41684569686192785
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.0111111	0.41684569686192785
LENTIGINES	0.0111111	0.41684569686192785
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.0111111	0.41684569686192785
AMYLOIDOSIS, CUTANEOUS BULLOUS	0.0111111	0.41684569686192785
LICHEN PLANUS, FAMILIAL	0.0111111	0.41684569686192785
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.0111111	0.41684569686192785
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.0111111	0.41684569686192785
CALLOSITIES, HEREDITARY PAINFUL	0.0111111	0.41684569686192785
ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL	0.0111111	0.41684569686192785
KYRLE DISEASE	0.0111111	0.41684569686192785
ACROMIAL DIMPLES	0.0111111	0.41684569686192785
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.011091814	0.4161221603885202
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.011063564000000001	0.4150623291444176
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.011059429	0.4149071998632011
DESANTO-SHINAWI SYNDROME	0.011008973	0.4130142849870083
PEDIATRIC-ONSET GRAVES DISEASE	0.010992344000000001	0.41239042892477173
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.010972	0.4116272003644169
ZECHI-CEIDE SYNDROME	0.010929154	0.4100197833915027
FETAL TRIMETHADIONE SYNDROME	0.010899844	0.4089201850281523
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.010890863	0.40858325248290317
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.010890863	0.40858325248290317
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.010848553	0.40699594416651436
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.010838344	0.40661294178877827
SMITH-KINGSMORE SYNDROME; SKS	0.010834209	0.40645781250756174
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.01083013	0.40630478413075843
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.010806883	0.40543264618627506
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.010777333	0.40432404394686855
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.010777333	0.40432404394686855
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.010777333	0.40432404394686855
INFANTILE SIALIC ACID STORAGE DISEASE	0.010777333	0.40432404394686855
KBG SYNDROME	0.010771973	0.4041229573816158
MALAN OVERGROWTH SYNDROME	0.010715319	0.4019975174062744
LOWE OCULOCEREBRORENAL SYNDROME	0.010677978999999999	0.40059666435654717
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.010640443999999999	0.3991884956575243
5Q14.3 MICRODELETION SYNDROME	0.010636308999999998	0.3990333663763078
15Q14 MICRODELETION SYNDROME	0.010566723	0.39642276754614403
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.010537813	0.3953381756428871
DISTAL MONOSOMY 6P	0.010514204	0.3944524568520191
GAUCHER DISEASE TYPE 3	0.01050459	0.394091776583672
GAUCHER DISEASE TYPE 2	0.01050459	0.394091776583672
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.010496143	0.39377487766264774
8P23.1 MICRODELETION SYNDROME	0.010496143	0.39377487766264774
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.010496143	0.39377487766264774
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.01047634	0.3930319453395693
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.0103836	0.3895526975668938
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.010317983000000001	0.3870910003370076
OROFACIODIGITAL SYNDROME VI	0.010307134	0.3866839876231219
JOUBERT SYNDROME 2	0.010307134	0.3866839876231219
XIA-GIBBS SYNDROME	0.010307134	0.3866839876231219
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.010235914	0.3840120874034761
PELVISCAPULAR DYSPLASIA	0.0101739	0.3816855608628819
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.0101739	0.3816855608628819
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.0101739	0.3816855608628819
HOLMES-GANG SYNDROME	0.010151544	0.3808468498082568
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.010147409	0.38069172052704037
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.010147409	0.38069172052704037
CYSTINOSIS	0.01013656	0.38028470781315465
SIALURIA	0.010134433	0.3802049109616075
MAN1B1-CDG	0.010134433	0.3802049109616075
PELGER-HUET ANOMALY; PHA	0.010120134	0.3796684675294155
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.010094889999999999	0.37872140983291536
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.010057064000000001	0.3773023239341746
ISOLATED COMPLEX I DEFICIENCY	0.010045494	0.3768682620759704
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.01001569	0.3757501307344045
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.01001569	0.3757501307344045
PAINE SYNDROME	0.01001569	0.3757501307344045
MENTAL RETARDATION, X-LINKED 91; MRX91	0.010015543	0.37574461586032015
HALL-RIGGS SYNDROME	0.009992259	0.3748710898182781
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.009992258999999998	0.37487108981827805
ALAZAMI-YUAN SYNDROME	0.009978654000000002	0.3743606825943484
2Q32Q33 MICRODELETION SYNDROME	0.009954724	0.3734629211192553
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.009950589	0.3733077918380388
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.009936532999999999	0.3727804648303536
NIEMANN-PICK DISEASE, TYPE C2	0.009936532999999999	0.3727804648303536
MUCOPOLYSACCHARIDOSIS TYPE 2	0.009936532999999999	0.3727804648303536
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.009936532999999999	0.3727804648303536
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.009936532999999999	0.3727804648303536
MENTAL RETARDATION, X-LINKED 72	0.009936532999999999	0.3727804648303536
EMANUEL SYNDROME	0.009852803	0.369639237571284
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.3678388750377178
KRABBE DISEASE	0.009804814	0.3678388750377178
BIOTINIDASE DEFICIENCY	0.009804814	0.3678388750377178
ROIFMAN-CHITAYAT SYNDROME	0.009804814	0.3678388750377178
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009804814	0.3678388750377178
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.009804814	0.3678388750377178
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.3678388750377178
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.3678388750377178
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.3678388750377178
VERVERI-BRADY SYNDROME; VERBRAS	0.009803890000000001	0.36780421011490183
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.3676837457565013
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.3676837457565013
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.009776564000000001	0.3667790437936151
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.009752073	0.36586023575824095
BARDET-BIEDL SYNDROME 2	0.009732924	0.36514183899741537
EPILEPSY-TELANGIECTASIA	0.009705639	0.3641182108382882
PEMPHIGOID GESTATIONIS	0.00969036	0.36354500157886716
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00969036	0.36354500157886716
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00969036	0.36354500157886716
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00969036	0.36354500157886716
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00969036	0.36354500157886716
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.009685000000000001	0.36334391501361446
CRANIOFRONTONASAL DYSPLASIA	0.009685000000000001	0.36334391501361446
RING CHROMOSOME 6 SYNDROME	0.009685000000000001	0.36334391501361446
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.009685000000000001	0.36334391501361446
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.009685000000000001	0.36334391501361446
MCDONOUGH SYNDROME	0.00959786	0.3600747576822477
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.009593014	0.3598929544182151
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.009593014	0.3598929544182151
AYME-GRIPP SYNDROME; AYGRP	0.009588879	0.3597378251369986
2P15P16.1 MICRODELETION SYNDROME	0.009581444	0.3594588925600109
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00956528	0.35885248150763305
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.009561553	0.3587126588157119
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.009561553	0.3587126588157119
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.009561553	0.3587126588157119
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.009561553	0.3587126588157119
CHROMOSOME 5Q12 DELETION SYNDROME	0.009561553	0.3587126588157119
XP21 MICRODELETION SYNDROME	0.009561553	0.3587126588157119
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.009561553	0.3587126588157119
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.009561553	0.3587126588157119
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.009561553	0.3587126588157119
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00955127	0.3583268802428585
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.009490333	0.3560407585960661
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.009474124	0.3554326593169277
OCULOSKELETODENTAL SYNDROME; OCSKD	0.009474124	0.3554326593169277
19Q13.11 MICRODELETION SYNDROME	0.009450839999999999	0.3545591332748856
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00940917	0.35299583529464634
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.009395114	0.35246850828696114
HYDROXYKYNURENINURIA	0.009395114	0.35246850828696114
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.009395114	0.35246850828696114
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.009390978999999999	0.35231337900574466
CHILDHOOD DISINTEGRATIVE DISORDER	0.009390978999999999	0.35231337900574466
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.009390978999999999	0.35231337900574466
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.009390978999999999	0.35231337900574466
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.009390978999999999	0.35231337900574466
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.009390978999999999	0.35231337900574466
AUTISM	0.009390978999999999	0.35231337900574466
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.009390978999999999	0.35231337900574466
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.009390978999999999	0.35231337900574466
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.009365253	0.35134823852483194
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.009365253	0.35134823852483194
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.009365253	0.35134823852483194
PRADER-WILLI SYNDROME	0.009284929	0.3483347912734583
TRISOMY 18-LIKE SYNDROME	0.00928239	0.34823953776801486
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.009268874	0.34773246948145586
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.009264739	0.3475773402002394
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.009264739	0.3475773402002394
HYDROXYLYSINURIA	0.00925926	0.34737178921310885
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.34737178921310885
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.34737178921310885
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.34737178921310885
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.34737178921310885
CARNOSINEMIA	0.00925926	0.34737178921310885
CARNOSINASE DEFICIENCY	0.00925926	0.34737178921310885
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.34737178921310885
GLYCINE ENCEPHALOPATHY	0.00925926	0.34737178921310885
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00925926	0.34737178921310885
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.34737178921310885
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.34737178921310885
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.34737178921310885
FILIPPI SYNDROME	0.009250813	0.3470548902920846
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.009250813	0.3470548902920846
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.009250813	0.3470548902920846
17Q11.2 MICRODUPLICATION SYNDROME	0.009250813	0.3470548902920846
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.009250813	0.3470548902920846
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.009250813	0.3470548902920846
RUVALCABA SYNDROME	0.009250813	0.3470548902920846
XQ27.3Q28 DUPLICATION SYNDROME	0.009239964	0.3466478775781989
ADRENOMYODYSTROPHY	0.009235829	0.34649274829698246
2Q24 MICRODELETION SYNDROME	0.009235829	0.34649274829698246
CONO-SPONDYLAR DYSPLASIA	0.009235829	0.34649274829698246
ACHALASIA-MICROCEPHALY SYNDROME	0.009231010000000001	0.3463119579690062
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.009231010000000001	0.3463119579690062
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.009218089	0.34582721179183623
QAZI-MARKOUIZOS SYNDROME	0.009194159	0.3449294503167432
1Q41Q42 MICRODELETION SYNDROME	0.009194159	0.3449294503167432
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00918737	0.34467475317280644
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00918737	0.34467475317280644
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.009159790000000001	0.34364005774936035
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.009159790000000001	0.34364005774936035
RENAL TUBULAR DYSGENESIS	0.009159790000000001	0.34364005774936035
GMS SYNDROME	0.009159790000000001	0.34364005774936035
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.009159790000000001	0.34364005774936035
227320 FACIOTHORACOGENITAL SYNDROME	0.00904746	0.3394258685936062
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00904746	0.3394258685936062
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.009020134	0.33840070227231944
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.009020134	0.33840070227231944
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.009020134	0.33840070227231944
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.009020134	0.33840070227231944
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.009020134	0.33840070227231944
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.009020134	0.33840070227231944
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.009015999	0.33824557299110297
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.009015999	0.33824557299110297
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.009015999	0.33824557299110297
PACHYGYRIA, FRONTOTEMPORAL	0.009015999	0.33824557299110297
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.009015999	0.33824557299110297
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.009015999	0.33824557299110297
CONGENITAL MYASTHENIC SYNDROME	0.009015999	0.33824557299110297
CINCA SYNDROME	0.008948914	0.33572880205267364
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.33557367277145717
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00892857	0.33496557349231876
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00892857	0.33496557349231876
CATARACT-HYPERTRICHOSIS-INTELLECTUAL DISABILITY SYNDROME	0.00892857	0.33496557349231876
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00892857	0.33496557349231876
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00892857	0.33496557349231876
LEGIUS SYNDROME	0.00892857	0.33496557349231876
EMERY-NELSON SYNDROME	0.00892857	0.33496557349231876
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.00892857	0.33496557349231876
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.00892857	0.33496557349231876
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.00892857	0.33496557349231876
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.00892857	0.33496557349231876
THORACOMELIC DYSPLASIA	0.00892857	0.33496557349231876
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00892857	0.33496557349231876
WILDERVANCK SYNDROME	0.00892857	0.33496557349231876
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.00892857	0.33496557349231876
MAYER-ROKITANSKY-KÜSTER-HAUSER SYNDROME TYPE 2	0.00892857	0.33496557349231876
RING CHROMOSOME 8 SYNDROME	0.00892857	0.33496557349231876
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00892857	0.33496557349231876
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.00892857	0.33496557349231876
PTERYGIUM COLLI, ISOLATED	0.00892857	0.33496557349231876
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00892857	0.33496557349231876
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.008877532999999998	0.33305086173284015
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.008877532999999998	0.33305086173284015
TURNPENNY-FRY SYNDROME; TPFS	0.008865504	0.3325995799616787
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2	0.00884956	0.3320014224623522
PRIMARY DYSTONIA, DYT13 TYPE	0.00884956	0.3320014224623522
SMITH-MAGENIS SYNDROME	0.00884956	0.3320014224623522
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1	0.00884956	0.3320014224623522
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.00884956	0.3320014224623522
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2; ASPG2	0.00884956	0.3320014224623522
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00884956	0.3320014224623522
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 1; ASPG1	0.00884956	0.3320014224623522
15Q24 MICRODELETION SYNDROME	0.008835863	0.3314875637526009
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.008796029	0.3299931454241908
RENPENNING SYNDROME	0.008754359	0.3284298474439515
LIG4 SYNDROME	0.008709394	0.3267429337486921
CROME SYNDROME	0.008705259	0.3265878044674757
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.008705259	0.3265878044674757
SANJAD-SAKATI SYNDROME	0.008705259	0.3265878044674757
SECKEL SYNDROME 7; SCKL7	0.008705259	0.3265878044674757
DPM1-CDG	0.008705259	0.3265878044674757
TETRASOMY 18P	0.008705259	0.3265878044674757
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.008705259	0.3265878044674757
TEMPLE-BARAITSER SYNDROME	0.008705259	0.3265878044674757
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00869441	0.32618079175359
ATYPICAL WERNER SYNDROME	0.00869441	0.32618079175359
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.008676670000000001	0.32551525524844377
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.008676670000000001	0.32551525524844377
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.008652739999999999	0.3246174937733507
6Q25 MICRODELETION SYNDROME	0.008624913	0.3235735318607969
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.008624913	0.3235735318607969
COFFIN-SIRIS SYNDROME	0.008583242999999999	0.3220102338805576
AARSKOG-SCOTT SYNDROME	0.008572394	0.321603221166672
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.008494383	0.3186765487707889
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.008494383	0.3186765487707889
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00847458	0.3179336164477105
X-LINKED ENDOTHELIAL CORNEAL DYSTROPHY	0.00847458	0.3179336164477105
108450 ASYMMETRIC SHORT STATURE SYNDROME	0.00847458	0.3179336164477105
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.00847458	0.3179336164477105
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.00847458	0.3179336164477105
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.00847458	0.3179336164477105
PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY	0.00847458	0.3179336164477105
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00847458	0.3179336164477105
SCLEROSTEOSIS 1; SOST1	0.00847458	0.3179336164477105
RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA	0.00847458	0.3179336164477105
HYPEREKPLEXIA 2; HKPX2	0.00847458	0.3179336164477105
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.00847458	0.3179336164477105
RICHIERI COSTA-DA SILVA SYNDROME	0.00847458	0.3179336164477105
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.008465073	0.3175769504074385
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.3152617162280647
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.3152617162280647
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.3152617162280647
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.3152617162280647
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.3152617162280647
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00840336	0.3152617162280647
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00840336	0.3152617162280647
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	0.3152617162280647
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00840336	0.3152617162280647
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.3152617162280647
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.3152617162280647
TEMPLE SYNDROME	0.00840336	0.3152617162280647
OMPHALOCELE	0.00840336	0.3152617162280647
RETINOPATHY OF PREMATURITY	0.00840336	0.3152617162280647
NEMALINE MYOPATHY 10	0.00840336	0.3152617162280647
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.3152617162280647
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.3152617162280647
HEC SYNDROME	0.00840336	0.3152617162280647
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.3152617162280647
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.3152617162280647
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.3152617162280647
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.3152617162280647
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.3152617162280647
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.3152617162280647
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.3152617162280647
TEMPLE SYNDROME	0.00840336	0.3152617162280647
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.3152617162280647
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.3152617162280647
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.008344234	0.31304353632934556
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.008344233999999999	0.3130435363293455
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00816384	0.3062758479240832
CAREY-FINEMAN-ZITER SYNDROME	0.00816384	0.3062758479240832
DISTAL TRISOMY 5Q	0.00816384	0.3062758479240832
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00816384	0.3062758479240832
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00816384	0.3062758479240832
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00816384	0.3062758479240832
COFFIN-SIRIS SYNDROME 5	0.008119923000000001	0.3046282511542688
17P11.2 MICRODUPLICATION SYNDROME	0.008083494	0.30326157531740444
AICARDI-GOUTIÈRES SYNDROME	0.008054583	0.30217694589799726
6Q16 MICRODELETION SYNDROME	0.008041824	0.30169827733716514
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.008039599	0.30161480390289513
ALEXANDER DISEASE	0.008039599	0.30161480390289513
RAMON SYNDROME	0.008039599	0.30161480390289513
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00802684	0.30113613534206307
17Q21.31 MICRODUPLICATION SYNDROME	0.007965324	0.2988282918442853
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.007952964	0.2983645922273965
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.2983645922273965
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.2983645922273965
300270 ADRENOMYODYSTROPHY	0.007952964	0.2983645922273965
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.007948829	0.29820946294618
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.007948829	0.29820946294618
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.007948829	0.29820946294618
GLUTAMINE DEFICIENCY, CONGENITAL	0.007948829	0.29820946294618
LISSENCEPHALY 5; LIS5	0.007948829	0.29820946294618
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.007948829	0.29820946294618
RING CHROMOSOME 10 SYNDROME	0.007948829	0.29820946294618
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.007948829	0.29820946294618
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.007948829	0.29820946294618
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.007948829	0.29820946294618
MOSAIC TRISOMY 14	0.007868483	0.29519519033950126
JOUBERT SYNDROME WITH RENAL DEFECT	0.007826813	0.29363189235926196
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.007826813	0.29363189235926196
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00779868	0.29257645050473663
MELAS	0.00779868	0.29257645050473663
OLIVER SYNDROME	0.00779868	0.29257645050473663
MEIER-GORLIN SYNDROME 2; MGORS2	0.007790559999999999	0.29227181936483876
GLASS SYNDROME	0.007590533	0.2847675763820377
MULTIPLE SULFATASE DEFICIENCY	0.007590533	0.2847675763820377
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.007587804	0.2846651948080499
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.2846651948080499
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.007587804	0.2846651948080499
OROFACIODIGITAL SYNDROME TYPE 2	0.007587804	0.2846651948080499
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.28451006552683344
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.28451006552683344
%300712 CRANIOFACIOSKELETAL SYNDROME	0.007578504000000001	0.2843162946108763
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.007575548999999999	0.2842054343869356
MOMO SYNDROME	0.007533879	0.2826421364066964
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.007513164	0.2818649893546048
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.007513164	0.2818649893546048
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.007509029	0.28170986007338833
KEARNS-SAYRE SYNDROME; KSS	0.007509029	0.28170986007338833
CUSHING DISEASE	0.00749818	0.2813028473595026
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00749818	0.2813028473595026
ACTH-INDEPENDENT CUSHING SYNDROME	0.00749818	0.2813028473595026
ACTH-DEPENDENT CUSHING SYNDROME	0.00749818	0.2813028473595026
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.00749818	0.2813028473595026
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.00749818	0.2813028473595026
HALLERMANN-STREIFF SYNDROME	0.00749627	0.28123119151255627
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00740741	0.27789750640278754
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.27789750640278754
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.00740741	0.27789750640278754
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.00740741	0.27789750640278754
KID SYNDROME	0.00740741	0.27789750640278754
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.27789750640278754
CHARLIE M SYNDROME	0.00740741	0.27789750640278754
14Q11.2 MICRODELETION SYNDROME	0.00740741	0.27789750640278754
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.00740741	0.27789750640278754
TETRALOGY OF FALLOT	0.00740741	0.27789750640278754
TRISOMY XQ28	0.00740741	0.27789750640278754
RHINY	0.00740741	0.27789750640278754
FETAL VALPROATE SYNDROME	0.00740741	0.27789750640278754
TARP SYNDROME; TARPS	0.007327064	0.2748832337961088
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.007327064	0.2748832337961088
CUTIS LAXA	0.007309624000000001	0.27422895213603266
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.007298153	0.2737986043767016
17Q12 MICRODELETION SYNDROME	0.007298153	0.2737986043767016
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.007219743000000001	0.27085696303687534
MENTAL RETARDATION, X-LINKED 21	0.007163089	0.2687315230615339
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.0070491139999999996	0.26445561983864524
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.0070491139999999996	0.26445561983864524
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.264198108983441
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.264198108983441
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.264198108983441
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.264198108983441
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.264198108983441
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.264198108983441
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.264198108983441
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.264198108983441
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.264198108983441
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.264198108983441
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.264198108983441
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.264198108983441
FACIOCARDIORENAL SYNDROME	0.0070341299999999995	0.26389347784354317
PSEUDODIASTROPHIC DYSPLASIA	0.0070341299999999995	0.26389347784354317
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00699246	0.26233017986330387
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00696761	0.26139790352999587
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00696761	0.26139790352999587
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.006834102999999999	0.25638923486074205
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.006834102999999999	0.25638923486074205
CHROMOSOME 9P DELETION SYNDROME	0.006822074000000001	0.25593795308958067
HADZISELIMOVIC SYNDROME	0.006810504	0.25550389123137646
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.006796494	0.254978289966602
DISTAL TRISOMY 15Q	0.0067923589999999995	0.2548231606853855
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.0067923589999999995	0.2548231606853855
MICROPHTHALMIA, LENZ TYPE	0.0067923589999999995	0.2548231606853855
MATTHEW-WOOD SYNDROME	0.00678151	0.25441614797149986
MARSHALL-SMITH SYNDROME	0.00678151	0.25441614797149986
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.006756734	0.2534866478333091
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.006756734	0.2534866478333091
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.006756734	0.2534866478333091
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.006752599	0.2533315185520927
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.006752599	0.2533315185520927
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.006752599	0.2533315185520927
WOLFRAM SYNDROME	0.006752599	0.2533315185520927
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00673984	0.2528528499912606
ANTLEY-BIXLER SYNDROME	0.00673984	0.2528528499912606
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00673984	0.2528528499912606
LAURENCE-MOON SYNDROME	0.00673984	0.2528528499912606
15Q26 OVERGROWTH SYNDROME	0.00673984	0.2528528499912606
MOSAIC TRISOMY 8	0.00673984	0.2528528499912606
APERT SYNDROME	0.00673984	0.2528528499912606
HOLOPROSENCEPHALY 11	0.006678324	0.2505450064934829
GOLDBERG-SHPRINTZEN SYNDROME	0.006678324	0.2505450064934829
DESBUQUOIS DYSPLASIA 2; DBQD2	0.006678324	0.2505450064934829
HOLOPROSENCEPHALY 5; HPE5	0.006678324	0.2505450064934829
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.0066741890000000005	0.2503898772122664
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.0066216700000000005	0.2484195665181415
NON-DISTAL MONOSOMY 10Q	0.0066216700000000005	0.2484195665181415
GASTROCUTANEOUS SYNDROME	0.0066216700000000005	0.2484195665181415
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.0066216700000000005	0.2484195665181415
15Q11Q13 MICRODUPLICATION SYNDROME	0.006581483	0.24691190498869878
TEEBI-SHALTOUT SYNDROME; TBSH	0.006503559999999999	0.2439885340140363
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.006463313	0.24247862151557967
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.006463313	0.24247862151557967
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.006389063	0.2396930473607257
MENTAL RETARDATION, X-LINKED 107; MRX107	0.006292684	0.23607727831734962
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.006292684	0.23607727831734962
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.006292684	0.23607727831734962
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.006288548999999999	0.23592214903613312
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.006276520000000001	0.2354708672649717
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.006276520000000001	0.2354708672649717
JACOBSEN SYNDROME	0.00626495	0.2350368054067675
FAMILIAL VISCERAL MYOPATHY	0.00625094	0.23451120414199308
BARTSOCAS-PAPAS SYNDROME	0.00625094	0.23451120414199308
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00625094	0.23451120414199308
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00625094	0.23451120414199308
MONOSOMY 13Q14	0.00625094	0.23451120414199308
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00625094	0.23451120414199308
NON-DISTAL TRISOMY 10Q	0.00625094	0.23451120414199308
WOODHOUSE-SAKATI SYNDROME	0.00621118	0.2330195620087002
ATAXIA WITH VITAMIN E DEFICIENCY	0.00621118	0.2330195620087002
167755 PANCREAS, DORSAL, AGENESIS OF	0.00621118	0.2330195620087002
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00621118	0.2330195620087002
GLUCAGONOMA	0.00621118	0.2330195620087002
MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS	0.00621118	0.2330195620087002
HEMOCHROMATOSIS TYPE 2	0.00621118	0.2330195620087002
PANCREATITIS, HEREDITARY	0.00621118	0.2330195620087002
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00621118	0.2330195620087002
INSULINOMATOSIS AND DIABETES MELLITUS; INSDM	0.00621118	0.2330195620087002
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.00621118	0.2330195620087002
DIABETES MELLITUS, KETOSIS-PRONE; KPD	0.00621118	0.2330195620087002
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.00621118	0.2330195620087002
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.00621118	0.2330195620087002
FAMILIAL PANCREATIC CARCINOMA	0.00621118	0.2330195620087002
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.00621118	0.2330195620087002
FAMILIAL PARTIAL LIPODYSTROPHY, KÖBBERLING TYPE	0.00621118	0.2330195620087002
NEUROTROPHIC KERATOPATHY	0.00621118	0.2330195620087002
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00621118	0.2330195620087002
FRIEDREICH ATAXIA	0.00621118	0.2330195620087002
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.00621118	0.2330195620087002
SPLENOPORTAL VASCULAR ANOMALIES	0.00621118	0.2330195620087002
STIFF-PERSON SYNDROME; SPS	0.00621118	0.2330195620087002
BETA-THALASSEMIA MAJOR	0.00621118	0.2330195620087002
BETA-THALASSEMIA INTERMEDIA	0.00621118	0.2330195620087002
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 14; MODY14	0.00621118	0.2330195620087002
VIPOMA	0.00621118	0.2330195620087002
CUSHING SYNDROME	0.00621118	0.2330195620087002
WOLFRAM-LIKE SYNDROME	0.00621118	0.2330195620087002
DYSBETALIPOPROTEINEMIA	0.00621118	0.2330195620087002
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.00621118	0.2330195620087002
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00621118	0.2330195620087002
DYSTROPHIA MYOTONICA 2	0.00621118	0.2330195620087002
NEUTRAL LIPID STORAGE MYOPATHY	0.00621118	0.2330195620087002
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.00621118	0.2330195620087002
BARDET-BIEDL SYNDROME 6; BBS6	0.00621118	0.2330195620087002
WOLFRAM SYNDROME 2; WFS2	0.00621118	0.2330195620087002
DIABETES MELLITUS, INSULIN-DEPENDENT, 6	0.00621118	0.2330195620087002
ACERULOPLASMINEMIA	0.00621118	0.2330195620087002
DIABETES MELLITUS, INSULIN-DEPENDENT, 2	0.00621118	0.2330195620087002
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.00621118	0.2330195620087002
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00621118	0.2330195620087002
SHORT SYNDROME	0.00621118	0.2330195620087002
DIABETES MELLITUS, INSULIN-DEPENDENT, 10	0.00621118	0.2330195620087002
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.00621118	0.2330195620087002
CRANIAL NERVES, RECURRENT PARESIS OF	0.00621118	0.2330195620087002
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.00621118	0.2330195620087002
HEREDITARY CHRONIC PANCREATITIS	0.00621118	0.2330195620087002
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.00621118	0.2330195620087002
PREAXIAL HALLUCAL POLYDACTYLY	0.00621118	0.2330195620087002
SOMATOSTATINOMA	0.00621118	0.2330195620087002
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.00621118	0.2330195620087002
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.00621118	0.2330195620087002
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11	0.00621118	0.2330195620087002
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.00621118	0.2330195620087002
HYPERLIPOPROTEINEMIA, TYPE V	0.00621118	0.2330195620087002
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.00621118	0.2330195620087002
RCAD (RENAL CYSTS AND DIABETES)	0.00621118	0.2330195620087002
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00621118	0.2330195620087002
ACERULOPLASMINEMIA	0.00621118	0.2330195620087002
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.00621118	0.2330195620087002
MT-ATP6-RELATED MITOCHONDRIAL SPASTIC PARAPLEGIA	0.00621118	0.2330195620087002
GOOD SYNDROME	0.00621118	0.2330195620087002
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.00621118	0.2330195620087002
%601666 DIABETES MELLITUS, INSULIN-DEPENDENT, 15; IDDM15;;INSULIN-DEPENDENT DIABETES MELLITUS 15	0.00621118	0.2330195620087002
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.00621118	0.2330195620087002
BULLOUS PEMPHIGOID	0.00621118	0.2330195620087002
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.00613277	0.23007792066887392
PIEBALDISM	0.00613277	0.23007792066887392
XYLT1-CDG	0.00613277	0.23007792066887392
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00613277	0.23007792066887392
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00613277	0.23007792066887392
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.0061201829999999995	0.22960570488588206
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.0061201829999999995	0.22960570488588206
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.0061065930000000004	0.22909586040420574
WEAVER SYNDROME	0.006040064	0.22659994844530634
DISTAL MONOSOMY 9P	0.006040064	0.22659994844530634
TRISOMY 8Q	0.006040064	0.22659994844530634
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.006040064	0.22659994844530634
TRISOMY 12P	0.006040064	0.22659994844530634
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.006035929000000001	0.2264448191640899
ISOLATED SPINA BIFIDA	0.006035929000000001	0.2264448191640899
KALLMANN SYNDROME	0.006035929000000001	0.2264448191640899
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.006035929000000001	0.2264448191640899
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.0059218940000000005	0.2221666649721872
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.0059218940000000005	0.2221666649721872
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.0059218940000000005	0.2221666649721872
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.005917759	0.22201153569097073
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.005917759	0.22201153569097073
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.005917759	0.22201153569097073
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.005917759	0.22201153569097073
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.005917759	0.22201153569097073
ZLOTOGORA-OGUR SYNDROME	0.005917759	0.22201153569097073
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.005917759	0.22201153569097073
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.005917759	0.22201153569097073
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.005847644000000001	0.21938109081733326
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.005847644000000001	0.21938109081733326
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.005847644000000001	0.21938109081733326
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.005847644	0.2193810908173332
AREDYLD SYNDROME	0.00574713	0.2156101924927407
BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 2; BNAH2	0.00574713	0.2156101924927407
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00574713	0.2156101924927407
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.005632633	0.21131470583943004
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.005632633	0.21131470583943004
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.005631283000000001	0.21126405903661455
HYPERLEUCINE-ISOLEUCINEMIA	0.005616299	0.21070191704151237
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.005574629	0.20913861906127312
GAPO SYNDROME; GAPOS	0.005574628999999999	0.20913861906127312
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.005565174	0.20878390386081325
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.005565174	0.20878390386081325
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.005561039	0.20862877457959683
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.005561039	0.20862877457959683
FANCONI ANEMIA	0.005523503999999999	0.20722060588057398
CONGENITAL RUBELLA SYNDROME	0.005519369	0.20706547659935753
ALAGILLE SYNDROME 1; ALGS1	0.00550852	0.20665846388547188
ALAGILLE SYNDROME	0.00550852	0.20665846388547188
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00549451	0.2061328626206974
KEIPERT SYNDROME	0.00549451	0.2061328626206974
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.00549451	0.2061328626206974
LARYNX ATRESIA	0.00549451	0.2061328626206974
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00549451	0.2061328626206974
INIENCEPHALY	0.00549451	0.2061328626206974
HOLZGREVE SYNDROME	0.00549451	0.2061328626206974
ACQUIRED VON WILLEBRAND SYNDROME	0.00549451	0.2061328626206974
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00549451	0.2061328626206974
ACHONDROGENESIS TYPE 1B	0.00549451	0.2061328626206974
CONGENITAL DIAPHRAGMATIC HERNIA	0.00549451	0.2061328626206974
ACHONDROGENESIS TYPE 2	0.00549451	0.2061328626206974
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.00549451	0.2061328626206974
ACHONDROGENESIS	0.00549451	0.2061328626206974
ACHONDROGENESIS TYPE 1A	0.00549451	0.2061328626206974
AUROCEPHALOSYNDACTYLY	0.00549451	0.2061328626206974
ISOLATED HEMIHYPERPLASIA	0.00549451	0.2061328626206974
ACALVARIA	0.00549451	0.2061328626206974
PSEUDODIASTROPHIC DYSPLASIA	0.00549451	0.2061328626206974
FRONTONASAL DYSPLASIA	0.00549451	0.2061328626206974
46,XY PARTIAL GONADAL DYSGENESIS	0.00549451	0.2061328626206974
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.00549451	0.2061328626206974
PHENYLKETONURIA	0.00549451	0.2061328626206974
VACTERL WITH HYDROCEPHALUS	0.00549451	0.2061328626206974
NAGER SYNDROME	0.00549451	0.2061328626206974
CONGENITAL HEART DEFECT-ROUND FACE-DEVELOPMENTAL DELAY SYNDROME	0.00549451	0.2061328626206974
BEEMER-ERTBRUGGEN SYNDROME	0.00549451	0.2061328626206974
CAT-EYE SYNDROME	0.00549451	0.2061328626206974
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00549451	0.2061328626206974
THALIDOMIDE EMBRYOPATHY	0.00549451	0.2061328626206974
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.00549451	0.2061328626206974
AXENFELD-RIEGER SYNDROME	0.00549451	0.2061328626206974
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00549451	0.2061328626206974
X-LINKED EHLERS-DANLOS SYNDROME	0.00549451	0.2061328626206974
FACIOSCAPULOHUMERAL DYSTROPHY	0.00549451	0.2061328626206974
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.00537634	0.20169957914757827
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00537634	0.20169957914757827
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00537634	0.20169957914757827
WAARDENBURG-SHAH SYNDROME	0.00537634	0.20169957914757827
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00537634	0.20169957914757827
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00537634	0.20169957914757827
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.00537634	0.20169957914757827
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00537634	0.20169957914757827
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00537634	0.20169957914757827
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00537634	0.20169957914757827
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.00537634	0.20169957914757827
ISOLATED TRIGONOCEPHALY	0.00537634	0.20169957914757827
MENTAL RETARDATION, X-LINKED 73	0.00537634	0.20169957914757827
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00537634	0.20169957914757827
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.005308493000000001	0.19915422090267085
OCULOECTODERMAL SYNDROME; OES	0.005308493000000001	0.19915422090267085
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.005308493000000001	0.19915422090267085
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.005302090000000001	0.19891400499272432
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.005302090000000001	0.19891400499272432
CHROMOSOME 1P35 DELETION SYNDROME	0.005143733000000001	0.19297305999016254
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.005143733	0.1929730599901625
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.005132884000000001	0.19256604727627685
POPOV-CHANG SYNDROME; POPCHAS	0.005132884000000001	0.19256604727627685
COFFIN-SIRIS SYNDROME 8; CSS8	0.005128749	0.19241091799506038
2Q23.1 MICRODUPLICATION SYNDROME	0.005091214	0.19100274929603758
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.005091214	0.19100274929603758
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.005091214	0.19100274929603758
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.005091214	0.19100274929603758
ASPARTYLGLUCOSAMINURIA; AGU	0.005085729000000001	0.1907969732120056
XYLOSIDASE DEFICIENCY	0.005085729	0.1907969732120056
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00507488	0.19038996049811993
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00507488	0.19038996049811993
GLUTATHIONURIA	0.00503321	0.18882666251788066
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00503321	0.18882666251788066
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.004874853	0.18288571751531887
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.0048195930000000005	0.18081257505340328
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.0048195930000000005	0.18081257505340328
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.0048195930000000005	0.18081257505340328
GENITOPATELLAR SYNDROME	0.0048195930000000005	0.18081257505340328
MCKUSICK-KAUFMAN SYNDROME	0.004808744	0.18040556233951763
OROTIC ACIDURIA	0.004808744	0.18040556233951763
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.004808744	0.18040556233951763
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.004808744	0.18040556233951763
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.004804609	0.18025043305830116
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.004804609	0.18025043305830116
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.0047670740000000005	0.17884226435927836
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.004767074	0.17884226435927833
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.004762939000000001	0.17868713507806194
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.004762939000000001	0.17868713507806194
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.004602314	0.17266110344677002
AL-RAQAD SYNDROME; ARS	0.004602314	0.17266110344677002
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.004598179000000001	0.1725059741655536
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.004598179000000001	0.1725059741655536
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.004598179000000001	0.1725059741655536
13Q12.3 MICRODELETION SYNDROME	0.004587330000000001	0.17209896145166792
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00454566	0.17053566347142865
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00454566	0.17053566347142865
TETRASOMY 12P	0.00454566	0.17053566347142865
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00454566	0.17053566347142865
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00454566	0.17053566347142865
CARDIAC LIPIDOSIS, FAMILIAL	0.00454431	0.17048501666861313
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00454431	0.17048501666861313
46,XX GONADAL DYSGENESIS	0.00454431	0.17048501666861313
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00454431	0.17048501666861313
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.004387303	0.16459471846886686
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.004387303	0.16459471846886686
WILSON-TURNER SYNDROME	0.004387303	0.16459471846886686
MONOSOMY 18Q	0.004375733	0.16416065661066265
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.004375733	0.16416065661066265
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.004375733	0.16416065661066265
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.004375733	0.16416065661066265
C SYNDROME	0.004375733	0.16416065661066265
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.004375733	0.16416065661066265
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.004375733	0.16416065661066265
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.004375733	0.16416065661066265
PITT-HOPKINS SYNDROME	0.004375733	0.16416065661066265
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.004375733	0.16416065661066265
ALG11-CDG	0.004375733	0.16416065661066265
LARSEN-LIKE SYNDROME	0.004333434	0.16257376097192638
REVESZ SYNDROME	0.004333434	0.16257376097192638
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004333434	0.16257376097192638
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.004333434	0.16257376097192638
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.004329299	0.16241863169070994
ICHTHYOSIS AND MALE HYPOGONADISM	0.004329299	0.16241863169070994
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.004329299	0.16241863169070994
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.004278174	0.16050061851001082
MOSAIC TRISOMY 9	0.004278174	0.16050061851001082
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.004278174	0.16050061851001082
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.004278174	0.16050061851001082
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.004278174	0.16050061851001082
GENITOPATELLAR SYNDROME; GTPTS	0.004278174	0.16050061851001082
OROFACIODIGITAL SYNDROME XIV; OFD14	0.004278174	0.16050061851001082
TRISOMY 18	0.004278174	0.16050061851001082
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.004274039	0.16034548922879438
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.004274039	0.16034548922879438
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.004274039	0.16034548922879438
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.004274039	0.16034548922879438
OCULODENTODIGITAL DYSPLASIA; ODDD	0.004274039	0.16034548922879438
PRUNE BELLY SYNDROME	0.00426319	0.1599384765149087
CATEL-MANZKE SYNDROME	0.00426319	0.1599384765149087
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.00426319	0.1599384765149087
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.00426319	0.1599384765149087
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00426319	0.1599384765149087
NOONAN SYNDROME 8; NS8	0.00426319	0.1599384765149087
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.00426319	0.1599384765149087
CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERIES	0.00426319	0.1599384765149087
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00422152	0.15837517853466943
611961 STEVENSON-CAREY SYNDROME	0.004063163	0.15243423353210764
20P12.3 MICRODELETION SYNDROME	0.004063163	0.15243423353210764
SIMPSON-GOLABI-BEHMEL SYNDROME	0.004063163	0.15243423353210764
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.004063163	0.15243423353210764
CHÉDIAK-HIGASHI SYNDROME	0.004063163	0.15243423353210764
CODAS SYNDROME	0.004063163	0.15243423353210764
SHASHI-PENA SYNDROME; SHAPNS	0.004063163	0.15243423353210764
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.004063163	0.15243423353210764
ROIFMAN SYNDROME	0.00405676	0.15219401762216112
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.00405676	0.15219401762216112
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00405676	0.15219401762216112
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.003845884	0.1442827619254744
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.003845884	0.1442827619254744
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.003845884	0.1442827619254744
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.003845884	0.1442827619254744
AICA-RIBOSIDURIA	0.003841749	0.14412763264425793
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.003841749	0.14412763264425793
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.003834314	0.14384870006727019
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.003834314	0.14384870006727019
MARINESCO-SJOGREN SYNDROME; MSS	0.003834314	0.14384870006727019
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.003830179	0.14369357078605374
XERODERMA PIGMENTOSUM	0.003830179	0.14369357078605374
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00378788	0.14210667514731745
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.14210667514731745
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.14210667514731745
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.14210667514731745
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	0.14210667514731745
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00378788	0.14210667514731745
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.14210667514731745
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.14210667514731745
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.14210667514731745
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.14210667514731745
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.14210667514731745
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.14210667514731745
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.14210667514731745
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.14210667514731745
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	0.14210667514731745
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00378788	0.14210667514731745
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.14210667514731745
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.14210667514731745
ZINC, ELEVATED PLASMA	0.00378788	0.14210667514731745
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.14210667514731745
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.14210667514731745
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.14210667514731745
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.14210667514731745
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.14210667514731745
MYOPATHY, SPHEROID BODY	0.00378788	0.14210667514731745
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.14210667514731745
GONADOBLASTOMA	0.00378788	0.14210667514731745
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00378788	0.14210667514731745
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.14210667514731745
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.14210667514731745
DERMATOLEUKODYSTROPHY	0.00378788	0.14210667514731745
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	0.14210667514731745
HYPOASCORBEMIA	0.00378788	0.14210667514731745
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00378788	0.14210667514731745
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.14210667514731745
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.14210667514731745
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.14210667514731745
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.14210667514731745
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.14210667514731745
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.14210667514731745
ETHANOLAMINOSIS	0.00378788	0.14210667514731745
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00378788	0.14210667514731745
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.14210667514731745
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.14210667514731745
SCHIZOPHRENIA 4	0.00378788	0.14210667514731745
FETAL IODINE DEFICIENCY DISORDER	0.00378788	0.14210667514731745
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.14210667514731745
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.14210667514731745
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.14210667514731745
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	0.14210667514731745
ACETYLATION, SLOW	0.00378788	0.14210667514731745
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.14210667514731745
CITRULLINE TRANSPORT DEFECT	0.00378788	0.14210667514731745
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.14210667514731745
AREDYLD	0.00378788	0.14210667514731745
PREMATURE OVARIAN FAILURE 1	0.00378788	0.14210667514731745
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.14210667514731745
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00378788	0.14210667514731745
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.14210667514731745
XM SYSTEM	0.00378788	0.14210667514731745
DELETED IN AZOOSPERMIA	0.00378788	0.14210667514731745
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.14210667514731745
LYMPHOKINE DEFICIENCY	0.00378788	0.14210667514731745
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.14210667514731745
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.14210667514731745
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.14210667514731745
LIPASE DEFICIENCY, COMBINED	0.00378788	0.14210667514731745
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.14210667514731745
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.14210667514731745
CEPHALIN LIPIDOSIS	0.00378788	0.14210667514731745
CEREBELLOPARENCHYMAL DISORDER V	0.00378788	0.14210667514731745
MACROCYTOSIS, FAMILIAL	0.00378788	0.14210667514731745
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00378788	0.14210667514731745
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	0.14210667514731745
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	0.14210667514731745
APOLIPOPROTEIN(A)	0.00378788	0.14210667514731745
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.14210667514731745
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00378788	0.14210667514731745
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.14210667514731745
PITUITARY DWARFISM IV	0.00378788	0.14210667514731745
LARON SYNDROME	0.00378788	0.14210667514731745
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00378788	0.14210667514731745
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00378788	0.14210667514731745
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.14210667514731745
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.14210667514731745
CALVARIAL HYPEROSTOSIS	0.00378788	0.14210667514731745
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.14210667514731745
PENDRED SYNDROME	0.00378788	0.14210667514731745
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	0.14210667514731745
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.14210667514731745
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	0.14210667514731745
OSTEOGENIC SARCOMA	0.00378788	0.14210667514731745
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	0.14210667514731745
COUMARIN RESISTANCE	0.00378788	0.14210667514731745
PROGESTERONE RESISTANCE	0.00378788	0.14210667514731745
OVARIAN CANCER	0.00378788	0.14210667514731745
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.14210667514731745
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.14210667514731745
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.14210667514731745
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.14210667514731745
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00378788	0.14210667514731745
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	0.14210667514731745
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.14210667514731745
ALAND ISLAND EYE DISEASE	0.00378788	0.14210667514731745
FLOOD FACTOR DEFICIENCY	0.00378788	0.14210667514731745
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	0.14210667514731745
GLUTATHIONE REDUCTASE	0.00378788	0.14210667514731745
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.14210667514731745
HEINZ BODY ANEMIAS	0.00378788	0.14210667514731745
MACULAR CORNEAL DYSTROPHY	0.00378788	0.14210667514731745
HYPERPROGLUCAGONEMIA	0.00378788	0.14210667514731745
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	0.14210667514731745
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.14210667514731745
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	0.14210667514731745
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00378788	0.14210667514731745
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.14210667514731745
PACMAN DYSPLASIA	0.00378788	0.14210667514731745
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	0.14210667514731745
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.14210667514731745
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00378788	0.14210667514731745
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.14210667514731745
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00378788	0.14210667514731745
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.14210667514731745
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00378788	0.14210667514731745
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.14210667514731745
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	0.14210667514731745
BARTTER SYNDROME	0.00378788	0.14210667514731745
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.14210667514731745
PARAOXONASE 1	0.00378788	0.14210667514731745
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00378788	0.14210667514731745
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.14210667514731745
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00378788	0.14210667514731745
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	0.14210667514731745
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00378788	0.14210667514731745
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	0.14210667514731745
FINGERPRINT BODY MYOPATHY	0.00378788	0.14210667514731745
XANTHINURIA, TYPE I	0.00378788	0.14210667514731745
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	0.14210667514731745
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.14210667514731745
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00378788	0.14210667514731745
X-LINKED ADRENOLEUKODYSTROPHY	0.00378788	0.14210667514731745
PERRY SYNDROME	0.00378788	0.14210667514731745
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.14210667514731745
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	0.14210667514731745
CARBOXYLESTERASE 1	0.00378788	0.14210667514731745
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.14210667514731745
BEETURIA	0.00378788	0.14210667514731745
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00378788	0.14210667514731745
T-SUBSTANCE ANOMALY	0.00378788	0.14210667514731745
OCULORENOCEREBELLAR SYNDROME	0.00378788	0.14210667514731745
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	0.14210667514731745
REFSUM DISEASE	0.00378788	0.14210667514731745
MECKEL SYNDROME, TYPE 4; MKS4	0.00373262	0.1400335326854019
CHARGE SYNDROME	0.00373262	0.1400335326854019
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00373262	0.1400335326854019
WAARDENBURG SYNDROME TYPE 3	0.00373262	0.1400335326854019
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00373262	0.1400335326854019
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00373262	0.1400335326854019
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00373262	0.1400335326854019
XK APROSENCEPHALY SYNDROME	0.00373262	0.1400335326854019
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.0036193030000000004	0.13578231508936703
PONTINE TEGMENTAL CAP DYSPLASIA	0.0036193030000000004	0.13578231508936703
6Q TERMINAL DELETION SYNDROME	0.0036193030000000004	0.13578231508936703
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.0036193030000000004	0.13578231508936703
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.0036193030000000004	0.13578231508936703
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.0036193030000000004	0.13578231508936703
1Q21.1 MICRODUPLICATION SYNDROME	0.0036193030000000004	0.13578231508936703
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.0036193030000000004	0.13578231508936703
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.0036193030000000004	0.13578231508936703
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.003619303	0.135782315089367
3C SYNDROME	0.0035217440000000003	0.13212227698871518
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.0035217440000000003	0.13212227698871518
NOONAN SYNDROME 11; NS11	0.0035217440000000003	0.13212227698871518
NOONAN SYNDROME 3; NS3	0.0035217440000000003	0.13212227698871518
CHROMOSOME 15Q14 DELETION SYNDROME	0.0035217440000000003	0.13212227698871518
16P13.11 MICRODUPLICATION SYNDROME	0.0035217440000000003	0.13212227698871518
LYMPHEDEMA, HEREDITARY, III	0.0035217440000000003	0.13212227698871518
NOONAN SYNDROME 5; NS5	0.0035217440000000003	0.13212227698871518
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.0035217440000000003	0.13212227698871518
SYNDROMIC DIARRHEA	0.0035217440000000003	0.13212227698871518
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0035217440000000003	0.13212227698871518
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.003517609	0.13196714770749873
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.003517609	0.13196714770749873
THANATOPHORIC DYSPLASIA TYPE 2	0.003517609	0.13196714770749873
THANATOPHORIC DYSPLASIA	0.003517609	0.13196714770749873
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.003517609	0.13196714770749873
THANATOPHORIC DYSPLASIA TYPE 1	0.003517609	0.13196714770749873
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.003517609	0.13196714770749873
FRYNS SYNDROME; FRNS	0.003517609	0.13196714770749873
ACROCARDIOFACIAL SYNDROME	0.003517609	0.13196714770749873
HUNTER-MACDONALD SYNDROME	0.00330033	0.12381567610086548
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00330033	0.12381567610086548
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00330033	0.12381567610086548
2Q37 MONOSOMY	0.00330033	0.12381567610086548
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.00330033	0.12381567610086548
258840 ORAL AND DIGITAL ANOMALIES WITH ICHTHYOSIS	0.00330033	0.12381567610086548
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00330033	0.12381567610086548
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00330033	0.12381567610086548
ATELOSTEOGENESIS TYPE II	0.00330033	0.12381567610086548
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.00330033	0.12381567610086548
3Q27.3 MICRODELETION SYNDROME	0.00330033	0.12381567610086548
CHROMOSOME 13Q14 DELETION SYNDROME	0.00330033	0.12381567610086548
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00330033	0.12381567610086548
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00330033	0.12381567610086548
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00330033	0.12381567610086548
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00330033	0.12381567610086548
AUTOSOMAL DOMINANT POPLITEAL PTERYGIUM SYNDROME	0.00330033	0.12381567610086548
%613576 ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2; EDSS2	0.00330033	0.12381567610086548
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00328876	0.12338161424266128
MEIER-GORLIN SYNDROME 6; MGORS6	0.00328876	0.12338161424266128
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.003130403	0.11744066924009948
10Q22.3Q23.3 MICRODELETION SYNDROME	0.003130403	0.11744066924009948
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.003130403	0.11744066924009948
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.003130403	0.11744066924009948
RFT1-CDG	0.003130403	0.11744066924009948
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.003130403	0.11744066924009948
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.003130403	0.11744066924009948
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.003130403	0.11744066924009948
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.003130403	0.11744066924009948
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.003130403	0.11744066924009948
STT3A-CDG	0.003130403	0.11744066924009948
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.003130403	0.11744066924009948
STT3B-CDG	0.003130403	0.11744066924009948
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.003130403	0.11744066924009948
INFANTILE LIVER FAILURE SYNDROME 1	0.003130403	0.11744066924009948
LATHOSTEROLOSIS	0.003130403	0.11744066924009948
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.003130403	0.11744066924009948
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.003130403	0.11744066924009948
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.003130403	0.11744066924009948
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.003130403	0.11744066924009948
VICI SYNDROME; VICIS	0.003130403	0.11744066924009948
JABERI-ELAHI SYNDROME; JABELS	0.003130403	0.11744066924009948
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.003130403	0.11744066924009948
PELIZAEUS-MERZBACHER DISEASE	0.003130403	0.11744066924009948
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.003130403	0.11744066924009948
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.003130403	0.11744066924009948
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.003130403	0.11744066924009948
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.003130403	0.11744066924009948
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.003088733	0.11587737125986022
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.003088733	0.11587737125986022
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.003088733	0.11587737125986022
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.003088733	0.11587737125986022
MEHMO SYNDROME; MEHMO	0.003088733	0.11587737125986022
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.003088733	0.11587737125986022
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.003088733	0.11587737125986022
ADAMS-OLIVER SYNDROME 2; AOS2	0.003088733	0.11587737125986022
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.003088733	0.11587737125986022
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.003088733	0.11587737125986022
CK SYNDROME	0.003088733	0.11587737125986022
MATERNAL PHENYLKETONURIA	0.003088733	0.11587737125986022
CHROMOSOME 19P13.13 DELETION SYNDROME	0.003088733	0.11587737125986022
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.0030887329999999998	0.11587737125986022
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.0030887329999999998	0.11587737125986022
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.0030887329999999998	0.11587737125986022
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.0030887329999999998	0.11587737125986022
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.0030887329999999998	0.11587737125986022
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.0030887329999999998	0.11587737125986022
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.003077884	0.11547035854597455
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.0030737489999999998	0.11531522926475811
HADDAD SYNDROME	0.0030737489999999998	0.11531522926475811
HYPERTELORISM, TEEBI TYPE; TBHS	0.00297619	0.11165519116410624
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.00297619	0.11165519116410624
EISENMENGER SYNDROME	0.00297619	0.11165519116410624
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00297619	0.11165519116410624
DIAMOND-BLACKFAN ANEMIA 4	0.00297619	0.11165519116410624
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.00297619	0.11165519116410624
MEACHAM SYNDROME	0.00297619	0.11165519116410624
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.00297619	0.11165519116410624
PENTALOGY OF CANTRELL	0.00297619	0.11165519116410624
ATRIAL SEPTAL DEFECT 5	0.00297619	0.11165519116410624
ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	0.00297619	0.11165519116410624
HETEROTAXY, VISCERAL, 7, AUTOSOMAL; HTX7	0.00297619	0.11165519116410624
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.00297619	0.11165519116410624
AORTIC VALVE DISEASE 3; AOVD3	0.00297619	0.11165519116410624
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5; CHTD5	0.00297619	0.11165519116410624
CONGENITAL PULMONARY VALVE STENOSIS	0.00297619	0.11165519116410624
LYMPHATIC MALFORMATION 7; LMPHM7	0.00297619	0.11165519116410624
SIFRIM-HITZ-WEISS SYNDROME	0.00297619	0.11165519116410624
HOLT-ORAM SYNDROME	0.00297619	0.11165519116410624
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.00297619	0.11165519116410624
PERICARDIAL AND DIAPHRAGMATIC DEFECT	0.00297619	0.11165519116410624
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.00297619	0.11165519116410624
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00297619	0.11165519116410624
CARDIAC-UROGENITAL SYNDROME; CUGS	0.00297619	0.11165519116410624
ELLIS-VAN CREVELD SYNDROME	0.00297619	0.11165519116410624
WHITE FORELOCK WITH MALFORMATIONS	0.00297619	0.11165519116410624
8P23.1 DELETION SYNDROME	0.00297619	0.11165519116410624
MEGALENCEPHALY	0.00297619	0.11165519116410624
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00297619	0.11165519116410624
FAMILIAL CUTANEOUS COLLAGENOMA	0.00297619	0.11165519116410624
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.00297619	0.11165519116410624
ALAGILLE SYNDROME 2	0.00297619	0.11165519116410624
PORENCEPHALY, CEREBELLAR HYPOPLASIA, AND INTERNAL MALFORMATIONS	0.00297619	0.11165519116410624
DIAMOND-BLACKFAN ANEMIA 16	0.00297619	0.11165519116410624
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00297619	0.11165519116410624
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00297619	0.11165519116410624
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 3; CHTD3	0.00297619	0.11165519116410624
%241310 HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00297619	0.11165519116410624
ABRUZZO-ERICKSON SYNDROME	0.00297619	0.11165519116410624
EBSTEIN ANOMALY	0.00297619	0.11165519116410624
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.00297619	0.11165519116410624
3Q29 MICRODELETION SYNDROME	0.002588984	0.09712871269670702
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.002588984	0.09712871269670702
EAR-PATELLA-SHORT STATURE SYNDROME	0.002588984	0.09712871269670702
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.002588984	0.09712871269670702
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.002588984	0.09712871269670702
MEVALONIC ACIDURIA; MEVA	0.002588984	0.09712871269670702
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.002588984	0.09712871269670702
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.002588984	0.09712871269670702
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.002588984	0.09712871269670702
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.002588984	0.09712871269670702
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.002588984	0.09712871269670702
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.002588984	0.09712871269670702
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.002588984	0.09712871269670702
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.002588984	0.09712871269670702
LIG4 SYNDROME	0.002588984	0.09712871269670702
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.002588984	0.09712871269670702
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.002588984	0.09712871269670702
SYMMETRICAL THALAMIC CALCIFICATIONS	0.002584849	0.09697358341549057
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.002584849	0.09697358341549057
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.0025848489999999997	0.09697358341549056
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.0025848489999999997	0.09697358341549056
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0025848489999999997	0.09697358341549056
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.0025848489999999997	0.09697358341549056
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.0025848489999999997	0.09697358341549056
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.0025848489999999997	0.09697358341549056
HARROD SYNDROME	0.0025848489999999997	0.09697358341549056
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.0025848489999999997	0.09697358341549056
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.0025848489999999997	0.09697358341549056
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.0025848489999999997	0.09697358341549056
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.0025848489999999997	0.09697358341549056
OROFACIODIGITAL SYNDROME IX; OFD9	0.002547314	0.09556541471646775
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.002547314	0.09556541471646775
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.002547314	0.09556541471646775
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.002547314	0.09556541471646775
OPTIC ATROPHY 11; OPA11	0.002547314	0.09556541471646775
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.002547314	0.09556541471646775
MUCOLIPIDOSIS IV; ML4	0.002547314	0.09556541471646775
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.002547314	0.09556541471646775
CRANIOSYNOSTOSIS 6; CRS6	0.002547314	0.09556541471646775
MIETENS SYNDROME	0.002547314	0.09556541471646775
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.002547314	0.09556541471646775
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.002547314	0.09556541471646775
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.002547314	0.09556541471646775
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.002547314	0.09556541471646775
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.002547314	0.09556541471646775
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.002547314	0.09556541471646775
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.002547314	0.09556541471646775
MARINESCO-SJÖGREN SYNDROME	0.002547314	0.09556541471646775
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.002547314	0.09556541471646775
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.002547314	0.09556541471646775
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.002547314	0.09556541471646775
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.002543179	0.09541028543525129
COG5-CDG	0.002543179	0.09541028543525129
COCKAYNE SYNDROME A; CSA	0.002543179	0.09541028543525129
ANGELMAN SYNDROME	0.002543179	0.09541028543525129
PITT-HOPKINS SYNDROME	0.002543179	0.09541028543525129
SECKEL SYNDROME 1; SCKL1	0.002543179	0.09541028543525129
MARDEN-WALKER SYNDROME	0.002543179	0.09541028543525129
PRIMARY CUTIS VERTICIS GYRATA	0.002543179	0.09541028543525129
CYCLIC VOMITING SYNDROME	0.002543179	0.09541028543525129
INCONTINENTIA PIGMENTI; IP	0.002543179	0.09541028543525129
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.002543179	0.09541028543525129
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.002543179	0.09541028543525129
PROGEROID SYNDROME, PETTY TYPE	0.00253233	0.09500327272136563
FREEMAN-SHELDON SYNDROME	0.00253233	0.09500327272136563
MULTIMINICORE MYOPATHY	0.00253233	0.09500327272136563
MELNICK-NEEDLES SYNDROME	0.00253233	0.09500327272136563
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.0023739729999999997	0.08906232771880382
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.0023739729999999997	0.08906232771880382
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.0023739729999999997	0.08906232771880382
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.0023739729999999997	0.08906232771880382
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.0023739729999999997	0.08906232771880382
METHYLMALONIC ACIDURIA, CBLA TYPE	0.0023739729999999997	0.08906232771880382
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.0023739729999999997	0.08906232771880382
INFANTILE REFSUM DISEASE	0.0023739729999999997	0.08906232771880382
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.0023739729999999997	0.08906232771880382
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.0023739729999999997	0.08906232771880382
FUCOSIDOSIS	0.0023739729999999997	0.08906232771880382
ARGININOSUCCINIC ACIDURIA	0.0023739729999999997	0.08906232771880382
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.0023739729999999997	0.08906232771880382
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.0023739729999999997	0.08906232771880382
PITUITARY STALK INTERRUPTION SYNDROME	0.0023739729999999997	0.08906232771880382
2P21 MICRODELETION SYNDROME	0.0023739729999999997	0.08906232771880382
NEPHROGENIC DIABETES INSIPIDUS	0.0023739729999999997	0.08906232771880382
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.0023739729999999997	0.08906232771880382
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.0023739729999999997	0.08906232771880382
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.0023739729999999997	0.08906232771880382
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.0023739729999999997	0.08906232771880382
TETRASOMY 5P	0.0023739729999999997	0.08906232771880382
FOLATE MALABSORPTION, HEREDITARY	0.0023739729999999997	0.08906232771880382
COWDEN SYNDROME	0.0023739729999999997	0.08906232771880382
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.0023739729999999997	0.08906232771880382
EAST SYNDROME	0.0023739729999999997	0.08906232771880382
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.0023739729999999997	0.08906232771880382
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.0023739729999999997	0.08906232771880382
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.0023739729999999997	0.08906232771880382
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.0023739729999999997	0.08906232771880382
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.0023739729999999997	0.08906232771880382
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.0023739729999999997	0.08906232771880382
CITRULLINEMIA, CLASSIC	0.0023739729999999997	0.08906232771880382
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.0023739729999999997	0.08906232771880382
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.0023739729999999997	0.08906232771880382
GRACILE BONE DYSPLASIA; GCLEB	0.0023739729999999997	0.08906232771880382
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.0023739729999999997	0.08906232771880382
HEREDITARY FOLATE MALABSORPTION	0.0023739729999999997	0.08906232771880382
PROPIONIC ACIDEMIA	0.0023739729999999997	0.08906232771880382
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.0023739729999999997	0.08906232771880382
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.002332303	0.08749902973856458
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.002332303	0.08749902973856458
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.002332303	0.08749902973856458
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.002332303	0.08749902973856458
MUENKE SYNDROME	0.002332303	0.08749902973856458
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.002332303	0.08749902973856458
SCHIZENCEPHALY	0.002332303	0.08749902973856458
MONOSOMY 9Q22.3	0.002332303	0.08749902973856458
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.002332303	0.08749902973856458
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.002332303	0.08749902973856458
RAYNAUD-CLAES SYNDROME; MRXSRC	0.002332303	0.08749902973856458
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.002332303	0.08749902973856458
SCHINDLER DISEASE, TYPE I	0.002332303	0.08749902973856458
MENTAL RETARDATION, X-LINKED 104; MRX104	0.002332303	0.08749902973856458
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.002332303	0.08749902973856458
GLYCEROL KINASE DEFICIENCY; GKD	0.002332303	0.08749902973856458
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.002332303	0.08749902973856458
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.002332303	0.08749902973856458
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.002332303	0.08749902973856458
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.002332303	0.08749902973856458
POTOCKI-SHAFFER SYNDROME	0.002332303	0.08749902973856458
XQ21 MICRODELETION SYNDROME	0.002332303	0.08749902973856458
MENTAL RETARDATION, X-LINKED 90	0.002332303	0.08749902973856458
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.002332303	0.08749902973856458
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.002332303	0.08749902973856458
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.002332303	0.08749902973856458
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.002332303	0.08749902973856458
HARTNUP DISEASE	0.002332303	0.08749902973856458
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.002332303	0.08749902973856458
OPTIC PATHWAY GLIOMA	0.002332303	0.08749902973856458
INCONTINENTIA PIGMENTI	0.002332303	0.08749902973856458
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.002332303	0.08749902973856458
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.002332303	0.08749902973856458
WEAVER SYNDROME	0.002332303	0.08749902973856458
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.002332303	0.08749902973856458
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.002332303	0.08749902973856458
CHROMOSOME 16P13.2 DELETION SYNDROME	0.002332303	0.08749902973856458
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.002332303	0.08749902973856458
MENTAL RETARDATION, X-LINKED 101; MRX101	0.002332303	0.08749902973856458
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.0020434299999999997	0.07666162687209808
MEIER-GORLIN SYNDROME 3; MGORS3	0.0020434299999999997	0.07666162687209808
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.0020434299999999997	0.07666162687209808
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.0020434299999999997	0.07666162687209808
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.0020434299999999997	0.07666162687209808
JOHNSON NEUROECTODERMAL SYNDROME	0.0020434299999999997	0.07666162687209808
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.0020434299999999997	0.07666162687209808
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.0020434299999999997	0.07666162687209808
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.0020434299999999997	0.07666162687209808
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.0020434299999999997	0.07666162687209808
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.0020434299999999997	0.07666162687209808
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0020434299999999997	0.07666162687209808
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.0020434299999999997	0.07666162687209808
GROWTH HORMONE INSENSITIVITY SYNDROME	0.0020434299999999997	0.07666162687209808
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.0020434299999999997	0.07666162687209808
PSEUDOPROGERIA SYNDROME	0.0020434299999999997	0.07666162687209808
SEVERE COMBINED IMMUNODEFICIENCY	0.0020434299999999997	0.07666162687209808
ACROOTOOCULAR SYNDROME	0.0020434299999999997	0.07666162687209808
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00200176	0.07509832889185883
OTOMANDIBULAR SYNDROME	0.00200176	0.07509832889185883
FOCAL DERMAL HYPOPLASIA; FDH	0.00200176	0.07509832889185883
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00200176	0.07509832889185883
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00200176	0.07509832889185883
MASA SYNDROME	0.00200176	0.07509832889185883
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00200176	0.07509832889185883
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00200176	0.07509832889185883
MUCOLIPIDOSIS TYPE IV	0.00200176	0.07509832889185883
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00200176	0.07509832889185883
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00200176	0.07509832889185883
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00200176	0.07509832889185883
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00200176	0.07509832889185883
LAMBOTTE SYNDROME	0.00200176	0.07509832889185883
SECKEL SYNDROME 5; SCKL5	0.00200176	0.07509832889185883
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001843403	0.06915738388929704
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001843403	0.06915738388929704
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001843403	0.06915738388929704
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001843403	0.06915738388929704
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001843403	0.06915738388929704
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001843403	0.06915738388929704
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.001843403	0.06915738388929704
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.001843403	0.06915738388929704
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001843403	0.06915738388929704
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001843403	0.06915738388929704
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001843403	0.06915738388929704
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001843403	0.06915738388929704
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001843403	0.06915738388929704
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001843403	0.06915738388929704
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001843403	0.06915738388929704
CLASSIC PHENYLKETONURIA	0.001843403	0.06915738388929704
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001843403	0.06915738388929704
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.001843403	0.06915738388929704
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001843403	0.06915738388929704
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001843403	0.06915738388929704
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001843403	0.06915738388929704
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001843403	0.06915738388929704
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001843403	0.06915738388929704
MICRO SYNDROME	0.001843403	0.06915738388929704
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001843403	0.06915738388929704
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.001843403	0.06915738388929704
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001843403	0.06915738388929704
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001843403	0.06915738388929704
MEVALONIC ACIDURIA	0.001843403	0.06915738388929704
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001843403	0.06915738388929704
LISSENCEPHALY 4	0.001843403	0.06915738388929704
3Q29 MICRODUPLICATION SYNDROME	0.001843403	0.06915738388929704
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001843403	0.06915738388929704
HOLOPROSENCEPHALY 2; HPE2	0.001843403	0.06915738388929704
ALG3-CDG	0.001843403	0.06915738388929704
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001843403	0.06915738388929704
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001843403	0.06915738388929704
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001843403	0.06915738388929704
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001843403	0.06915738388929704
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001843403	0.06915738388929704
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001843403	0.06915738388929704
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001843403	0.06915738388929704
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001843403	0.06915738388929704
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001843403	0.06915738388929704
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001843403	0.06915738388929704
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001843403	0.06915738388929704
DPAGT1-CDG	0.001843403	0.06915738388929704
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.001843403	0.06915738388929704
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.001843403	0.06915738388929704
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001843403	0.06915738388929704
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001843403	0.06915738388929704
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001843403	0.06915738388929704
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001843403	0.06915738388929704
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001843403	0.06915738388929704
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001843403	0.06915738388929704
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001843403	0.06915738388929704
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001843403	0.06915738388929704
LISSENCEPHALY 8; LIS8	0.001843403	0.06915738388929704
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001843403	0.06915738388929704
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001843403	0.06915738388929704
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001843403	0.06915738388929704
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001843403	0.06915738388929704
WALKER-WARBURG SYNDROME	0.001843403	0.06915738388929704
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001843403	0.06915738388929704
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001843403	0.06915738388929704
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.001843403	0.06915738388929704
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001843403	0.06915738388929704
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001843403	0.06915738388929704
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.001843403	0.06915738388929704
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001843403	0.06915738388929704
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001843403	0.06915738388929704
RING CHROMOSOME 22 SYNDROME	0.001843403	0.06915738388929704
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001843403	0.06915738388929704
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001843403	0.06915738388929704
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001843403	0.06915738388929704
MACDERMOT-WINTER SYNDROME	0.001843403	0.06915738388929704
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.001843403	0.06915738388929704
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001843403	0.06915738388929704
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001843403	0.06915738388929704
HEART AND BRAIN MALFORMATION SYNDROME	0.001843403	0.06915738388929704
KLEEFSTRA SYNDROME 2; KLEFS2	0.001843403	0.06915738388929704
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001843403	0.06915738388929704
HSD10 DISEASE	0.001843403	0.06915738388929704
HOLOPROSENCEPHALY 1; HPE1	0.001843403	0.06915738388929704
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001843403	0.06915738388929704
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001843403	0.06915738388929704
SPINOCEREBELLAR ATAXIA TYPE 7	0.001832554	0.06875037117541137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.001832554	0.06875037117541137
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.001832554	0.06875037117541137
HYPOTONIA-CYSTINURIA SYNDROME	0.001832554	0.06875037117541137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.001832554	0.06875037117541137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.001832554	0.06875037117541137
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.001832554	0.06875037117541137
METHYLMALONIC ACIDURIA, CBLB TYPE	0.001832554	0.06875037117541137
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.001832554	0.06875037117541137
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.001832554	0.06875037117541137
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.001832554	0.06875037117541137
SHWACHMAN-DIAMOND SYNDROME	0.001832554	0.06875037117541137
PEROXISOME BIOGENESIS DISORDER 3B	0.001832554	0.06875037117541137
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.001832554	0.06875037117541137
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001832554	0.06875037117541137
NIEMANN-PICK DISEASE, TYPE A	0.001832554	0.06875037117541137
FARBER DISEASE	0.001832554	0.06875037117541137
GALACTOSE EPIMERASE DEFICIENCY	0.001832554	0.06875037117541137
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.001832554	0.06875037117541137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.001832554	0.06875037117541137
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.001832554	0.06875037117541137
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.001832554	0.06875037117541137
LYSOSOMAL ACID LIPASE DEFICIENCY	0.001832554	0.06875037117541137
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.001832554	0.06875037117541137
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.001832554	0.06875037117541137
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.001832554	0.06875037117541137
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.001832554	0.06875037117541137
CHROMOSOME 16Q22 DELETION SYNDROME	0.001832554	0.06875037117541137
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.001832554	0.06875037117541137
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.001832554	0.06875037117541137
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.001828419	0.06859524189419491
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.001828419	0.06859524189419491
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.001828419	0.06859524189419491
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.001828419	0.06859524189419491
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.001828419	0.06859524189419491
CENTRAL DIABETES INSIPIDUS	0.001828419	0.06859524189419491
KRABBE DISEASE	0.001828419	0.06859524189419491
ADDISON DISEASE	0.001828419	0.06859524189419491
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.001828419	0.06859524189419491
GLUTARIC ACIDEMIA I; GA1	0.001828419	0.06859524189419491
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.001828419	0.06859524189419491
MOGS-CDG	0.001828419	0.06859524189419491
CITRULLINEMIA TYPE I	0.001828419	0.06859524189419491
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.001828419	0.06859524189419491
HISTIOCYTOID CARDIOMYOPATHY	0.001828419	0.06859524189419491
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.001828419	0.06859524189419491
HYPER-BETA-ALANINEMIA	0.001828419	0.06859524189419491
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001828419	0.06859524189419491
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001828419	0.06859524189419491
ACUTE ADRENAL INSUFFICIENCY	0.001828419	0.06859524189419491
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.001828419	0.06859524189419491
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.001828419	0.06859524189419491
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.001828419	0.06859524189419491
GITELMAN SYNDROME	0.001828419	0.06859524189419491
ECTODERMAL DYSPLASIA SYNDROME	0.001828419	0.06859524189419491
RETINITIS PIGMENTOSA 59; RP59	0.001828419	0.06859524189419491
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.001790884	0.0671870731951721
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.001790884	0.0671870731951721
THAUVIN-ROBINET-FAIVRE SYNDROME	0.001790884	0.0671870731951721
16P11.2P12.2 MICRODELETION SYNDROME	0.001790884	0.0671870731951721
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.001790884	0.0671870731951721
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.001790884	0.0671870731951721
JOUBERT SYNDROME 31; JBTS31	0.001790884	0.0671870731951721
RICHARDS-RUNDLE SYNDROME; RRNS	0.001790884	0.0671870731951721
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.001790884	0.0671870731951721
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.001790884	0.0671870731951721
ARTERIAL TORTUOSITY SYNDROME	0.001790884	0.0671870731951721
OROFACIODIGITAL SYNDROME VIII; OFD8	0.001790884	0.0671870731951721
RAHMAN SYNDROME	0.001790884	0.0671870731951721
GABRIELE-DE VRIES SYNDROME; GADEVS	0.001790884	0.0671870731951721
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.001790884	0.0671870731951721
JOUBERT SYNDROME 14	0.001790884	0.0671870731951721
CHAR SYNDROME	0.001790884	0.0671870731951721
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.001790884	0.0671870731951721
CHROMOSOME 17P13.1 DELETION SYNDROME	0.001790884	0.0671870731951721
HYPERTRYPTOPHANEMIA; HYPTRP	0.001790884	0.0671870731951721
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.001790884	0.0671870731951721
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.001790884	0.0671870731951721
JOUBERT SYNDROME 21	0.001790884	0.0671870731951721
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.001790884	0.0671870731951721
SENIOR-LOKEN SYNDROME 9	0.001790884	0.0671870731951721
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.001790884	0.0671870731951721
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.001790884	0.0671870731951721
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.001790884	0.0671870731951721
NEPHRONOPHTHISIS 11; NPHP11	0.001790884	0.0671870731951721
CHAR SYNDROME	0.001790884	0.0671870731951721
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.001790884	0.0671870731951721
ISOLATED PLAGIOCEPHALY	0.001790884	0.0671870731951721
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.001790884	0.0671870731951721
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.001790884	0.0671870731951721
CODAS SYNDROME	0.001790884	0.0671870731951721
FRAGILE X SYNDROME	0.001786749	0.06703194391395566
CROUZON SYNDROME	0.001786749	0.06703194391395566
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.001786749	0.06703194391395566
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.001786749	0.06703194391395566
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.001786749	0.06703194391395566
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.001786749	0.06703194391395566
DYSEQUILIBRIUM SYNDROME	0.001786749	0.06703194391395566
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.001786749	0.06703194391395566
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.001786749	0.06703194391395566
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.001786749	0.06703194391395566
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.001786749	0.06703194391395566
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.001786749	0.06703194391395566
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.001786749	0.06703194391395566
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.001786749	0.06703194391395566
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.001786749	0.06703194391395566
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.001786749	0.06703194391395566
MUSCLE-EYE-BRAIN DISEASE	0.001786749	0.06703194391395566
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.001786749	0.06703194391395566
LINEAR VERRUCOUS NEVUS SYNDROME	0.001786749	0.06703194391395566
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.001786749	0.06703194391395566
CHIME SYNDROME	0.001786749	0.06703194391395566
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.001786749	0.06703194391395566
GAUCHER DISEASE, TYPE IIIC	0.001786749	0.06703194391395566
PHENOBARBITAL EMBRYOPATHY	0.001301984	0.04884542734590456
CEREBELLOFACIODENTAL SYNDROME	0.001301984	0.04884542734590456
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.001301984	0.04884542734590456
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.001301984	0.04884542734590456
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.001301984	0.04884542734590456
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.001301984	0.04884542734590456
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.001301984	0.04884542734590456
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.001301984	0.04884542734590456
RIDDLE SYNDROME	0.001301984	0.04884542734590456
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.001301984	0.04884542734590456
AICARDI-GOUTIERES SYNDROME 6	0.001301984	0.04884542734590456
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.001301984	0.04884542734590456
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.001301984	0.04884542734590456
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.001301984	0.04884542734590456
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.001301984	0.04884542734590456
CONGENITAL VARICELLA SYNDROME	0.001301984	0.04884542734590456
MONOSOMY 13Q34	0.001301984	0.04884542734590456
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.001301984	0.04884542734590456
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.001301984	0.04884542734590456
RAINE SYNDROME	0.001301984	0.04884542734590456
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.001301984	0.04884542734590456
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.001301984	0.04884542734590456
ADAMS-OLIVER SYNDROME 3; AOS3	0.001301984	0.04884542734590456
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.001301984	0.04884542734590456
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.001301984	0.04884542734590456
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.001301984	0.04884542734590456
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.001301984	0.04884542734590456
OROFACIODIGITAL SYNDROME TYPE 14	0.001301984	0.04884542734590456
CRANIOTELENCEPHALIC DYSPLASIA	0.001301984	0.04884542734590456
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.001301984	0.04884542734590456
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.001301984	0.04884542734590456
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.001301984	0.04884542734590456
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.001301984	0.04884542734590456
SECKEL SYNDROME 8; SCKL8	0.001301984	0.04884542734590456
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.001301984	0.04884542734590456
AICARDI-GOUTIERES SYNDROME 5	0.001301984	0.04884542734590456
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.001301984	0.04884542734590456
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.001301984	0.04884542734590456
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.001301984	0.04884542734590456
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.001301984	0.04884542734590456
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.001301984	0.04884542734590456
WARSAW BREAKAGE SYNDROME; WABS	0.001301984	0.04884542734590456
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.001301984	0.04884542734590456
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.001301984	0.04884542734590456
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.001301984	0.04884542734590456
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.001301984	0.04884542734590456
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.001301984	0.04884542734590456
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.001301984	0.04884542734590456
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.001301984	0.04884542734590456
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.001301984	0.04884542734590456
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.001301984	0.04884542734590456
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.001301984	0.04884542734590456
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.001301984	0.04884542734590456
BRESEK SYNDROME	0.001301984	0.04884542734590456
MENTAL RETARDATION, X-LINKED 106; MRX106	0.001301984	0.04884542734590456
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.001301984	0.04884542734590456
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.001301984	0.04884542734590456
HARTSFIELD SYNDROME; HRTFDS	0.001301984	0.04884542734590456
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.001301984	0.04884542734590456
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.001301984	0.04884542734590456
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.001301984	0.04884542734590456
HOLOPROSENCEPHALY 3; HPE3	0.001301984	0.04884542734590456
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.001301984	0.04884542734590456
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.001301984	0.04884542734590456
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.001301984	0.04884542734590456
TRIPLE A SYNDROME	0.001297849	0.048690298064688116
3-HYDROXYISOBUTYRIC ACIDURIA	0.001297849	0.048690298064688116
WORSTER-DROUGHT SYNDROME	0.001297849	0.048690298064688116
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.001297849	0.048690298064688116
SJÖGREN-LARSSON SYNDROME	0.001297849	0.048690298064688116
RENIER-GABREELS-JASPER SYNDROME	0.001297849	0.048690298064688116
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.001297849	0.048690298064688116
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.001297849	0.048690298064688116
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.001297849	0.048690298064688116
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.001297849	0.048690298064688116
TYROSINEMIA TYPE 2	0.001297849	0.048690298064688116
LEUKOCYTE ADHESION DEFICIENCY	0.001297849	0.048690298064688116
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.001297849	0.048690298064688116
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.001297849	0.048690298064688116
MENKES DISEASE	0.001297849	0.048690298064688116
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.001297849	0.048690298064688116
WOLF-HIRSCHHORN SYNDROME	0.001297849	0.048690298064688116
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.001297849	0.048690298064688116
LISSENCEPHALY 3; LIS3	0.001297849	0.048690298064688116
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.001297849	0.048690298064688116
5Q35 MICRODUPLICATION SYNDROME	0.001297849	0.048690298064688116
PERRAULT SYNDROME 3	0.001297849	0.048690298064688116
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.001297849	0.048690298064688116
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.001297849	0.048690298064688116
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.001297849	0.048690298064688116
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.001297849	0.048690298064688116
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.001297849	0.048690298064688116
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.001297849	0.048690298064688116
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.001297849	0.048690298064688116
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.001297849	0.048690298064688116
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.001297849	0.048690298064688116
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.001297849	0.048690298064688116
MOYNAHAN SYNDROME	0.001297849	0.048690298064688116
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.001297849	0.048690298064688116
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.001297849	0.048690298064688116
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.001297849	0.048690298064688116
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.001297849	0.048690298064688116
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.001297849	0.048690298064688116
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.001297849	0.048690298064688116
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.001297849	0.048690298064688116
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.001297849	0.048690298064688116
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.001297849	0.048690298064688116
BANGSTAD SYNDROME	0.001297849	0.048690298064688116
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.001297849	0.048690298064688116
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.001297849	0.048690298064688116
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.001297849	0.048690298064688116
MICROPHTHALMIA, SYNDROMIC 1	0.001297849	0.048690298064688116
COHEN SYNDROME	0.001297849	0.048690298064688116
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.001297849	0.048690298064688116
PSEUDO-TORCH SYNDROME 2	0.001297849	0.048690298064688116
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.001297849	0.048690298064688116
SUPRABULBAR PARESIS, CONGENITAL	0.001297849	0.048690298064688116
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.001297849	0.048690298064688116
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.001297849	0.048690298064688116
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.001297849	0.048690298064688116
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.001297849	0.048690298064688116
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.001297849	0.048690298064688116
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.001297849	0.048690298064688116
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.001297849	0.048690298064688116
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.001297849	0.048690298064688116
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.001297849	0.048690298064688116
ANGELMAN SYNDROME (TYPE 1)	0.001297849	0.048690298064688116
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.001297849	0.048690298064688116
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.001297849	0.048690298064688116
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.001297849	0.048690298064688116
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.001297849	0.048690298064688116
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.001297849	0.048690298064688116
ANGELMAN SYNDROME (TYPE 2)	0.001297849	0.048690298064688116
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.001297849	0.048690298064688116
T-CELL RECEPTOR-ALPHA/BETA DEFICIENCY	0.001287	0.04828328535080245
LYSINURIC PROTEIN INTOLERANCE; LPI	0.001287	0.04828328535080245
DIARRHEA 9; DIAR9	0.001287	0.04828328535080245
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.001287	0.04828328535080245
APPARENT MINERALOCORTICOID EXCESS	0.001287	0.04828328535080245
MULTIPLE OSTEOCHONDROMAS	0.001287	0.04828328535080245
AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME; AIPDS	0.001287	0.04828328535080245
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.001287	0.04828328535080245
ENTEROKINASE DEFICIENCY	0.001287	0.04828328535080245
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.001287	0.04828328535080245
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.001287	0.04828328535080245
MAJEED SYNDROME	0.001287	0.04828328535080245
PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	0.001287	0.04828328535080245
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.001287	0.04828328535080245
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.001287	0.04828328535080245
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE	0.001287	0.04828328535080245
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.001287	0.04828328535080245
46,XY DISORDER OF SEX DEVELOPMENT DUE TO ISOLATED 17,20-LYASE DEFICIENCY	0.001287	0.04828328535080245
ERYTHRODERMA, LETHAL CONGENITAL	0.001287	0.04828328535080245
HYPERCALCEMIA, INFANTILE 2	0.001287	0.04828328535080245
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.001287	0.04828328535080245
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.001287	0.04828328535080245
CRYPTOSPORIDIOSIS	0.001287	0.04828328535080245
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.001287	0.04828328535080245
OMENN SYNDROME	0.001287	0.04828328535080245
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.001287	0.04828328535080245
IMMUNODEFICIENCY 52; IMD52	0.001287	0.04828328535080245
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.001287	0.04828328535080245
601095 HARROD SYNDROME	0.001287	0.04828328535080245
MANNOSE-BINDING LECTIN DEFICIENCY	0.001287	0.04828328535080245
BARE LYMPHOCYTE SYNDROME, TYPE II	0.001287	0.04828328535080245
ERYTHRODERMA DESQUAMATIVUM	0.001287	0.04828328535080245
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.001287	0.04828328535080245
TRICHOHEPATOENTERIC SYNDROME 2	0.001287	0.04828328535080245
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.001287	0.04828328535080245
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.001287	0.04828328535080245
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.001287	0.04828328535080245
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.001287	0.04828328535080245
IMMUNODEFICIENCY 53; IMD53	0.001287	0.04828328535080245
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.001287	0.04828328535080245
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3	0.001287	0.04828328535080245
MONOCYTE AND DENDRITIC CELL DEFICIENCY, AUTOSOMAL RECESSIVE	0.001287	0.04828328535080245
HYPOTONIA-CYSTINURIA SYNDROME	0.001287	0.04828328535080245
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.001287	0.04828328535080245
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.001287	0.04828328535080245
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.001287	0.04828328535080245
CONGENITAL SHORT BOWEL SYNDROME	0.001287	0.04828328535080245
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.001287	0.04828328535080245
WILSON DISEASE	0.001287	0.04828328535080245
CLASSIC MULTIMINICORE MYOPATHY	0.001287	0.04828328535080245
IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	0.001287	0.04828328535080245
GALACTOSEMIA	0.001287	0.04828328535080245
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 1	0.001287	0.04828328535080245
CHYLOMICRON RETENTION DISEASE	0.001287	0.04828328535080245
CLASSIC GALACTOSEMIA	0.001287	0.04828328535080245
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.001287	0.04828328535080245
IMMUNODEFICIENCY 57; IMD57	0.001287	0.04828328535080245
CHRONIC ATRIAL AND INTESTINAL DYSRHYTHMIA; CAID	0.001287	0.04828328535080245
TYROSINEMIA, TYPE I; TYRSN1	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	0.001287	0.04828328535080245
FAMILIAL HYPOALDOSTERONISM	0.001287	0.04828328535080245
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.001287	0.04828328535080245
VALINEMIA	0.001287	0.04828328535080245
DOUBLE OUTLET RIGHT VENTRICLE	0.001287	0.04828328535080245
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 3	0.001287	0.04828328535080245
GLYCOGEN STORAGE DISEASE IV	0.001287	0.04828328535080245
ADRENAL HYPOPLASIA, CONGENITAL	0.001287	0.04828328535080245
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.001287	0.04828328535080245
PRIMARY HYPEROXALURIA	0.001287	0.04828328535080245
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.001287	0.04828328535080245
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.001287	0.04828328535080245
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.001287	0.04828328535080245
NEPHROPATHIC INFANTILE CYSTINOSIS	0.001287	0.04828328535080245
LYSOSOMAL ACID LIPASE DEFICIENCY	0.001287	0.04828328535080245
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.001287	0.04828328535080245
IMMUNODEFICIENCY 46; IMD46	0.001287	0.04828328535080245
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.001287	0.04828328535080245
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.001287	0.04828328535080245
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.001287	0.04828328535080245
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.001287	0.04828328535080245
RETICULAR DYSGENESIS	0.001287	0.04828328535080245
BARTH SYNDROME; BTHS	0.001287	0.04828328535080245
IMMUNODEFICIENCY 22; IMD22	0.001287	0.04828328535080245
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.001287	0.04828328535080245
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.001287	0.04828328535080245
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.001287	0.04828328535080245
BARBER-SAY SYNDROME	0.001287	0.04828328535080245
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.001287	0.04828328535080245
ATRESIA OF SMALL INTESTINE	0.001287	0.04828328535080245
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.001287	0.04828328535080245
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.001287	0.04828328535080245
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.001287	0.04828328535080245
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.001287	0.04828328535080245
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.001287	0.04828328535080245
HYPERLIPOPROTEINEMIA, TYPE ID	0.001287	0.04828328535080245
JUNCTIONAL EPIDERMOLYSIS BULLOSA, NON-HERLITZ TYPE	0.001287	0.04828328535080245
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.001287	0.04828328535080245
AUTOSOMAL AGAMMAGLOBULINEMIA	0.001287	0.04828328535080245
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY DUE TO COMPLETE RAG1/2 DEFICIENCY	0.001287	0.04828328535080245
IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	0.001287	0.04828328535080245
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.001287	0.04828328535080245
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.001287	0.04828328535080245
GRAFT VERSUS HOST DISEASE	0.001287	0.04828328535080245
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.001287	0.04828328535080245
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.001287	0.04828328535080245
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.001287	0.04828328535080245
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.001287	0.04828328535080245
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.001287	0.04828328535080245
PYLORIC STENOSIS, INFANTILE HYPERTROPHIC 1	0.001287	0.04828328535080245
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.001287	0.04828328535080245
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.001287	0.04828328535080245
ISOLATED AGAMMAGLOBULINEMIA	0.001287	0.04828328535080245
FAMILIAL DILATED CARDIOMYOPATHY	0.001287	0.04828328535080245
INFANTILE SYSTEMIC HYALINOSIS	0.001287	0.04828328535080245
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.001287	0.04828328535080245
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.001287	0.04828328535080245
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	0.001287	0.04828328535080245
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.001287	0.04828328535080245
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.001287	0.04828328535080245
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.001287	0.04828328535080245
HAWKINSINURIA	0.001287	0.04828328535080245
MELORHEOSTOSIS	0.001287	0.04828328535080245
HAWKINSINURIA	0.001287	0.04828328535080245
PEARSON SYNDROME	0.001287	0.04828328535080245
KAPUR-TORIELLO SYNDROME	0.001287	0.04828328535080245
LATE-ONSET FAMILIAL HYPOALDOSTERONISM	0.001287	0.04828328535080245
RIGID SPINE MUSCULAR DYSTROPHY 1	0.001287	0.04828328535080245
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.001287	0.04828328535080245
JUVENILE POLYPOSIS SYNDROME	0.001287	0.04828328535080245
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.001287	0.04828328535080245
CHYLOMICRON RETENTION DISEASE	0.001287	0.04828328535080245
614044 TRYPSINOGEN DEFICIENCY	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY DUE TO DCLRE1C DEFICIENCY	0.001287	0.04828328535080245
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.001287	0.04828328535080245
SEVERE COMBINED IMMUNODEFICIENCY DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.001287	0.04828328535080245
PORPHYRIA, ACUTE HEPATIC	0.001287	0.04828328535080245
CONGENITAL LETHAL ERYTHRODERMA	0.001287	0.04828328535080245
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.001287	0.04828328535080245
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.001287	0.04828328535080245
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.001287	0.04828328535080245
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.001287	0.04828328535080245
ICHTHYOSIS-INTELLECTUAL DISABILITY-DWARFISM-RENAL IMPAIRMENT SYNDROME	0.001287	0.04828328535080245
SECONDARY SHORT BOWEL SYNDROME	0.001287	0.04828328535080245
IMMUNODEFICIENCY 9; IMD9	0.001287	0.04828328535080245
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.001287	0.04828328535080245
MYOPATHIC EHLERS-DANLOS SYNDROME	0.001287	0.04828328535080245
GLUCOSE/GALACTOSE MALABSORPTION; GGM	0.001287	0.04828328535080245
MUCOPOLYSACCHARIDOSIS TYPE 6	0.001287	0.04828328535080245
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.001287	0.04828328535080245
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00124533	0.04671998737056318
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.04671998737056318
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.00124533	0.04671998737056318
SPINOCEREBELLAR ATAXIA TYPE 25	0.00124533	0.04671998737056318
BENCZE SYNDROME	0.00124533	0.04671998737056318
PETERS ANOMALY	0.00124533	0.04671998737056318
MARSHALL SYNDROME	0.00124533	0.04671998737056318
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00124533	0.04671998737056318
MORNING GLORY DISC ANOMALY	0.00124533	0.04671998737056318
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00124533	0.04671998737056318
FETAL IODINE SYNDROME	0.00124533	0.04671998737056318
8Q21.11 MICRODELETION SYNDROME	0.00124533	0.04671998737056318
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00124533	0.04671998737056318
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.00124533	0.04671998737056318
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00124533	0.04671998737056318
IVIC SYNDROME	0.00124533	0.04671998737056318
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00124533	0.04671998737056318
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.00124533	0.04671998737056318
ABDUCENS PALSY	0.00124533	0.04671998737056318
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00124533	0.04671998737056318
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.00124533	0.04671998737056318
RETINOBLASTOMA	0.00124533	0.04671998737056318
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.00124533	0.04671998737056318
LEBER CONGENITAL AMAUROSIS 16	0.00124533	0.04671998737056318
IVIC SYNDROME	0.00124533	0.04671998737056318
SPASTIC PARAPLEGIA 16, X-LINKED	0.00124533	0.04671998737056318
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.00124533	0.04671998737056318
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.00124533	0.04671998737056318
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00124533	0.04671998737056318
OCULOCUTANEOUS ALBINISM	0.00124533	0.04671998737056318
RETINAL CONE DYSTROPHY 3B	0.00124533	0.04671998737056318
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00124533	0.04671998737056318
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00124533	0.04671998737056318
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00124533	0.04671998737056318
NANCE-HORAN SYNDROME	0.00124533	0.04671998737056318
GROENOUW TYPE I CORNEAL DYSTROPHY	0.00124533	0.04671998737056318
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00124533	0.04671998737056318
X-LINKED RECESSIVE OCULAR ALBINISM	0.00124533	0.04671998737056318
HERMANSKY-PUDLAK SYNDROME	0.00124533	0.04671998737056318
OCULOCUTANEOUS ALBINISM TYPE 2	0.00124533	0.04671998737056318
OCULOCUTANEOUS ALBINISM TYPE 4	0.00124533	0.04671998737056318
COATS DISEASE	0.00124533	0.04671998737056318
OCULAR ALBINISM	0.00124533	0.04671998737056318
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00124533	0.04671998737056318
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00124533	0.04671998737056318
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00124533	0.04671998737056318
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00124533	0.04671998737056318
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	0.00124533	0.04671998737056318
PSEUDOXANTHOMA ELASTICUM-LIKE SKIN MANIFESTATIONS WITH RETINITIS PIGMENTOSA	0.00124533	0.04671998737056318
NANOPHTHALMOS	0.00124533	0.04671998737056318
BRANCHIOGENIC DEAFNESS SYNDROME	0.00124533	0.04671998737056318
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.00124533	0.04671998737056318
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00124533	0.04671998737056318
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00124533	0.04671998737056318
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.00124533	0.04671998737056318
BASAL CELL NEVUS SYNDROME	0.00124533	0.04671998737056318
CHANARIN-DORFMAN SYNDROME	0.00124533	0.04671998737056318
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00124533	0.04671998737056318
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00124533	0.04671998737056318
SPINOCEREBELLAR ATAXIA TYPE 27	0.00124533	0.04671998737056318
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00124533	0.04671998737056318
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00124533	0.04671998737056318
NEPHRONOPHTHISIS 18; NPHP18	0.00124533	0.04671998737056318
X-LINKED INTELLECTUAL DISABILITY-DANDY-WALKER MALFORMATION-BASAL GANGLIA DISEASE-SEIZURES SYNDROME	0.00124533	0.04671998737056318
ODONTOCHONDRODYSPLASIA	0.00124533	0.04671998737056318
SENGERS SYNDROME	0.00124533	0.04671998737056318
PETERS ANOMALY	0.00124533	0.04671998737056318
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00124533	0.04671998737056318
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00124533	0.04671998737056318
FOCAL DERMAL HYPOPLASIA	0.00124533	0.04671998737056318
MOEBIUS SYNDROME	0.00124533	0.04671998737056318
VITREORETINOCHOROIDOPATHY; VRCP	0.00124533	0.04671998737056318
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.00124533	0.04671998737056318
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.04671998737056318
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.00124533	0.04671998737056318
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00124533	0.04671998737056318
STICKLER SYNDROME	0.00124533	0.04671998737056318
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00124533	0.04671998737056318
%193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4;;VESTIBULOCEREBELLAR DISORDER WITH PREDOMINANT OCULAR SIGNS	0.00124533	0.04671998737056318
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00124533	0.04671998737056318
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.00124533	0.04671998737056318
X-LINKED RETINAL DYSPLASIA	0.00124533	0.04671998737056318
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00124533	0.04671998737056318
EEM SYNDROME	0.00124533	0.04671998737056318
HIDROTIC ECTODERMAL DYSPLASIA	0.00124533	0.04671998737056318
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00124533	0.04671998737056318
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00124533	0.04671998737056318
SPINOCEREBELLAR ATAXIA TYPE 34	0.00124533	0.04671998737056318
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00124533	0.04671998737056318
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.00124533	0.04671998737056318
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00124533	0.04671998737056318
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00124533	0.04671998737056318
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00124533	0.04671998737056318
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.00124533	0.04671998737056318
WOOLLY HAIR	0.00124533	0.04671998737056318
SOTOS SYNDROME 2	0.00124533	0.04671998737056318
JACKSON-WEISS SYNDROME	0.00124533	0.04671998737056318
ACRO-RENAL-OCULAR SYNDROME	0.00124533	0.04671998737056318
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.00124533	0.04671998737056318
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00124533	0.04671998737056318
ROBINOW-SORAUF SYNDROME	0.00124533	0.04671998737056318
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.00124533	0.04671998737056318
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00124533	0.04671998737056318
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00124533	0.04671998737056318
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.00124533	0.04671998737056318
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.04671998737056318
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00124533	0.04671998737056318
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00124533	0.04671998737056318
OPTIC ATROPHY 1; OPA1	0.00124533	0.04671998737056318
STIFF SKIN SYNDROME	0.00124533	0.04671998737056318
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.00124533	0.04671998737056318
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00124533	0.04671998737056318
PROXIMAL SYMPHALANGISM	0.00124533	0.04671998737056318
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00124533	0.04671998737056318
HEMIFACIAL MICROSOMIA	0.00124533	0.04671998737056318
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.00124533	0.04671998737056318
OCULOCUTANEOUS ALBINISM TYPE 3	0.00124533	0.04671998737056318
RENAL COLOBOMA SYNDROME	0.00124533	0.04671998737056318
CONGENITAL STATIONARY NIGHT BLINDNESS	0.00124533	0.04671998737056318
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.00124533	0.04671998737056318
FRONTORHINY	0.00124533	0.04671998737056318
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.00124533	0.04671998737056318
SUMMITT SYNDROME	0.00124533	0.04671998737056318
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00124533	0.04671998737056318
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00124533	0.04671998737056318
COOPER-JABS SYNDROME	0.00124533	0.04671998737056318
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00124533	0.04671998737056318
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.001086973	0.040779042368001395
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001086973	0.040779042368001395
CRANIOPHARYNGIOMA	0.001086973	0.040779042368001395
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001086973	0.040779042368001395
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.040779042368001395
TAY-SACHS DISEASE	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.001086973	0.040779042368001395
IMMUNODEFICIENCY 49; IMD49	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.001086973	0.040779042368001395
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001086973	0.040779042368001395
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001086973	0.040779042368001395
LUSCAN-LUMISH SYNDROME; LLS	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.040779042368001395
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001086973	0.040779042368001395
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.040779042368001395
SULFOCYSTEINURIA	0.001086973	0.040779042368001395
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.001086973	0.040779042368001395
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.040779042368001395
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.040779042368001395
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.040779042368001395
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001086973	0.040779042368001395
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.040779042368001395
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.040779042368001395
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.040779042368001395
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001086973	0.040779042368001395
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.040779042368001395
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.040779042368001395
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.040779042368001395
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.040779042368001395
PETTIGREW SYNDROME	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.040779042368001395
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.040779042368001395
WAISMAN SYNDROME; WSMN	0.001086973	0.040779042368001395
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001086973	0.040779042368001395
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001086973	0.040779042368001395
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001086973	0.040779042368001395
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.040779042368001395
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.001086973	0.040779042368001395
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001086973	0.040779042368001395
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.040779042368001395
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.001086973	0.040779042368001395
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.040779042368001395
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001086973	0.040779042368001395
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.040779042368001395
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.040779042368001395
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.040779042368001395
LEBER CONGENITAL AMAUROSIS	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.040779042368001395
CATEL-MANZKE SYNDROME; CATMANS	0.001086973	0.040779042368001395
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001086973	0.040779042368001395
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.001086973	0.040779042368001395
DYSTONIA-APHONIA SYNDROME	0.001086973	0.040779042368001395
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.001086973	0.040779042368001395
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY 7	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.040779042368001395
PHACE ASSOCIATION	0.001086973	0.040779042368001395
NARP SYNDROME	0.001086973	0.040779042368001395
NIEMANN-PICK DISEASE TYPE C	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.040779042368001395
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.040779042368001395
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001086973	0.040779042368001395
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.040779042368001395
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.040779042368001395
XQ25 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001086973	0.040779042368001395
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001086973	0.040779042368001395
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001086973	0.040779042368001395
MAPLE SYRUP URINE DISEASE	0.001086973	0.040779042368001395
MEND SYNDROME; MEND	0.001086973	0.040779042368001395
XQ25 DUPLICATION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.040779042368001395
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001086973	0.040779042368001395
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.040779042368001395
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.001086973	0.040779042368001395
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.040779042368001395
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.040779042368001395
CENTRAL BILATERAL MACROGYRIA	0.001086973	0.040779042368001395
HYPEREKPLEXIA 4; HKPX4	0.001086973	0.040779042368001395
CITRULLINEMIA TYPE II	0.001086973	0.040779042368001395
TRISOMY X	0.001086973	0.040779042368001395
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.040779042368001395
ARGININEMIA	0.001086973	0.040779042368001395
ISOVALERIC ACIDEMIA	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA TYPE 13	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001086973	0.040779042368001395
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.040779042368001395
SEVERE CANAVAN DISEASE	0.001086973	0.040779042368001395
KETOADIPICACIDURIA	0.001086973	0.040779042368001395
ADULT-ONSET DYSTONIA-PARKINSONISM	0.001086973	0.040779042368001395
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001086973	0.040779042368001395
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001086973	0.040779042368001395
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.040779042368001395
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001086973	0.040779042368001395
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.040779042368001395
DONNAI-BARROW SYNDROME	0.001086973	0.040779042368001395
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.040779042368001395
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.040779042368001395
DISTAL MONOSOMY 19P13.3	0.001086973	0.040779042368001395
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001086973	0.040779042368001395
SIALIDOSIS TYPE 2	0.001086973	0.040779042368001395
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001086973	0.040779042368001395
LANDAU-KLEFFNER SYNDROME	0.001086973	0.040779042368001395
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.040779042368001395
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.001086973	0.040779042368001395
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.040779042368001395
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001086973	0.040779042368001395
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.040779042368001395
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.040779042368001395
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001086973	0.040779042368001395
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.040779042368001395
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.001086973	0.040779042368001395
DISTAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.040779042368001395
COACH SYNDROME	0.001086973	0.040779042368001395
KEUTEL SYNDROME	0.001086973	0.040779042368001395
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
L1 SYNDROME	0.001086973	0.040779042368001395
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.001086973	0.040779042368001395
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.040779042368001395
TEMTAMY SYNDROME; TEMTYS	0.001086973	0.040779042368001395
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.040779042368001395
CANAVAN DISEASE	0.001086973	0.040779042368001395
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.040779042368001395
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.040779042368001395
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.040779042368001395
HARTNUP DISORDER	0.001086973	0.040779042368001395
VICI SYNDROME	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.001086973	0.040779042368001395
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.001086973	0.040779042368001395
PFEIFFER SYNDROME TYPE 2	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001086973	0.040779042368001395
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.00075643	0.028378341521295647
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00075643	0.028378341521295647
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00075643	0.028378341521295647
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00075643	0.028378341521295647
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.00075643	0.028378341521295647
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00075643	0.028378341521295647
601453 TRICHODENTAL DYSPLASIA	0.00075643	0.028378341521295647
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00075643	0.028378341521295647
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00075643	0.028378341521295647
207790 ARACHNOID CYSTS, INTRACRANIAL	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.00075643	0.028378341521295647
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00075643	0.028378341521295647
BOWEN-CONRADI SYNDROME	0.00075643	0.028378341521295647
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00075643	0.028378341521295647
CERNUNNOS-XLF DEFICIENCY	0.00075643	0.028378341521295647
DYSOSTOSIS, STANESCU TYPE	0.00075643	0.028378341521295647
LOWRY-WOOD SYNDROME	0.00075643	0.028378341521295647
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00075643	0.028378341521295647
ISOLATED OSTEOPOIKILOSIS	0.00075643	0.028378341521295647
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00075643	0.028378341521295647
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00075643	0.028378341521295647
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00075643	0.028378341521295647
FEINGOLD SYNDROME 2; FGLDS2	0.00075643	0.028378341521295647
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.00075643	0.028378341521295647
MARTSOLF SYNDROME	0.00075643	0.028378341521295647
SATOYOSHI SYNDROME	0.00075643	0.028378341521295647
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00075643	0.028378341521295647
FETAL METHYLMERCURY SYNDROME	0.00075643	0.028378341521295647
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.00075643	0.028378341521295647
ANE SYNDROME	0.00075643	0.028378341521295647
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00075643	0.028378341521295647
RING CHROMOSOME 13 SYNDROME	0.00075643	0.028378341521295647
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00075643	0.028378341521295647
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.00075643	0.028378341521295647
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00075643	0.028378341521295647
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00075643	0.028378341521295647
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00075643	0.028378341521295647
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00075643	0.028378341521295647
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00075643	0.028378341521295647
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.00075643	0.028378341521295647
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00075643	0.028378341521295647
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00075643	0.028378341521295647
PAGOD SYNDROME	0.00075643	0.028378341521295647
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00075643	0.028378341521295647
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00075643	0.028378341521295647
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00075643	0.028378341521295647
VELOCARDIOFACIAL SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00075643	0.028378341521295647
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00075643	0.028378341521295647
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00075643	0.028378341521295647
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00075643	0.028378341521295647
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00075643	0.028378341521295647
MECKEL SYNDROME	0.00075643	0.028378341521295647
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00075643	0.028378341521295647
2P15-16.1 MICRODELETION SYNDROME	0.00075643	0.028378341521295647
1Q21.1 RECURRENT MICRODELETION (SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.00075643	0.028378341521295647
ERMINE PHENOTYPE	0.00075643	0.028378341521295647
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00075643	0.028378341521295647
CRI DU CHAT SYNDROME (5P DELETION)	0.00075643	0.028378341521295647
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00075643	0.028378341521295647
XFE PROGEROID SYNDROME; XFEPS	0.00075643	0.028378341521295647
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00075643	0.028378341521295647
FRYNS-SMEETS-THIRY SYNDROME	0.00075643	0.028378341521295647
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00075643	0.028378341521295647
FRONTONASAL DYSPLASIA 2; FND2	0.00075643	0.028378341521295647
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00075643	0.028378341521295647
RUVALCABA SYNDROME	0.00075643	0.028378341521295647
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.00075643	0.028378341521295647
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00075643	0.028378341521295647
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.00075643	0.028378341521295647
FEINGOLD SYNDROME 1; FGLDS1	0.00075643	0.028378341521295647
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00075643	0.028378341521295647
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.00075643	0.028378341521295647
ATAXIA-PANCYTOPENIA SYNDROME	0.00075643	0.028378341521295647
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.00075643	0.028378341521295647
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00075643	0.028378341521295647
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00075643	0.028378341521295647
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00075643	0.028378341521295647
LARYNGEAL ABDUCTOR PARALYSIS	0.00075643	0.028378341521295647
KERATOSIS FOLLICULARIS-DWARFISM-CEREBRAL ATROPHY SYNDROME	0.00075643	0.028378341521295647
LARYNGEAL ABDUCTOR PARALYSIS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00075643	0.028378341521295647
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
HYPERREFLEXIA	0.00075643	0.028378341521295647
MICROCEPHALY-ALBINISM-DIGITAL ANOMALIES SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00075643	0.028378341521295647
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00075643	0.028378341521295647
STIMMLER SYNDROME	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00075643	0.028378341521295647
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00075643	0.028378341521295647
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00075643	0.028378341521295647
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00075643	0.028378341521295647
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00075643	0.028378341521295647
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00075643	0.028378341521295647
MICROCEPHALY-CARDIOMYOPATHY	0.00075643	0.028378341521295647
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00075643	0.028378341521295647
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00075643	0.028378341521295647
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00075643	0.028378341521295647
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00075643	0.028378341521295647
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00075643	0.028378341521295647
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00075643	0.028378341521295647
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00075643	0.028378341521295647
DE SANCTIS-CACCHIONE SYNDROME	0.00075643	0.028378341521295647
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.00075643	0.028378341521295647
MMEP SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00075643	0.028378341521295647
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00075643	0.028378341521295647
MENTAL RETARDATION, X-LINKED 63	0.00075643	0.028378341521295647
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00075643	0.028378341521295647
MECKEL SYNDROME 12; MKS12	0.00075643	0.028378341521295647
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.00075643	0.028378341521295647
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00075643	0.028378341521295647
CHROMOSOME XP11.3 DELETION SYNDROME	0.00075643	0.028378341521295647
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00075643	0.028378341521295647
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00075643	0.028378341521295647
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00075643	0.028378341521295647
BARDET-BIEDL SYNDROME 20	0.00075643	0.028378341521295647
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00075643	0.028378341521295647
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00075643	0.028378341521295647
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.00075643	0.028378341521295647
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.00075643	0.028378341521295647
OCULOPALATOCEREBRAL SYNDROME	0.00075643	0.028378341521295647
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00075643	0.028378341521295647
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.00075643	0.028378341521295647
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00075643	0.028378341521295647
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00075643	0.028378341521295647
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00075643	0.028378341521295647
RHIZOMELIC SYNDROME	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00075643	0.028378341521295647
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00075643	0.028378341521295647
IMMUNODEFICIENCY 55; IMD55	0.00075643	0.028378341521295647
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00075643	0.028378341521295647
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.00075643	0.028378341521295647
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.00075643	0.028378341521295647
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00075643	0.028378341521295647
OCULOAURICULOFRONTONASAL SYNDROME	0.00075643	0.028378341521295647
NIJMEGEN BREAKAGE SYNDROME	0.00075643	0.028378341521295647
COFFIN-SIRIS SYNDROME 10; CSS10	0.00075643	0.028378341521295647
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00075643	0.028378341521295647
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00075643	0.028378341521295647
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00075643	0.028378341521295647
WAGR SYNDROME	0.00075643	0.028378341521295647
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00075643	0.028378341521295647
GERODERMA OSTEODYSPLASTICUM; GO	0.00075643	0.028378341521295647
ANONYCHIA-MICROCEPHALY SYNDROME	0.00075643	0.028378341521295647
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00075643	0.028378341521295647
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00075643	0.028378341521295647
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.00075643	0.028378341521295647
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00075643	0.028378341521295647
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00075643	0.028378341521295647
TETRAPLOIDY	0.00075643	0.028378341521295647
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.00075643	0.028378341521295647
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00075643	0.028378341521295647
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO ZNF335 DEFICIENCY	0.00075643	0.028378341521295647
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00075643	0.028378341521295647
BONNEMANN-MEINECKE-REICH SYNDROME	0.00075643	0.028378341521295647
HUMERO-RADIAL SYNOSTOSIS	0.00075643	0.028378341521295647
STROMME SYNDROME; STROMS	0.00075643	0.028378341521295647
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.00075643	0.028378341521295647
ACHALASIA-MICROCEPHALY SYNDROME	0.00075643	0.028378341521295647
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00075643	0.028378341521295647
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00075643	0.028378341521295647
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00075643	0.028378341521295647
NEU-LAXOVA SYNDROME 2; NLS2	0.00075643	0.028378341521295647
CEREBROCOSTOMANDIBULAR SYNDROME	0.00075643	0.028378341521295647
ENCEPHALOMALACIA, MULTILOCULAR	0.00075643	0.028378341521295647
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.00075643	0.028378341521295647
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.02046708582460892
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.02046708582460892
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.02046708582460892
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.02046708582460892
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.02046708582460892
DIAPHANOSPONDYLODYSOSTOSIS	0.000545554	0.02046708582460892
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.02046708582460892
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.02046708582460892
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000545554	0.02046708582460892
HURLER SYNDROME	0.000545554	0.02046708582460892
PELLAGRA-LIKE SYNDROME	0.000545554	0.02046708582460892
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.02046708582460892
WOLMAN DISEASE	0.000545554	0.02046708582460892
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.02046708582460892
JOUBERT SYNDROME 1	0.000545554	0.02046708582460892
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.02046708582460892
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.02046708582460892
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.000545554	0.02046708582460892
ALPHA-MANNOSIDOSIS	0.000545554	0.02046708582460892
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.02046708582460892
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.02046708582460892
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.02046708582460892
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.02046708582460892
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.02046708582460892
8P23.1 DUPLICATION SYNDROME	0.000545554	0.02046708582460892
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.02046708582460892
MEDULLOBLASTOMA	0.000545554	0.02046708582460892
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.02046708582460892
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.02046708582460892
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.02046708582460892
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.02046708582460892
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.02046708582460892
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.02046708582460892
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.02046708582460892
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.02046708582460892
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.02046708582460892
CURRARINO SYNDROME	0.000545554	0.02046708582460892
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.02046708582460892
ALG6-CDG	0.000545554	0.02046708582460892
AUSTRALIA ANTIGEN	0.000545554	0.02046708582460892
SEPTOOPTIC DYSPLASIA	0.000545554	0.02046708582460892
CDAGS SYNDROME	0.000545554	0.02046708582460892
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.02046708582460892
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.02046708582460892
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.02046708582460892
THYROID HYPOPLASIA	0.000545554	0.02046708582460892
THYROID HEMIAGENESIS	0.000545554	0.02046708582460892
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.02046708582460892
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.02046708582460892
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.02046708582460892
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.02046708582460892
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.02046708582460892
ATHYREOSIS	0.000545554	0.02046708582460892
ARIMA SYNDROME	0.000545554	0.02046708582460892
THYROID ECTOPIA	0.000545554	0.02046708582460892
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.02046708582460892
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.02046708582460892
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.02046708582460892
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.02046708582460892
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.02046708582460892
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.02046708582460892
FRIED SYNDROME	0.000545554	0.02046708582460892
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.02046708582460892
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.02046708582460892
JOUBERT SYNDROME 10	0.000545554	0.02046708582460892
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.02046708582460892
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.02046708582460892
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.02046708582460892
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.02046708582460892
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.02046708582460892
WAARDENBURG-SHAH SYNDROME	0.000545554	0.02046708582460892
RIGID SPINE SYNDROME	0.000545554	0.02046708582460892
ZEBRA BODY MYOPATHY	0.000545554	0.02046708582460892
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.02046708582460892
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000545554	0.02046708582460892
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.02046708582460892
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.02046708582460892
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.02046708582460892
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.02046708582460892
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.02046708582460892
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.02046708582460892
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.000545554	0.02046708582460892
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.02046708582460892
OTOFACIOCERVICAL SYNDROME	0.000545554	0.02046708582460892
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.02046708582460892
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000545554	0.02046708582460892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.02046708582460892
GERODERMA OSTEODYSPLASTICA	0.000545554	0.02046708582460892
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.02046708582460892
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.02046708582460892
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.02046708582460892
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.02046708582460892
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.02046708582460892
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.02046708582460892
OCCIPITAL HORN SYNDROME	0.000545554	0.02046708582460892
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.02046708582460892
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.02046708582460892
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.02046708582460892
JOUBERT SYNDROME 24	0.000545554	0.02046708582460892
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.02046708582460892
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.02046708582460892
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000545554	0.02046708582460892
JOUBERT SYNDROME 25	0.000545554	0.02046708582460892
JOUBERT SYNDROME 26	0.000545554	0.02046708582460892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.02046708582460892
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.02046708582460892
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.02046708582460892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.02046708582460892
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.02046708582460892
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.02046708582460892
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.02046708582460892
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.02046708582460892
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.02046708582460892
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.02046708582460892
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.02046708582460892
CULLER-JONES SYNDROME; CJS	0.000545554	0.02046708582460892
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.02046708582460892
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.02046708582460892
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.02046708582460892
HEREDITARY OROTIC ACIDURIA	0.000545554	0.02046708582460892
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.02046708582460892
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.02046708582460892
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.02046708582460892
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.02046708582460892
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.02046708582460892
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.02046708582460892
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.02046708582460892
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.02046708582460892
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.02046708582460892
ABETAL34V AMYLOIDOSIS	0.000545554	0.02046708582460892
TEMTAMY SYNDROME	0.000545554	0.02046708582460892
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.02046708582460892
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.02046708582460892
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.02046708582460892
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.02046708582460892
AURICULOCONDYLAR SYNDROME	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.02046708582460892
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.02046708582460892
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02046708582460892
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.02046708582460892
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.02046708582460892
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.02046708582460892
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.02046708582460892
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.02046708582460892
SENIOR-LOKEN SYNDROME	0.000545554	0.02046708582460892
DEXTROCARDIA	0.000545554	0.02046708582460892
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.02046708582460892
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.02046708582460892
JOUBERT SYNDROME 27	0.000545554	0.02046708582460892
JOUBERT SYNDROME 28	0.000545554	0.02046708582460892
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.02046708582460892
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.02046708582460892
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.02046708582460892
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.02046708582460892
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.02046708582460892
COHEN-GIBSON SYNDROME; COGIS	0.000545554	0.02046708582460892
MECKEL SYNDROME 13; MKS13	0.000545554	0.02046708582460892
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.02046708582460892
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.02046708582460892
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.02046708582460892
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.02046708582460892
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.02046708582460892
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.02046708582460892
OPITZ G/BBB SYNDROME	0.000545554	0.02046708582460892
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.02046708582460892
ATELOSTEOGENESIS TYPE III	0.000545554	0.02046708582460892
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.02046708582460892
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000545554	0.02046708582460892
OGDEN SYNDROME	0.000545554	0.02046708582460892
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.02046708582460892
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.02046708582460892
JOUBERT SYNDROME 7	0.000545554	0.02046708582460892
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.02046708582460892
FRIAS SYNDROME	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.02046708582460892
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.02046708582460892
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.02046708582460892
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.02046708582460892
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.02046708582460892
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.02046708582460892
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.02046708582460892
JOUBERT SYNDROME 6	0.000545554	0.02046708582460892
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.02046708582460892
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.02046708582460892
NOONAN SYNDROME 6; NS6	0.000545554	0.02046708582460892
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.02046708582460892
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.02046708582460892
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.02046708582460892
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.02046708582460892
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.02046708582460892
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.02046708582460892
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.02046708582460892
JOUBERT SYNDROME 15	0.000545554	0.02046708582460892
14Q22Q23 MICRODELETION SYNDROME	0.000545554	0.02046708582460892
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000545554	0.02046708582460892
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.02046708582460892
STEEL SYNDROME; STLS	0.000545554	0.02046708582460892
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.02046708582460892
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.02046708582460892
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.02046708582460892
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.000545554	0.02046708582460892
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.02046708582460892
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.02046708582460892
JOUBERT SYNDROME 8	0.000545554	0.02046708582460892
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.02046708582460892
MICROVILLUS INCLUSION DISEASE	0.000545554	0.02046708582460892
N SYNDROME	0.000545554	0.02046708582460892
USHER SYNDROME TYPE 1	0.000545554	0.02046708582460892
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.02046708582460892
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.02046708582460892
1P21.3 MICRODELETION SYNDROME	0.000545554	0.02046708582460892
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.02046708582460892
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.02046708582460892
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.02046708582460892
ICF SYNDROME	0.000545554	0.02046708582460892
RIFT VALLEY FEVER	0.000541419	0.020311956543392472
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.020311956543392472
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000541419	0.020311956543392472
DYSOSTEOSCLEROSIS	0.000541419	0.020311956543392472
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020311956543392472
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.020311956543392472
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.020311956543392472
HUNTINGTON DISEASE-LIKE 1	0.000541419	0.020311956543392472
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.020311956543392472
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.000541419	0.020311956543392472
HEREDITARY HYPEREKPLEXIA	0.000541419	0.020311956543392472
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.020311956543392472
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.020311956543392472
PAPILLORENAL SYNDROME	0.000541419	0.020311956543392472
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.020311956543392472
PFEIFFER SYNDROME TYPE 3	0.000541419	0.020311956543392472
ASPARTYLGLUCOSAMINURIA	0.000541419	0.020311956543392472
CRYPTOCOCCOSIS	0.000541419	0.020311956543392472
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000541419	0.020311956543392472
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020311956543392472
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392472
DIAMINOPENTANURIA	0.000541419	0.020311956543392472
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020311956543392472
CRISPONI SYNDROME	0.000541419	0.020311956543392472
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.020311956543392472
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.020311956543392472
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.020311956543392472
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020311956543392472
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392472
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392472
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.020311956543392472
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.000541419	0.020311956543392472
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.020311956543392472
SYSTEMIC SCLEROSIS	0.000541419	0.020311956543392472
CADASIL	0.000541419	0.020311956543392472
BETA-KETOTHIOLASE DEFICIENCY	0.000541419	0.020311956543392472
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.020311956543392472
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.020311956543392472
NASU-HAKOLA DISEASE	0.000541419	0.020311956543392472
TAKAYASU ARTERITIS	0.000541419	0.020311956543392472
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.020311956543392472
HYPERLYSINEMIA, TYPE I	0.000541419	0.020311956543392472
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.020311956543392472
MERCURY POISONING	0.000541419	0.020311956543392472
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020311956543392472
1P36 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
2Q33.1 DELETION SYNDROME	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.000541419	0.020311956543392472
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.020311956543392472
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.020311956543392472
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.020311956543392472
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.020311956543392472
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020311956543392472
NIPAH VIRUS DISEASE	0.000541419	0.020311956543392472
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.020311956543392472
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.020311956543392472
LYNCH SYNDROME	0.000541419	0.020311956543392472
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.020311956543392472
LUJO HEMORRHAGIC FEVER	0.000541419	0.020311956543392472
CEREBROTENDINOUS XANTHOMATOSIS	0.000541419	0.020311956543392472
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.020311956543392472
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.020311956543392472
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.020311956543392472
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.020311956543392472
SECONDARY SYRINGOMYELIA	0.000541419	0.020311956543392472
OROFACIODIGITAL SYNDROME TYPE 1	0.000541419	0.020311956543392472
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.020311956543392472
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.020311956543392472
FOUNTAIN SYNDROME	0.000541419	0.020311956543392472
EBOLA HEMORRHAGIC FEVER	0.000541419	0.020311956543392472
FAMILIAL DYSAUTONOMIA	0.000541419	0.020311956543392472
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.020311956543392472
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.020311956543392472
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392472
CYSTATHIONINURIA	0.000541419	0.020311956543392472
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020311956543392472
EPISODIC ATAXIA TYPE 6	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020311956543392472
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.020311956543392472
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.000541419	0.020311956543392472
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.020311956543392472
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020311956543392472
HYPERPROLINEMIA, TYPE II	0.000541419	0.020311956543392472
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020311956543392472
JUVENILE HUNTINGTON DISEASE	0.000541419	0.020311956543392472
CRIGLER-NAJJAR SYNDROME	0.000541419	0.020311956543392472
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.020311956543392472
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.020311956543392472
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000541419	0.020311956543392472
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.020311956543392472
HENNEKAM SYNDROME	0.000541419	0.020311956543392472
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020311956543392472
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.020311956543392472
SNEDDON SYNDROME	0.000541419	0.020311956543392472
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392472
PROLACTINOMA	0.000541419	0.020311956543392472
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.020311956543392472
SPONTANEOUS PERIODIC HYPOTHERMIA	0.000541419	0.020311956543392472
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.020311956543392472
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020311956543392472
PORENCEPHALY	0.000541419	0.020311956543392472
PARIETAL FORAMINA	0.000541419	0.020311956543392472
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.020311956543392472
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.020311956543392472
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.020311956543392472
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020311956543392472
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.020311956543392472
INSULINOMA	0.000541419	0.020311956543392472
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.020311956543392472
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020311956543392472
CHOREOACANTHOCYTOSIS	0.000541419	0.020311956543392472
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020311956543392472
CRONKHITE-CANADA SYNDROME	0.000541419	0.020311956543392472
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.020311956543392472
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020311956543392472
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.020311956543392472
FRONTAL ENCEPHALOCELE	0.000541419	0.020311956543392472
NOCARDIOSIS	0.000541419	0.020311956543392472
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.020311956543392472
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.020311956543392472
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.020311956543392472
MOYAMOYA DISEASE	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.020311956543392472
DARIER-WHITE DISEASE; DAR	0.000541419	0.020311956543392472
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392472
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020311956543392472
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.020311956543392472
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.020311956543392472
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392472
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020311956543392472
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.020311956543392472
ROSAÏ-DORFMAN DISEASE	0.000541419	0.020311956543392472
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020311956543392472
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.020311956543392472
MICROSPORIDIOSIS	0.000541419	0.020311956543392472
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020311956543392472
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.020311956543392472
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.020311956543392472
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.020311956543392472
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.000541419	0.020311956543392472
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.000541419	0.020311956543392472
ALEXANDER DISEASE	0.000541419	0.020311956543392472
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.000541419	0.020311956543392472
EPENDYMOMA	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.020311956543392472
SUBEPENDYMOMA	0.000541419	0.020311956543392472
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.020311956543392472
PINEOBLASTOMA	0.000541419	0.020311956543392472
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020311956543392472
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.020311956543392472
PARTINGTON SYNDROME	0.000541419	0.020311956543392472
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.020311956543392472
FLYNN-AIRD SYNDROME	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
EPILEPSY, READING	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.020311956543392472
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.020311956543392472
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020311956543392472
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.020311956543392472
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020311956543392472
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.020311956543392472
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.020311956543392472
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.020311956543392472
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.020311956543392472
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020311956543392472
PORPHYRIA	0.000541419	0.020311956543392472
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.020311956543392472
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020311956543392472
GURRIERI SYNDROME	0.000541419	0.020311956543392472
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.020311956543392472
POTOCKI-SHAFFER SYNDROME	0.000541419	0.020311956543392472
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392472
RABIES	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.020311956543392472
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.020311956543392472
EPISODIC ATAXIA TYPE 3	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020311956543392472
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392472
CLARK-BARAITSER SYNDROME	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.020311956543392472
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020311956543392472
FAMILIAL COLORECTAL CANCER TYPE X	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.020311956543392472
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.020311956543392472
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 47	0.000541419	0.020311956543392472
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.020311956543392472
FABRY DISEASE	0.000541419	0.020311956543392472
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.020311956543392472
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.020311956543392472
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.020311956543392472
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.020311956543392472
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.020311956543392472
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020311956543392472
KUFOR-RAKEB SYNDROME	0.000541419	0.020311956543392472
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020311956543392472
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020311956543392472
LIPOID PROTEINOSIS	0.000541419	0.020311956543392472
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.020311956543392472
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000541419	0.020311956543392472
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020311956543392472
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.020311956543392472
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.020311956543392472
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.020311956543392472
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000541419	0.020311956543392472
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.020311956543392472
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.020311956543392472
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.020311956543392472
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.020311956543392472
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392472
CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392472
ALZHEIMER DISEASE 3; AD	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.020311956543392472
MYASTHENIA GRAVIS	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.020311956543392472
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.020311956543392472
WHIM SYNDROME	0.000541419	0.020311956543392472
RECURRENT ACUTE PANCREATITIS	0.000541419	0.020311956543392472
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020311956543392472
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020311956543392472
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.020311956543392472
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000541419	0.020311956543392472
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.020311956543392472
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.020311956543392472
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.020311956543392472
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.020311956543392472
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020311956543392472
EPISODIC ATAXIA, TYPE 6	0.000541419	0.020311956543392472
CRANIOSYNOSTOSIS 2	0.000541419	0.020311956543392472
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020311956543392472
ONDINE SYNDROME	0.000541419	0.020311956543392472
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020311956543392472
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020311956543392472
LHERMITTE-DUCLOS DISEASE	0.000541419	0.020311956543392472
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020311956543392472
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.020311956543392472
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.020311956543392472
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.020311956543392472
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.020311956543392472
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392472
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020311956543392472
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020311956543392472
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020311956543392472
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020311956543392472
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000541419	0.020311956543392472
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020311956543392472
GLIOBLASTOMA	0.000541419	0.020311956543392472
NEURAMINIDASE DEFICIENCY	0.000541419	0.020311956543392472
FETAL GAUCHER DISEASE	0.000541419	0.020311956543392472
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020311956543392472
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.020311956543392472
ADIPOSIS DOLOROSA	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.020311956543392472
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020311956543392472
WHIPPLE DISEASE	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.020311956543392472
BETA-MANNOSIDOSIS	0.000541419	0.020311956543392472
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020311956543392472
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.020311956543392472
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020311956543392472
THYROCEREBRORENAL SYNDROME	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020311956543392472
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.020311956543392472
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020311956543392472
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000541419	0.020311956543392472
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.020311956543392472
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.020311956543392472
KIFAFA SEIZURE DISORDER	0.000541419	0.020311956543392472
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.020311956543392472
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.020311956543392472
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000541419	0.020311956543392472
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.020311956543392472
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.000541419	0.020311956543392472
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.020311956543392472
ADRENOLEUKODYSTROPHY	0.000541419	0.020311956543392472
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.020311956543392472
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.020311956543392472
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020311956543392472
HYPERPROLINEMIA TYPE 1	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.020311956543392472
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.020311956543392472
ALG9-CDG	0.000541419	0.020311956543392472
ALG2-CDG	0.000541419	0.020311956543392472
GRISCELLI SYNDROME TYPE 2	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.020311956543392472
MPDU1-CDG	0.000541419	0.020311956543392472
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.020311956543392472
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.000541419	0.020311956543392472
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.020311956543392472
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020311956543392472
ATKIN-FLAITZ SYNDROME	0.000541419	0.020311956543392472
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.020311956543392472
PORPHYRIA VARIEGATA	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.020311956543392472
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.020311956543392472
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392472
ENCEPHALITIS LETHARGICA	0.000541419	0.020311956543392472
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392472
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392472
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020311956543392472
SCRUB TYPHUS	0.000541419	0.020311956543392472
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020311956543392472
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020311956543392472
SNEDDON SYNDROME	0.000541419	0.020311956543392472
THYROCEREBRORETINAL SYNDROME	0.000541419	0.020311956543392472
CLASSIC HOMOCYSTINURIA	0.000541419	0.020311956543392472
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020311956543392472
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.020311956543392472
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.020311956543392472
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.020311956543392472
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.020311956543392472
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.020311956543392472
SCLERODERMA	0.000541419	0.020311956543392472
TAY-SACHS DISEASE; TSD	0.000541419	0.020311956543392472
THREONINEMIA	0.000541419	0.020311956543392472
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.020311956543392472
